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ABSTRACT 
Metal nanoparticles (NPs) such as gold (AuNP), silver (AgNP), and zinc oxide (ZnONP) 
demonstrate variety of applications including drug delivery, imaging, nanomedicine, and 
sensing. However, many of their applications involve biological systems, which might trigger 
their interaction with various biomolecules such as proteins. Proteins are highly sensitive to 
various stresses and ligand interaction due to the intimate correlation of their structure with 
biological function. Moreover, it is also a well-known fact that protein misfolding and 
aggregation process is the prime cause of a number of neurodegenerative disorders like 
Alzheimer’s disease, Parkinson disease, Prion disease, etc. The interaction of NP with the 
proteins can cause the change of structure as well as the function of proteins and can generate 
a new identity such as ‘nanoparticle-protein’ complex.  
Here, in our present study, we investigated the interaction of two small homologous proteins: 
bovine α-lactalbumin (BLA) and hen egg white lysozyme (HEWL) with three different 
nanoparticles (AuNP, AgNP, ZnONP) in vitro. The structure, function, stability and amyloid 
forming propensity of the proteins were studied during the interaction with three different NPs 
using various spectroscopic and microscopic techniques. We synthesized NPs by chemical as 
well as semi-green methods using non-toxic materials such as starch, PEG, and NaOH with 
precursor salts with a size of below 20 nm. Moreover, we synthesized the self-assembly of 
ZnONP of an average size of 163 nm. The NPs were further characterized using field emission 
scanning electron microscopy (FESEM), transmission electron microscopy (TEM), X-ray 
diffraction (XRD) as well as dynamic light scattering (DLS) zeta sizer for the analysis of size 
and shape and stability of NP. 
The conformational change of proteins, due to the interaction of NP with proteins was analyzed 
by fluorescence as well as circular dichroism (CD) spectroscopy. The fluorescence 
spectroscopic analysis showed quenching of Trp fluorescence as well as a shift in emission 
peak. This fact indirectly confirmed the alteration of protein structure to a different extent. The 
CD spectroscopy of BLA and HEWL revealed a drastic alteration of β-sheet as well as α-helix 
contents substantially during their interaction with NP. Further, DLS and FESEM analysis 
 iii 
 
showed that BLA and HEWL both formed multilayer protein corona over NPs. The stability 
of both the proteins was analyzed under thermal, strong denaturant (GdnHCl) and Proteinase 
K stress. Protein in conjugation with AuNPST, AgNPST and ZnONPST showed alteration in 
susceptibility to Proteinase K, and stability in thermal as well as in presence of GdnHCl. This 
study proved that NP-protein interaction not only alters the structure and function of protein 
but also can alter its stability under stress condition.  
Further, we investigated the effect of three NPs in the amyloid growth of HEWL. We found 
that all three starch capped NP demonstrated dose-dependent inhibition of fibrillar amyloid 
formation. Further, the effect of capping agent on HEWL amyloid growth was also observed 
and revealed that PEGylation of AuNP and AgNP increased their amyloid inhibition potential, 
contrary to uncapped, and assembly of ZnONP. Moreover, we observed that all NPs prolonged 
the nucleation and shorten elongation phase of amyloid growth with reduction of amyloid 
amount. Further, we also evaluated the cellular toxicity of various amyloid samples in vitro. 
While amyloid demonstrated substantial cellular toxicity in two different cell lines, amyloid 
prepared in the presence of all three NP showed much reduced cellular toxicity in both mouse 
carcinoma (N2a) as well as human keratinocytes (HaCaT) cells. We also observed that 
inhibition of amyloid formation was effective when NP was administered during the nucleation 
phase and less effective duirng elongation as well as maturation phase.  
Therefore, from our study, we concluded that suitable tuning of core nanomaterial properties 
and surface capping could altered its interaction with proteins significantly, thus alter the 
structural and functional alteration of those proteins. Moreover, they also could inhibit amyloid 
forming inclination of proteins and thus might help to open a new avenue in the therapy in 
various neurodegenerative disorders. 
KEYWORDS: Lysozyme; bovine α-lactalbumin; conformational change; gold nanoparticles; 
silver nanoparticles; zinc oxide nanoparticles; amyloid; thioflavin-T; cellular toxicity. 
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CHAPTER 1 
INTRODUCTION 
Nanoparticles (NPs) attracted great interest in various research groups for exploring new 
biomedical, optical and electronic applications. The evolution of new properties at the 
nanoscale size and the increase in surface to volume ratio to make number of atoms available 
per unit surface for the reaction. Moreover, the tuning of optical, magnetic, electrical, and 
chemical properties of NP can be achieved by controlling size, shape, and surface 
functionalization of nanomaterials. These physical and chemical properties of NP showed 
numerous biological and non-biological applications. Among the inorganic NP, gold, silver, 
and zinc oxide NP exhibited great potential in the area of imaging [1-5], sensing [4, 6-10], drug 
delivery [11-14], and pharmaceuticals [15-19]. Since, their applications involve biological 
systems consisting of cells, tissues, and bio-molecules; it readily triggers the interaction 
between NP with biomolecules such as proteins, nucleic acid (DNA and RNA), lipids, and 
carbohydrates. However, the fate of these biomolecules after interaction with NPs such as 
proteins is not yet clear. 
It was already reported by various research groups that administration of NPs in the biological 
system causes the interaction of proteins with the surface of NPs and form protein corona (soft 
and hard) over NP surface [20-23]. Such interactions not only change the surface properties of 
NPs but can also change structure and function of proteins [23, 24]. It was also found that the 
effect of NPs on the biological system depends on material composition [25], size [26, 27], 
shape [28], surface functionality [29] and surface charge [30] of NPs. Moreover, during the 
use of NPs, various groups reported that the possible cause of side effect or toxicity produced 
in biological system is due to generation of reactive oxygen species (ROS) [31], release of 
active ions [32], and interaction with specific biomolecules [33], which collectively might alter 
the structure and function of biomolecules.  
To the best of our knowledge, all previous studies related to NP and protein interactions did 
not address the detailed study of few aspects such as the stability and fate of the protein present 
 2 
 
in the NP-protein conjugate with altered structure and function under various stress conditions 
like high temperature, denaturant, proteinase-K, etc. Moreover, the interaction was not studied 
with various NPs with different capping agents like starch, etc. Moreover, the detailed study 
of protein interaction with NP in self-assembly state, which usually achieved novel properties, 
was also not studied.  
Protein misfolding and aggregation process are few most important cellular phenomena that 
can change the structure and function of proteins and sometimes can cause a series of 
neurodegenerative disorders such as an Alzheimer’s disease [34], Parkinson’s disease [34, 35], 
Prion disease [36], etc. However, the role/effect of NPs on such aggregation or amyloid 
formation have not been studied in detail except few reports with some nanoparticles such as 
a copolymer, cerium oxide, quantum dots, carbon nanotubes, gold [37] and titanium dioxide 
[38], which enhanced the protein amyloid formation by reducing the nucleation phase of 
amyloids. In some other studies, functionalized gold nanoparticles [39-41] and iron oxide 
magnetic NP [42] showed inhibition of amyloid growth. Therefore, it was clear that the 
interaction of proteins with a nanomaterial could affect the amyloid formation and growth. 
From all the above reports, it was also concluded that the interaction of NP with proteins highly 
depends on its surface properties that further depends on the core material and its assembly, 
type of functional molecules present, its density [43], and type of proteins. However, it is 
important to analyze in detail on the effect of NP on the amyloid formation of proteins under 
varying core materials, doses, administration time, and surface capping of NPs.  
To address all these above issues, we synthesized gold (Au), silver (Ag), and zinc oxide (ZnO) 
NPs by using starch, and PEG as reducing as well as capping agent and NaOH as reaction 
accelerator and modifier. To study the NP-protein interaction, bovine α-lactalbumin (BLA) 
and hen egg lysozyme (HEWL) were used as model proteins. The conformational changes of 
proteins due to the interaction with AuNP, AgNP, and ZnONP were analyzed by fluorescence 
and circular dichroism (CD) spectroscopy. The effect of NPs on unfolding of protein in the 
presence of guanidine hydrochloride (GdnHCl) and heat was analyzed. The stability of protein 
in NP-protein conjugate to proteinase-K was also analyzed. The effect of NP on protein 
amyloid growth was also analyzed under various conditions by thioflavin-T fluorescence assay 
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and microscopic techniques such as AFM, FESEM, and TEM. Further, cellular toxicity of 
amyloid formed in the presence of different NPs was also analyzed in N2a (neuroblastoma 
cells of mice) and HaCaT cells (human keratinocytes) by MTT assay and compared. The 
mechanism of cellular toxicity was also studied and reported.  
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Metal-based nanoparticles (NP) and their Applications 
Noble metal nanoparticles created great interest in various areas of research due its optical 
[44], electronic [45], mechanical [46], cellular toxicity [47, 48]. Moreover, availability of 
simple synthesis method to tune the size and surface of NP make the metal based NP, a material 
of choice for various studies. Among these metal based NP such as gold (AuNP), silver 
(AgNP), zinc oxide (ZnONP) were few well studied NP for their various applications.  
2.1.1 Gold nanoparticle 
Due to excellent surface plasmon resonance and photoluminescence properties, gold 
nanoparticles (AuNP) has become the material of choice for various applications such as 
nanosensors [49], electronic devices [2], nanomedicine, drug delivery [4], and photothermal 
therapy. To synthesize such nanoparticles for different applications, a number of methods like 
chemical [50-52], physical, and green/ biomolecule based route [53-60] can be used to 
produce desired shape, size, surface functionality. Cui et al. [61] used AuNP and carbon 
nanosphere-based hybrid material for electrochemical immunoassay. Phadtare et al. [62] used 
AuNP shells with polyurethane microsphere core as an enzyme immobilization template. Due 
to non-toxic nature of AuNP, it is used for drug and gene delivery for treatment of various 
diseases [13]. Liu et al. [63] developed an one-step immunoassay for detection of cancer 
biomarker using AuNP. Kim et al. [64] synthesized the drug loaded aptamer-AuNP conjugates 
that can be used for CT imaging and treatment of prostate cancer. Due to excellent optical and 
electrical properties, AuNP can be used for photothermal therapy of cancer [65].  
 Lee et al. [66] reported the application of AuNP-DNA-based reversible network as a 
diagnosis tool that specifically attached to cell surface marker. Yehezkeli et al. [67] developed 
an electrode for glucose sensing and biofuel cell application. They engineered the AuNP 
surface using flavin-dependent glucose dehydrogenase for application. Guerrero et al. [68] 
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synthesized the AuNP labeled with 18F and conjugated with peptide for in vivo biomedical 
application. Yang et al. [69] used AuNP for label-free DNA detection by enhancing the charge 
transfer by it. Almeida et al. [70] used AuNP for delivery of peptide vaccine and observed the 
anti-tumor immune response in tumor models such as prophylactic and therapeutic tumor. 
Sinha et al. [71] used AuNP for enhancing the radiation-based damage to tumor cells in 
brachytherapy and observed the damage to tumor cells is increased due to AuNP 
administration. 
2.1.2 Silver nanoparticles 
Silver nanoparticle (AgNP) showed great potential as a broad spectrum antimicrobial agent 
[72-74]. Moreover, its optical properties also attracted the attention for various application 
such as SPR based sensor [75, 76], biomedical devices/ products [77-80], consumer products 
[81-83], and as an antimicrobial agent [84-87]. It was found that its properties can be 
manipulated by varying size [88], shape [89], surface properties [90, 91]. Moreover, the 
synthesis of AgNP can be performed by chemical, green and physical method for various 
applications such as fabrication of various biomedical and sensing devices [92]. Tai et al. [93] 
used AgNP for molecular imaging of cancer cells by generation of enhanced third harmonic 
plasmon resonance. AgNP has a very excellent antimicrobial property, which can be used to 
kill the many antibiotic resistance bacteria and fungus [73, 86]. Due to their excellent 
antimicrobial properties, AgNP can be used in developing polymeric, ceramic, and hybrid 
nanoparticle such as graphene oxide-AgNP based filter, which can be used for water 
purification [94-96]. Hence, AgNP has possible applications in pharmaceutical industry, water 
purification industry, and use in fabrication of various biomedical devices make a valuable NP 
for study. 
2.1.3 Zinc oxide nanoparticles  
Due to the unique properties of ZnONP such as wide band gap (3.37 eV), exciton binding 
energy (60 meV), it has been utilized in various fields of research such as electronics [36], 
sensing [37] and medicine [38, 4]. Various scientific groups have already developed ZnO 
nanostructure by mechanical [39], chemical [40], and green [41] method for different 
applications. Moreover, the properties of nanoparticle also vary with their size, shape, and 
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functionality. The various applications like solar cell, semiconductor based electronic devices 
and photocatalysis use larger particle assembly. Ansari et al. [97] used Concanavalin layered 
ZnONP for β-galactosidase immobilization and showed that immobilized enzyme showed 
more than 60% activity. Reddy et al. [98] observed that ZnONP showed toxicity against E. 
coli, S. aureus, and primary human cells. Vigneshwaran et al. [99] reported the synthesis of 
soluble starch capped ZnONP of more than 50 nm and showed the UV absorption potential of 
ZnONP when doped in cotton fibers. Moreover, ZnONP showed potential to selectively kill 
the cancer cells and can be used in drug delivery system [18]. Huang et al. [100] reported that 
ZnONP can be used as imaging tool during apoptosis process of cell. Yuan et al. [101] prepared 
the chitosan encapsulated ZnONP for drug delivery response in tumor cells while Nie et al. 
[102] used tetrapod shape nanosized ZnO for plasmid DNA delivery. Zhao et al. [103] 
developed enzyme biosensor by using ZnONP. Zhang et al. [104] reported that ZnO nanorods 
can be used for photodynamic therapy due to its excellent light absorption property.  
Therefore, broad applications of AuNP, AgNP, and ZnONP and reported cellular toxicity 
against various cells make them a suitable candidate for NP and biomolecule interaction study 
and possible side effects for developing safe and efficient NP based devices and therapies. 
2.2 Importance of structure, folding, and aggregation of proteins 
The 3D conformation and function of proteins are highly correlated with each other. Moreover, 
correct folding of a protein is essential to get the native structure and function of the protein 
[105]. However, misfolding of proteins due to internal and external factors causes protein 
aggregation [106]. Protein misfolding that produces cross β-sheet secondary structure causes 
assembly and deposition known as amyloid protein and causes amyloid-related disease [107-
111]. Therefore, understanding the protein structure, folding and aggregation process is very 
important to manipulate the protein structure and function as well as find therapeutic avenues 
in protein misfolding-related problem. However, study the protein structure using very large 
protein is very difficult due to multistep folding mechanism followed by larger protein and 
complex secondary and tertiary structure. Therefore, small globular proteins are suitable to 
understand the protein structure and folding mechanism before study such complex 
phenomenon with larger proteins. 
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Moreover, small proteins are ideal for the study of interfacial interaction, conformational 
changes, and folding study. Small proteins (<20 kDa) have a high surface to volume ratio that 
makes them highly reactive to environmental changes and interfacial interactions. Moreover, 
half of their surface may be covered by nonpolar side chains. Therefore, small protein such as 
α-lactalbumin, cytochrome-C, lysozyme can be selected as a model protein for the study of the 
interfacial phenomenon. Moreover, α-lactalbumin, lysozyme showed evolutionarily conserved 
sequences from prokaryotic to mammalian protein. Therefore, analyzing the effect of NP on 
these proteins from one organism can be used to predict the effect of tested NP on these 
proteins from other organism.  
Bovine α-lactalbumin (BLA) and hen white egg lysozyme (HEWL) were used as model 
protein, since the beginning of protein structure, and folding studies [112-116]. Due to their 
small size, well-known secondary structure and simple folding pathway make both the proteins 
an ideal choice for selecting as a model protein for understanding the protein folding pathway. 
Moreover, HEWL was also used as model protein for the study of the mechanism of amyloid 
formation [117] and effect of various molecules on amyloid formations to analyze the amyloid 
inhibition potential of tested molecules [118].  
Moreover, both proteins received utter importance in recent research due to their anti-
cancerous properties shown by a specific conformational state of the protein [119-123]. 
Therefore, use of these proteins might help to understand the effect of NP on protein structure, 
function, and stability in different conditions but also might create an opportunity to design 
NP surface to obtain the desired manipulation of protein structure in in vivo conditions, which 
can be utilized for the treatment of various diseases. 
2.3 Overview of nanoparticle-protein interaction 
Nanotechnology attracted the attention of different branches of sciences and engineering such 
as biomedical [124, 125], electronics, mechanical [126] for the development of nanomaterial-
based technologies. It involves fabrication of nanoparticles (NP) and exploration of their new 
physiochemical properties for various applications. Moreover, the primary interest of current 
research is focused on various biomedical applications of NP such as bioimaging [127], 
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sensing [128], drug delivery [129, 130], medicine [131], etc. Due to the small size and unique 
physical and chemical properties, NP can interact with cellular machinary [132] and can reach 
to the brain by crossing blood brain barrier [133]. Furthermore, the large-scale application of 
NP in a different area of research and industry causes direct or indirect exposure of NP to the 
biological systems and ultimately to biological fluids [134] and cells by different pathways 
such as oral, transdermal, pulmonary and intravenous (Figure 2.1). Therefore, active surface 
and novel properties at nanoscale provide opportunity as well as challenges regarding the 
assessment of nanotoxicity and safety of nanomaterials, which can be used to develop effective 
and safe nanomaterials for biological application [135, 136]. 
Moreover, the introduction of NP in biological system encounters a great identity crisis created 
by the interaction of nanoparticles (NP) and biomolecules (e.g. proteins, nucleic acid, 
carbohydrates, lipid and other natural molecules), which determines the biological distribution, 
cellular response and function of NP [22, 137-139]. Interestingly, NP interaction with 
biomolecules produces new responses, which is different from its bulk counterpart in similar 
conditions. Therefore, the new identity of NP depends on the outcome of interfacial interaction 
and biomolecular corona (e.g. protein) over NP surface. Hence, understanding of bio-nano 
interface become very important for biological applications of NP [140, 141]. Among 
biomolecular interaction study, protein interaction with NP surfaces created great interest due 
to the important role played by proteins in maintaining biological system. The study is more 
important due to the close correlation between protein structure and function and the active 
surface of NP might alter the structure and ultimately the function of proteins.  
2.2.1 Effect of NP shape 
The physiochemical properties of NP vary with variation in shape [44], which also determine 
the bio-nano interfacial response such as biomolecular interaction and protein corona 
formation over the surface, cellular uptake [142], and toxicity [88]. Therefore, NP with various 
shapes forms a different type of protein corona, which decides the biological identity of NP-
protein complex and responsible for a cellular response. For example, variation in the shape of 
gold NP from spherical to rod changed the cellular uptake [143].  
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Figure 2.1 The advantage and disadvantage of nanoparticle administration were shown. (reproduced 
under the creative common licences) [144]. 
It was observed that cellular toxicity was also altered by variation in the shape of NP; for 
example, iron oxide nanorods showed higher toxicity than spherical particles [145]. Therefore, 
it is very important to analyze the effect of the different shape of NP on protein structure and 
function.  
2.2.2 Effect of NP size:  
The variation in size also changes the curvature of NP, which plays an important role in 
adsorption and conformational alteration in proteins. It was observed that various size of gold 
NP also determined the affinity and thickness of adsorbed protein on NP surface [146]. 
Moreover, some other reports showed that binding constant of protein to gold nanoparticles 
(AuNP) increased with increasing the size from 2-70 nm for Herceptin capped AuNP and 2-
20 nm for citrate-capped AuNP. It was also reported that binding cooperativity of NP-protein 
interaction depends on the pair of NP and protein; for example human serum albumin (HSA), 
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fibrinogen, histone, and γ-globulin proteins showed anticooperative interaction with AuNP 
while the contrary effect was observed with insulin. Another study with hydrophobic NP of 
different size showed that the amount of protein on NP surface depends on the size of NP 
[147]. It was observed that amount of surface coverage by protein is increased with increasing 
NP size while reducing the NP size from 200 to 70 nm also suppressed the protein adsorption. 
Klein et al. reported that reducing the curvature of NP also suppress the adsorption of certain 
proteins [139]. Hence, it is important to understand the effect of the different size of NP on the 
protein corona formation, structural as well as functional alteration.  
2.2.3 Effect of NP synthetic identity: 
The synthetic identity of NP plays an important role in cellular response and protein corona 
formation [148]. The reason is synthetic identity defined surface properties of NP and adsorbed 
ions and molecules on the surface. It includes the surface charge, surface smoothness/ 
roughness, hydrophilicity/ hydrophobicity, weak/ strong surface capping agent, surface 
functional groups, adsorbed ions or molecules from synthesis ingredient or by-product of 
synthesis. The surface charge of NP is an important factor in determining the composition of 
protein on NP surfaces. It was observed that some positively charged NP showed rapid removal 
from the excretory system due to the rapid interaction of opsonins with NP. Therefore, 
application of these NP is limited by its rapid removal in a biological system. There are high 
chances of absorption of reagents and by-product of synthesis on the NP surfaces. Even the 
use of various purification methods unable to completely remove the adsorbed molecules. 
Therefore, the biological response to these NP vary due to variation in chemicals used in the 
synthesis of NP and hence altered the outcome of same NP protein interaction and cellular 
response.  
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Figure 2.2 The relation between the different type of identity of NPs is shown. The synthetic identity 
includes structural and chemical identity, which link with the biological identity such as aggregation, 
interaction, and distribution of NP. The biological identity finally decides the physiological response 
of biological systems and biomolecules. (image is used under the copyright rule of RSC for the use of 
image in thesis) [149]. 
2.2.2 Effect of NP on protein aggregation and amyloid formation: 
The deposition of the ordered cross β-sheet structure of protein causes Alzheimer’s disease 
(AD), Parkinson’s disease (PD), type-2 diabetes, Creutzfeldt-Jakob disease, and mad cow 
disease and symptoms such as inflammation [74]. The primary treatment method for these 
diseased conditions is inhibition and defibrillation of cross β-sheet assembly. Moreover, the 
available therapeutics such as short peptides and antibodies faces in vivo obstacle such as 
blood-brain barrier (BBB), complex synthesis process. The advent of NP-based therapeutics 
created new hope due to their small size and ability to cross BBB [75], the flexibility of 
designing NP surface [76-78]. 
Although NP has already been shown various kinds of surface reaction with biological 
systems, the effect of NP on amyloid growth have not been explored in detail. The highly 
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active surface of nanomaterial and its unique physiochemical properties [62, 63] showed a new 
hope as well as a threat to the biological systems. Moreover, few in vitro studies demonstrated 
some NP such as a copolymer, cerium oxide, quantum dots, carbon nanotubes [66] and 
titanium dioxide [67] that enhanced the protein amyloid formation by reducing the nucleation 
phase of amyloids. In contrary, functionalized gold NP [68-70] and iron oxide, NP [71] 
demonstrated the inhibition of amyloid growth. Therefore, it was clear that interaction of 
proteins with a nanomaterial could affect the amyloid formation and growth. However, the 
toxicity and degradability of these NP in physiological condition have been a big concern. 
Although consequences of the interaction of NP with proteins highly depends on its surface 
properties that further depends on the core material and its assembly, type of functional 
molecules present and its density [72]. It has already been established that intermediate state 
of amyloid fibrillation such as protofibrils is more toxic than their mature fibrils [73]. 
Therefore, it is very important to understand the effect of NP on a different state of amyloid 
growth. Moreover, biocompatibility and physiological stability of NPs is another issue. 
However, the use of non-biodegradable, self-assembly of inorganic NP could act as a new 
therapeutic agent by surface functionalization, variation in shape and size. Tuning surface and 
structure reduce the in vivo toxicity and enhance the target-specific interaction. 
In this regards metal nanoparticle such as gold nanoparticle was used as a drug carrier [4], 
imaging [8], nano-sensing [12], and therapeutic agent [13], but existing report about its effect 
on the amyloid is controversial. It was reported that gold NP capped with citric acid inhibit the 
amyloid aggregation of bovine β-lactoglobulin [79], bovine insulin [80] but accelerate the 
growth of α-synuclein [81]. 
Moreover, bovine insulin fibrillation was inhibited by tryptophan and tyrosine capped AuNP 
and AgNP, while Aβ (1-42) fibrillation was inhibited by polymeric histidine, and Cys-PEP 
capped AuNP [82]. Further, some other studies reported that N-acetyl cysteine (NAC), and 
curcumin capped gold NP inhibit the amyloid growth [83]. Moreover, NAC [84], tyrosine, 
tryptophan, histidine [85] and curcumin [86] themselves showed inhibitory effect.  
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Table 2.1 The effect of different NP and their effect on amyloid fibrillation of different proteins. 
 
Class of NPs NPs Key findings Refer
ences 
 
 
 
 
Metal and 
Metal oxide 
NP 
CdTe N-acetyl cysteine-capped CdTe NP inhibit 
the Aβ(1-40) amyloid formation 
[41] 
AuNP Tryptophan and tyrosine capped NP inhibit 
the bovine insulin in vitro condition 
Histidine, polyacrylate capped AuNP 
inhibit Aβ(1-42) fibrillation 
[40, 
150] 
TiO2 Enhance the Aβ amyloid growth [38] 
ZrO2 No effect on the Aβ [38] 
CeO2 Enhance the formation of amyloid by β2-
microglobuline 
[37] 
SiO2 NO significant effect on fibril formation of 
Aβ 
[38] 
 
 
 
Carbon based 
NP 
Fullerene   Inhibit the Aβ formation by interaction 
with hydrophobic region of protein 
[151] 
C60 and C70 No significant effect on the Aβ amyloid 
fibrillation 
[38] 
Fluorinated carbon 
NP 
Inhibit peptide fibrillation by enhancing α-
helical content 
[152] 
 
 
 
 
 
Polymer NP 
 (NIPAM)/  
(BAM) copolymer 
nanoparticle  
Acceleration of β2-microglobulin amyloid 
formation by reducing nucleation time 
With Aβ and IAPP retard the amyloid 
growth by delaying nucleation 
[37, 
153] 
Amino-Modified 
Polystyrene NP  
 
 The NP showed a dual effect against Aβ. 
At low protein, to NP ratio amyloid growth 
increased by reducing lag phase time and at 
high ratio showed inhibition of amyloid 
formation 
[154] 
Hydrophobic 
Dipeptide capped 
polyA-FF-ME 
Slow down the transition of α-helix to β-
sheet in Aβ40 during amyloid growth 
[155] 
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CHAPTER 3 
OBJECTIVES AND SCOPE 
The main aim of the current Ph.D. thesis was to study the effect of three metal-based 
nanoparticles; gold (AuNP) silver (AgNP) and zinc oxide (ZnONP) on the structure, function 
and amyloid growth of two small monomeric proteins upon their interaction. To achieve the 
aim following objectives were set: 
1. Synthesis of gold, silver, and zinc oxide nanoparticles (NPs) by chemical as well as 
semi-green method, and their characterization with regard to their size, shape, and 
stability. 
2. To study the formation and characterization of NP-protein conjugate in relation to the 
structure, function and the stability of the proteins under various stresses.  
3. To study the role of nanoparticles on amyloid fibrillation process of hen egg white 
lysozyme under various condition. 
4. To assess the cytotoxicity of amyloid prepared under various conditions and the 
mechanism of the cytotoxicity in two cell lines. 
 
Scope of the work: 
Nanoparticle (NP) interaction with proteins in a biological fluid is an unavoidable 
phenomenon. Moreover, the use of toxic chemicals in NP synthesis can act as a denaturant to 
many biomolecules including proteins, which makes this condition more severe. Hence, the 
focus has shifted to synthesize of biocompatible NPs using biomolecules as a capping agent. 
However, biomedical application of these NPs also requires detail characterization and 
understanding of their interaction with biomolecules such as proteins and subsequent possible 
side effects.  
The current research work on the interaction of metal-based NPs (gold, silver, and zinc oxide) 
with model proteins (bovine α-lactalbumin, and hen egg white lysozyme) under different 
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conditions has utter importance. In our work, we reported protein corona formation over NPs 
after their interaction. The structure, function, and stability of the protein during interaction 
(corona) might be changed, which could lead to substantial side effect to the biological system. 
Since metal nanoparticles are commonly used in various applications including biomedical 
areas, such kind of study must have utter importance. Therefore, understanding the 
characteristics of protein-NP interaction will be highly helpful to design and develop of 
suitable NPs that might cause the little or insignificant change to a protein during their 
interaction. Moreover, protein misfolding and aggregation process sometimes lead to form 
amyloid, which is indeed the prime cause of many neurodegenerations such as Alzheimer’s 
disease, Parkinson’s disease, Prion disease, etc. The interaction of NPs with proteins in relation 
to the amyloid formation propensity of the protein is also of huge curiosity. Here, we also 
studied the amyloid formation and growth under NP-rich environment to observe their effect 
on fiber formation, the outcome of which indeed might help to develop appropriate measure 
against multiple neurodegeneration. 
Hence, in brief, understanding the role of NP on the structure, function, and stability of protein 
in solution can be used to design and develop a strategy for optimal use of NPs with least loss 
of protein’s inherent properties in various industrial applications. Moreover, the effect of 
metal-based NPs on the amyloid growth of proteins would provide an understanding of 
whether NPs based effective therapeutics strategy can be developed for various 
neurodegenerative disorders.  
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CHAPTER 4 
SYNTHESIS OF GOLD, SILVER, AND ZINC OXIDE 
NANOPARTICLE AND CHARACTERIZATION 
4.1 Materials and methods 
4.1.1 Materials  
HAuCl4.3H2O, AgNO3, and Zn(NO3)2.6H2O were purchased from Sigma-Aldrich. NaOH, 
polyethylene glycol (PEG-400) and starch were purchased from Himedia, India and used 
without further purification. All the plastic wares were purchased from Tarson, India and 
glassware were purchased from Borosil, India. Before use, glass wares were cleaned using 
aquaregia and Milli-Q water. Milli-Q water was used throughout the study. The solution was 
filtered using membrane filter 0.2 μm (Millipore, India). 
4.2 Synthesis of nanoparticles 
4.2.1 Synthesis of gold nanoparticle  
For the synthesis of AuNP, we prepared 1.0% (w/v) starch solution in Milli-Q water by heating 
in a microwave oven for 1 min. In the clear soluble starch solution, we added 1.0 mM 
HAuCl4.3H2O and heated at 70 ⁰C for 5.0 min with constant stirring. After heating, NaOH (6.0 
mM) solution was added to HAuCl4.3H2O solution within 2 min. The reaction proceeded for 
further 40 min and cooled down to room temperature (RT). The AuNP solution was kept in 
freeze at -20 ⁰C for 1 h and thawed. This process precipitated the excess starch along with 
large size AuNP. The solution was centrifuged at 10,000 rpm for 10 min and supernatant was 
separated. This process was repeated three times to get a clear AuNP solution. The various 
parameters like temperature (RT, 40, 50, 60, 70, and 80 ⁰C), concentration of HAuCl4.3H2O 
(0.2, 0.5, and 1.0 mM), NaOH (2.0, 3.0, 4.0, 5.0, 6.0, 7.0, 8.0, 10, 20, 50, and 100 mM), and 
starch (0.05, 0.1, 0.2, 0.5 1.0, 2.0, and 3.0% w/v) were optimized. We also synthesized the 
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polyethylene glycol (PEG) capped AuNP by using PEG (0.5% v/v) in place of starch in similar 
condition. 
4.2.2 Synthesis of silver nanoparticle 
Silver nanoparticle (AgNP) was synthesized by using AgNO3, starch and sodium hydroxide 
(NaOH) as a precursor of the reaction. The reaction was performed at RT, 50, 60, 70, 80 and 
90 0C, and boiling condition with 0.5 mM of AgNO3, 1% (w/v) starch, and 0.5 mM of NaOH. 
The solution was continuously stirred for 30 min to get a yellow color solution. The effect of 
different concentrations of NaOH (3.0, 4.0, 5.0, 6.0, and 7.0 mM) in AgNP synthesis with 1% 
starch and 0.5 mM AgNO3 at boiling condition was analyzed. Similarly, the different 
concentration of starch (0.2, 0.5, 1, and 2% w/v) was used with 0.5 mM AgNO3 and 5 mM of 
NaOH and reaction performed at boiling of solution for 20 min. In another experiment, the 
different concentrations of AgNO3 (0.2, and 0.5 mM) was used with 1% starch and 5 mM 
NaOH and reaction performed for 30 min by heating above 90 0C. The reaction temperature 
was optimized by performing reaction at 60, 70, and above 90 ⁰C (i.e. 95-100 ⁰C) condition. 
We also synthesized the polyethylene glycol (PEG) capped AgNP by using PEG (0.5% v/v) in 
place of starch in similar condition. 
4.2.3 Synthesis of zinc oxide nanoparticle 
We synthesized three different ZnONP (uncapped, starch capped, and larger assembly) by the 
wet chemical method. In brief, 1% (w/v) of starch was mixed with Milli-Q water to get a clear 
solution. Thereafter, 10.0 mM Zn(NO3)2.6H2O was incorporated in the starch solution and kept 
on a magnetic stirrer, and NaOH (20 mM) was added drop-wise while larger assembly of 
ZnONP synthesized by further heating at 60-65 ⁰C for 2.0 h with stirring. To, get uncapped 
ZnONP, the reaction was performed without starch. The white precipitate was produced and 
washed three times with distilled water and centrifuged at 10,000 rpm for 10 min to remove 
impurities. The precipitate was dried in vacuum and calcinated at 70 ⁰C for overnight. Dried 
powder was collected, and desired concentration of ZnONP was prepared by ultrasonication 
of the sample for 10 min. 
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4.3 Characterization of nanoparticles 
4.3.1 UV-VIS spectroscopic analysis 
The surface plasmon resonance (SPR) of AuNP, AgNP, and ZnONP were analyzed by UV-
VIS spectrophotometer (Perkin Elmer, λ-35). The sample was prepared in Milli-Q water (18 
mΩ) and scanned in the range of 200-700 nm, with a slit width of 2.0 nm and scanning speed 
of 100 nm/min.  All the spectra were baseline corrected and plotted against wavelength. 
4.3.2 Electron microscopy imaging 
The samples were diluted and prepared on a silicon wafer by drop casting method and dried in 
a vacuum drier. The dried samples were gold coated for 30 seconds and analyzed. In addition, 
to perform the TEM analysis, NP sample was diluted with Milli-Q water and deposited on a 
copper grid (300 mesh) by drop casting method and dried in the vacuum. Transmission electron 
microscopic analysis of NP sample was performed by TEM (Jeol, JEM-2100F). 
4.3.3 X-ray diffraction analysis 
All the samples were deposited on the quartz slide and dried in vacuum. The baseline correction 
of spectra was done using a quartz slide. The samples were analyzed using XRD (XRD 
ULTIMA-IV, Rigaku, Japan) in the range of 25-90⁰, with 2θ/min scanning speed (2θ is 
scattering angle) and 0.5⁰ step size. The peak position was matched using JCPDS  
card No. 040784 for gold, 040783 for silver, and 361451 for ZnO. The crystallite size of AuNP 
sample was analyzed using Scherrer’s equation: D = 0.94λ /β (1/2 Cosθ); where λ is the 
wavelength of X-ray (1.54 A), β is line broadening, θ is Bragg’s angle. 
4.3.4 Dynamic light scattering 
The hydrodynamic size of particles was measured with respect to number percent of 
nanoparticles by Zeta Sizer (Nano-ZS, Malvern pvt. Ltd.). Simultaneously, the stability of 
nanoparticles was analyzed by zeta potential analysis. Transparent samples were prepared in 
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Milli-Q water and analyzed. The data was analyzed using DTS 7.0 software provided by the 
company. 
4.3.5 FTIR analysis of modification in starch 
The structural modification in starch due to heating (60-80 ⁰C) and the presence of NaOH was 
monitored by FTIR spectroscopy (Alpha-series, Malvern). The analysis was performed in the 
range of 500-4000 cm-1 with 2 nm resolution and average of 25 scans was evaluated for various 
vibrational bond analyses. We compared the transmission mode of starch without modification 
and after the heat and NaOH treatment. The transmission data of all the samples were analyzed. 
The baseline correction was performed with respect to water. 
4.3.6 Analyzing the surface activity of NP 
We have further analyzed the surface activity of synthesized NP. The surface activity of AuNP 
was analyzed by its heavy metal sensing potential with different heavy metal by SPR shift 
analysis and variation in color. The colorimetric and SPR based heavy metal sensing was 
performed with copper (Cu2+), nickel (Ni2+), zinc (Zn2+), lead (Pb2+), mercury (Hg2+), and 
arsenic (As5+) in water using CuSO4, Ni (CH3COO)2 ·4H2O, ZnSO4 ·7H2O, Pb(CH3COO)2 · 
3H2O, HgSO4, and Na2HAsO4·7H2O. The experiment was performed using a different dilution 
of a transparent 200 ppm stock solution of the heavy metal compound in deionized water. 
Initially, 50 ppm of metal was mixed with 100 μM of AuNP solution and incubated for 2 h and 
analyzed the sample after every 10 min. Visible color change was monitored, and SPR was 
measured for all samples 
The surface activity of AgNP was analyzed by its heavy metal sensing potential was also 
analyzed for heavy metals (above mentioned). The surface activity of ZnONP was analyzed 
by its photocatalytic degradation of two dyes methyl green (MG) and rhodamine-B (Rho-B). 
To examine, the photocatalytic potential of ZnONP in methyl green (MG) and rhodamine-B 
(Rho-B) dye, 5 mg/ml of both the dyes was mixed with 0.5 mg/ml of ZnONP and incubated 
for 30 min at 25 ⁰C in the dark condition. These mixtures were further incubated for 12 h in 
the wavelength of 254 nm (UV-C), and the absorbance of the dye was measured at 0, 2 h, 4 h, 
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and 6 h, 8 h, 10 h interval up to 12 h. In addition, the baseline correction of the sample was 
done with respect to ZnONP. The absorption peak at 632 nm for MG and 554 nm for Rho-B 
plotted against time (h) and analyzed up to 12 h to get time-dependent photocatalytic 
degradation of the dye.  
4.4 Results and discussion 
To synthesize the AuNP, AgNP, and ZnONP of below 50 nm average sizes with variation in 
surface capping, we used different parameters such as variation in precursor concentration 
(NaOH, starch (0.1-2% w/v) and polyethylene glycol (0.5% v/v)), and reaction temperatures 
(50-1000 ⁰C). The excess starch was separated by maintaining the solution at -20 ⁰C for 1 h 
followed by thawing and centrifugation at 8,000 rpm for 10 min, while ZnONP solution was 
centrifuged and washed three times before calcination at 70 ⁰C. The effect of various 
parameters on the development of the desired size of NP was discussed below. 
4.4.1 Synthesis and characterization of AuNP 
To synthesize the AuNP of below 20 nm average sizes, we varied different parameters such as 
NaOH, starch, gold salt concentrations and reaction temperatures. The excess starch was 
separated by maintaining the solution at -20 ⁰C for 1 h followed by thawing and centrifugation 
at 10,000 rpm for 10 min. The effect of various parameters on the synthesis of AuNP was 
discussed in the following sections. 
4.4.2 Effect of NaOH concentration 
The different concentration of NaOH (2.0, 3.0, 4.0, 5.0, 6.0, 7.0, and 8.0 mM) with 1% starch 
(w/v) was used in the synthesis of AuNP when 1.0 mM of HAuCl4.3H2O was used as initial 
precursor concentration at 70 ⁰C (Figure 4.1). Here, we found that the use of increasing NaOH 
concentration like 2.0, 3.0, and 4.0 mM resulted in a gradual change in color from yellow to 
light black. However, when 5.0 mM NaOH was used, the solution color initially turned black. 
However, it turned dark ruby red after that. Further increasing of NaOH concentration to 6.0, 
7.0, and 8.0 mM revealed no further change of ruby red color, indicates that the use of NaOH 
above 5 mM had the ability to produce AuNP while increasing concentration speed up the 
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reaction rate. The SPR analysis also showed a red shift from 516 nm to 544 nm of an absorption 
peak that indicates the increased size of the particle (Figure 4.1 A). When we plotted the SPR 
shift with respect to NaOH concentration and interpolated it within the working range of NaOH 
concentration (See Appendix Figure S1. A), we found a redshift in SPR for NaOH 
concentration of below 5.0 mM while the use of 5.0 to 6 mM of NaOH showed blue SPR shift.  
Further increase of NaOH concentration, i.e., 7 and 8 mM showed slight red shift (Appendix 
Figure S1. A). The fact collectively proved that the synthesis of AuNP and reaction rate was 
dependent on NaOH concentration. However, below and above a range of critical value of 
NaOH concentration, the synthesis of AuNP either not significant (below 5.0 mM) or produced 
larger particles (above 8.0 mM) as shown by the variation in SPR shift and color change. It 
was found that the application of higher concentration of NaOH (i.e. above 8 mM) caused 
immediate color change and for 20 mM or above, the color turned from violet to black (see 
Appendix Figure S3. A). This indicates that the NaOH accelerates the synthesis of AuNP while 
higher concentration speeds up the growth and produce larger AuNP.  
The dynamic light scattering (DLS) analysis was also performed to analyze the hydrodynamic 
size of AuNP and examine the major population. The intensity of number percentage with size 
with peak width was analyzed (Figure 4.1 C). The results revealed that NaOH concentration 
was critical for the synthesis of a higher population of AuNP with less than 20 nm and low 
polydispersity. When NaOH concentration was below a critical value (i.e. less than 5 mM), the 
larger particle was produced while the increase of NaOH concentration to 6 mM synthesized 
AuNP with a smaller size (10-20 nm). To monitor the stability of the suspension, when zeta 
potential was measured, we found that the stability was highest at NaOH concentration of 5 
and 6 mM (-25 to -20 mV). Further increase of NaOH concentration, i.e., 7 and 8 mM produced 
AuNP of larger size, higher polydispersity and reduced stability (Appendix Figure S1. C).  
Therefore, the overall experimental results indicated that for obtaining reduced size with high 
stability, the critical concentration of NaOH was required. Dongxiang et al. [156] also reported 
the synthesis of AuNP of control size by varying pH using different concentration of NaOH 
and temperature. Goia and Matijevic reported that changing the pH alter the composition of 
gold (III) complex and this complex is very essential for formation of AuNP [157].  
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4.4.3 Effect of reaction temperature  
To understand the role of reaction temperature, we also performed the reaction at room 
temperature (RT i.e. 25 ⁰C), 50 ⁰C, 60 ⁰C, 70 ⁰C, and 80 ⁰C (Figure 4.1 B and D), when other 
parameters were constant (1.0 mM AuCl4, 1% starch, and 6 mM NaOH). When we performed 
the reaction at RT for overnight and below 50 ⁰C for more than 1.0 h, we found that the 
solution became transparent after addition of NaOH (6 mM), and no significant color change 
was observed. However, when the reaction was performed at 50 0C or above, the solution was 
initially found transparent, however, turned black thereafter, and finally turned ruby red after 
40 min of reaction, indicated the synthesis of AuNP (Figure 4.1 B). When we plotted the 
temperature against SPR peak, we found that below 60 ⁰C (i.e. RT and 50 ⁰C) and above 70 
⁰C (i.e. 80 ⁰C), the SPR peak showed redshift ( Appendix Figure S1. B) while reaction below 
the critical temperature (50 ⁰C) revealed slow reaction rate.  
However, when the reaction was performed at 80 ⁰C with NaOH (5-8 mM), 1% starch and 1 
mM of gold salt, the reaction rate became fast. It explains that the reaction requires minimum 
activation energy. However, the energy achieved was less by lower NaOH concentration ( 
below 10 mM) and hence the reaction needed to be performed above 50 ⁰C to overcome such 
threshold energy barrier. However, temperature above 80 ⁰C perhaps caused a rapid burst of 
the nucleus and uncontrolled growth of particles that consequently produced poly-dispersity. 
In fact, the above result was also supported by the analysis of hydrodynamic size distribution 
(Figure 4.1 D) and zeta potential (see appendix Figure S1. D) measurement of AuNP 
suspension. 
It showed that at a higher temperature (i.e. more than or at 80 ⁰C) larger particle was formed 
with less stability while in the range of 60-70 ⁰C more population of a smaller particle of 10-
20 nm mean size were formed with higher stability (Figure 4.1 D & appendix Figure S1. D). 
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Figure 4.1 (A) The effect of NaOH concentration (4, 5, 6, 7, and 8 mM) on AuNP synthesis. Here, 1.0 
mM HAuCl4.3H2O, 1% starch, and the 70 ⁰C reaction temperature was used. (B) The effect of reaction 
temperature on the surface plasmon resonance (SPR). (C) DLS analysis of the hydrodynamic size of 
AuNP with various concentration of NaOH. (D) The effect of reaction temperature (60, 70, and 80 ⁰C) 
in AuNP hydrodynamic size was analyzed by DLS particle size analysis.  
Mountrichas et al. [158] reported that nanoparticle synthesis rate increased with increasing 
temperature and produce more homogenous nanoparticles while Muridharan et al. [159] 
reported that nanoparticle size increases with increment of reaction temperature. Therefore, the 
reaction temperature plays crucial role in size control synthesis of gold nanoparticle. 
4.4.4 The effect of starch concentration 
Further, we wanted to know the role of starch in controlling AuNP size when other parameters 
were kept constant (1.0 mM of AuCl4, 6 mM of NaOH, and reaction temperature at 70 ⁰C). 
Figure 4.2 A and C, showed how the variation in starch concentration affects SPR and 
subsequently the size of NP, which was further confirmed by color variation and DLS data. 
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The SPR analysis also revealed that at a lower concentration, larger particles were synthesized 
(shown by violet color for 0.05 % starch concentration) (see appendix Figure S3. B). With the 
increase of starch concentration, i.e., from 0.1 to 3%. 
AuNP solution turned light to dark ruby red indicates a synthesis of small particles. When SPR 
was analyzed between starch concentrations of 0.05 to 3%, it showed initially a blue shift in 
SPR up to 0.2 % with an increase of SPR up to 1% of starch (Figure 4.2 A), However, it became 
constant thereafter i.e. till 3% (see appendix Figure S2. A) starch. A comparative study was 
performed using corn starch (0.2%) with the existing potato starch with and without D-glucose. 
It showed that corn starch-based synthesized AuNP without D-glucose showed relatively 
narrow SPR peak (see appendix Figure S3. C) than the synthesis method using D-glucose (see 
appendix Figure S3. D). This fact further validated that potato starch (reduction and capping) 
with NaOH for AuNP synthesis not only compatible with other starch but also eliminate the 
use of D-glucose in reduction process and other buffer ingredients to produce the smaller size 
of AuNP.  
Further, we also analyzed the hydrodynamic size distribution with different starch 
concentration (0.2-1%). The results showed that increasing starch concentration from 0.2-1% 
also decreased the size of AuNP and produced a higher percentage of small particles (Figure 
4.2 C). We also found that increasing starch concentration also increased the zeta potential of 
AuNP and stabilized the suspension up to 1% of starch (see appendix Figure S2. C). The initial 
shift of SPR was found up to 0.2% (shown by violet color for 0.05% and ruby red for 0.2%) 
of starch, but a further increase of starch produced a larger population of small particles. 
However, DLS analysis showed that slight red shift in SPR also indicated the presence of a 
higher concentration of surface capping species on the particles that caused a slight red shift. 
Moreover, the use of 1% to 3% starch demonstrated no significant shift in SPR, which 
indicated the saturation of AuNP for further interaction with available starch concentration. A 
further role of starch concentration was also observed during retrogradation of starch (see 
appendix Figure S6). We found that lower concentration of starch was unable to stabilize the 
AuNP during freezing and thawing and produced particle suspension with violet color due to 
aggregation. The Higher concentration, i.e., above 1% of starch, however, caused a higher 
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amount of AuNP precipitation with starch although color variation was not found. Shimmin et 
al. [160] prepared gold nanoparticle of different size by varying size and concentration of 
capping agent and reported that the size of nanoparticle decrease with increasing capping agent 
molecular weight while nanoparticle showed polydispersity with less amount of thiol rich 
capping agent. Therefore, the surface capping agent play crucial role in size control synthesis.  
4.4.5 The effect of gold chloride concentration  
The effect of various concentration of gold salts was also observed when other parameters were 
constant (1% starch, 6 mM of NaOH, and reaction temperature at 70 ⁰C). The results showed 
that SPR of various AuNP solutions varied with gold salt concentration exponentially (data 
below 0.5 mM and above 1 mM not shown). However, no significant change was found up to 
0.5 mM of gold salt (Appendix Figure S2. B). The DLS analysis showed that both 0.5 mM and 
1 mM concentration of gold salt produced AuNP of the equivalent hydrodynamic size of 10-
15 nm (Figure 4.2 D) with a slightly broad peak width for AuNP synthesized from 0.5 mM 
gold salt. The zeta potential analysis also showed no significant change in stability of AuNP, 
as both showed zeta potential of -20 eV (see appendix Figure S2. D). 
4.4.6 Electron microscopic analysis of AuNP 
FESEM analysis of AuNP under various conditions and TEM imaging of the AuNP sample 
with the optimum condition (1 mM of HAuCl4.3H2O, 6 mM of NaOH, 1% of starch) was 
performed (Figure 4.3 A-F). The results showed that AuNP synthesized from 0.5 mM of 
HAuCl4.3H2O contains smaller particles.  
 However, AuNPs synthesized by using 1.0 mM of HAuCl4.3H2O produced larger particles 
with less polydispersity (Figure 4.3 B). In both cases, 6.0 mM NaOH and 70 ⁰C reaction 
temperatures were used. However, when NaOH concentration was increased to 8.0 mM, the 
AuNP image revealed the formation of a large particle with high polydispersity and irregulars 
shape (Figure 4.3 C). When AuNP was prepared at high-temperature like 80 ⁰C, the process 
produced large particles with the spherical shape (Figure 4.3 D) and little polydispersity. 
Furthermore, a precipitate of starch with AuNP was also analyzed (Figure 4.3 E), which 
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showed large randomly distributed starch granule. The TEM analysis of optimized sample was 
performed (Figure 4.3 F). The TEM image revealed small AuNP of 7-10 nm size, which was 
in agreement with the results obtained from DLS analysis. 
 
 Figure 4.2 The effect of different concentration of starch (0.2-1%) and AuCl4 analyzed. (A) SPR 
analysis of AuNP with different starch concentrations. (B) hydrodynamic size of AuNP with increasing 
temperature was analyzed by DLS analysis (C) The effect of various concentration of gold salt (0.5-1 
mM) on the SPR. (D) DLS analysis of AuNP synthesized from 0.5 and 1.0 mM.  
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Figure 4.3 (A) & (B) AuNP synthesized from HAuCl4.3H2O (0.5 mM and 1.0 mM), 1% starch and 6 
mM NaOH at 70 ⁰C (C) HAuCl4.3H2O (1.0 mM), 1% starch and NaOH (8 mM) at 70⁰C (D) the sample 
with HAuCl4.3H2O (1.0 mM), 1% starch and NaOH (6 mM) at 80 °C; (E) AuNP-starch precipitate was 
observed under FESEM (Jeol) for analyze the morphology of samples. (F) The purified AuNP 
(HAuCl4.3H2O (1.0 mM), 1% starch and NaOH (6 mM) at 70 ⁰C) sample prepared on a copper grid 
and observed under transmission electron microscope. 
 4.4.7 FTIR analysis of starch 
To analyze the structural change in starch on the AuNP surface, we performed FTIR 
spectroscopy analysis. The structural changes and variation in bending of bonds due to heating 
and NaOH treatment were analyzed by FTIR spectroscopy in ATR mode. We found that short 
period of treatment of starch in microwave irradiation and further heating at 50 ⁰C or above 
with different concentration of NaOH caused a structural modification in starch. FTIR analysis 
of native starch demonstrated no sharp peak, however, peaks between 907-1106 cm-1 showed 
crystalline nature of starch with water content and reduction in peak intensity indicate a 
reduction in crystalline nature (Figure 4.4). The peak between 1133-1158 cm-1 was of C-OH 
bond, 1347-1420 cm-1 of COO- group, 1425-1580 cm-1 of CH2 in aliphatic and 1582-1700 cm
-
1 was the peak of water and free OH group. The peak between 2743-3000 cm-1 represented 
CHO and CH3- a group with bending, 3515-3600 cm-1 of OH in alcohol . Starch with NaOH 
and heating resulted in reduced peak between 907-1106 cm-1 that indicated reduced crystalline 
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nature of starch (Figure 4.4 ). The peak between 2500-3100 cm-1 was found narrow, and other 
peaks between 3200-3800 cm-1 either were less intense or missing (Figure 4.4) . Here, we 
conclude that treatment of starch with mild alkali and heating perhaps modified the structure 
of starch molecules, which were perhaps responsible for the active nature of starch in 
nanoparticles. Further, we also analyzed the effect of various conditions for starch solubility 
to heat and analyzed by FTIR spectroscopy.  
 
Figure 4.4 FTIR analysis of native starch and starch in different conditions after treatment with heat 
(microwave and hot plate heating) and NaOH. 
4.4.8 X-Ray diffraction analysis 
XRD analysis was performed to observe the characteristic crystallite size and the effect of 
various parameters on the growth of AuNP crystallite size (Figure 4.5). The peak broadening 
and peak shift of nanostructure signified the decrease in the particle size. The data were 
analyzed by background subtraction and fitting of peaks. From Figure 4.5, we observed that 
the lattice points were located at 111, 200, 220, and 311 positions with some peak shift and 
peak broadening. The lattice planes were matched with JCPDS card No 40784 [161], which 
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confirmed the face centered cubic structure of the sample. The peak broadening at various 
positions indicated the formation of AuNP. The sample with a different concentration of NaOH 
(5, 6, 8 mM) showed peak broadening which varies with the concentration of NaOH (Figure 
4.5 A, C, and H) and showed crystallite size of 13.76, 7.95, and 14.56 nm, respectively. 
Moreover, we also analyzed the effect of various temperatures (60, 70, and 80 ⁰C) on the AuNP 
crystallite size (Figure 4.5 C, D, and E) that showed crystallite size of 8.68, 7.95, and 18.62 
nm, respectively. We found that AuNP produced at higher temperature demonstrated narrow 
peaks, which signified the synthesis of larger particles.  
Furthermore, we also analyzed the effect of various concentration of starch (0.5, 1, 2%) (Figure 
4.5 C, F, and G) which showed AuNP crystallite of 6.84, 7.95, and 7.55 nm, respectively and 
gold salt (0.5, and 1 mM) (Figure 4.5 B and C) that showed AuNP crystallite size of 7.16, and 
7.95, respectively. We observed that increase in the concentration of starch to 2% reduced the 
intensity of the peak at 200, while variation in gold salt concentration showed little shift in a 
peak at (200) and reduced intensity of the peak at (220), and (311). The crystallite size of AuNP 
samples were analyzed using Scherrer’s formula: D = 0.94λ /β (1/2 Cosθ); where λ is the 
wavelength of X-ray (1.54 A), β is line broadening, θ is Bragg’s angle. The peak at 38⁰, 44⁰, 
64⁰, and 77⁰ was used, and an average of crystallite size (nm) obtained by analysis of all four 
peaks was represented. 
The effect of various parameters on the characteristic peak intensity and broadening was 
analyzed. Accordingly, we proposed a mechanism of AuNP synthesis involving heat-mediated 
modification of starch in the presence of NaOH. Initially, when starch was heated, it caused 
the starch structure to open (amylose and amylopectin) while the addition of NaOH by 
alkalization of hydroxyl group activated the starch molecule and produced reducing species. 
When gold salt was added to the activated starch solution, excess NaOH first reacted with gold 
salt to produce hydroxyl intermediate Au(OH)x which further reacted the reducing species of 
the starch molecule and produced AuNP nucleus. AuNP nucleus was grown further to produce 
AuNP. When excess NaOH was added with heating, it produced a higher order of Au(OH)x 
that caused rapid growth and production of large particles. At low temperature, the generation 
rate of the nucleus was slow and required a larger amount of NaOH for starch modification 
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while heating with various concentration of NaOH (5-8 mM) rapidly produced the reducing 
species. Moreover, unreduced starch acted as a capping agent and prevented the production of 
larger particles due to heating. 
 
Figure 4.5 X-Ray diffraction spectra of various AuNP samples and crystallite size of respective 
samples.  
However, heating with a higher concentration of NaOH reduced to a great extent and hence 
less amount of unreduced starch was present for capping. Ji et al. [156] and Zhang et al. [157] 
reported that reaction of NaOH with auric chloride produce intermediate gold hydroxide that 
causes conversion of yellow color to transparent and the order of hydroxide increased from 1.0 
to 4.0 with increasing the NaOH concentration. Moreover, higher order of Au(OH)x was 
responsible for the different redox potential and reduction rate of gold [162, 163]. The plausible 
reaction mechanism of AuNP synthesis was represented below while detail of reaction with 
hydroxyl intermediate formation and higher order of gold chloride hydroxide was given in 
supplementary information (see appendix data Section 4): 
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HAuCl
 4
 .3H
 2
O + NaOH
50-80  0C
Au (OH)
 x
+ Starch (reduced)
Au-Nucleus
Au-Nucleus + Au (OH)x +Starch AuNP (starch capped)
50-80  0C
50-80  0C
 
 Furthermore, the TEM, SPR, DLS, Zeta potential of optimized AuNP capped with starch and 
polyethylene glycol (PEG-400) shown below (Figure 4.6 A & B). The results showed the 
formation of 7-10 nm average size of both the NP with SPR peak at 521 nm and 526 nm (Figure 
4.6 C), respectively. Zeta potential analysis showed -26 mV and -16.5 mV, respectively (Figure 
4.7 D). The XRD analysis showed a characteristic peaks corresponding (111), (200), (220), 
and (311) with peak broadening signifies the formation of the nanoparticle. The crystallite size 
analysis by Scherr’s equation showed 6.8 and 6.6 nm for AuNPST and AuNPPEG, respectively 
(Figure 4.7 A & B).  
 
Figure 4.6 Electron microscopy images of (A) AuNPST and (B) AuNPPEG. (C) Surface plasmon 
resonance analysis of AuNP. (D) Zeta potential; (E) Hydrodynamic size distribution of AuNPST (15 
nm) and AuNPPEG (10 nm). 
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Figure 4.7 XRD analysis of (A) AuNPST and (B) AuNPPEG in the range of 25-90⁰. The data were 
processed, and Gaussian peak fitting was performed.  
4.5 Synthesis and characterization of AgNP 
The various parameters were optimized to synthesize the AgNP with least polydispersity, high 
stability, and size below 20 nm. The parameter such as the concentration of the reactant (i.e. 
starch, NaOH, and AgNO3), and temperature (RT, 60, 70, and 90 
0C) vary to produce AgNP. 
4.5.1 Effect of NaOH concentration 
The different concentration of NaOH (3.0, 4.0, 5.0, 6.0, and 7.0 mM) with 1% starch (w/v) 
was used in the synthesis of AgNP when 0.5 mM of silver nitrate (AgNO3) was used as initial 
precursor concentration and reaction temperature 90 ⁰C (Figure 4.8). We found that increasing 
NaOH concentration from 3.0 to 5.0 mM causes a gradual change in color from brownish to 
pale yellow. The appearance of brown color indicates the formation of silver oxide, which we 
observed by the formation of the brown color solution when the reaction was performed with 
(0.5 mM) AgNO3 and (5 mM) NaOH of without starch. However, when 6.0 mM NaOH was 
used, the solution color initially turned dark brown and finally changed to yellow. Further 
increasing of NaOH concentration to 7.0 mM revealed dark yellow color. This indicates that 
the use of NaOH above 4 mM showed the ability to completely convert silver nitrate to silver 
hydroxide to silver oxide, which was further converted to Ag in the presence of starch at  
90 ⁰C. Moreover, more AgNP was producing when we used NaOH concentration of 6, and 7 
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mM, which was shown by dark yellow color. However, when higher NaOH concentration was 
used dark yellow color was converted to dark brown that showed the synthesis of larger 
particle.  
The SPR analysis also showed a shift from 401 nm to 400 nm with enhancing absorption peak 
indicates forming of the smaller size of the particle in higher concentration (Figure 4.8 A). 
However, further increasing of NaOH concentration to 7 mM causes a red shift in SPR peak 
to 402 nm, indicates the formation of larger size particles. Moreover, SPR peak broadening 
was also found when we increase the NaOH concentration above 5 mM, indicates the increase 
in a polydispersity of AgNP. Below 3 mM of NaOH either brown color was found indicates 
the formation of silver oxide or insufficient conversion, because it was possible that NaOH 
was not sufficient to modify the starch with the conversion of AgNO3 to Ag(OH) to produce 
AgNP.  
This fact collectively indicated that NaOH has a crucial role in starch modification and 
formation of a silver intermediate compound that converted to silver and finally AgNP. 
Moreover, the lower concentration was insufficient to proceed reaction while a higher 
concentration of NaOH causes an uncontrolled reaction and larger particle synthesis, which 
signifies by the color change from yellow to brown. 
The dynamic light scattering (DLS) analysis and zeta potential analysis of AgNP was 
performed. The volume percent of the different size of AgNP in suspension with respect to 
hydrodynamic size was plotted. The intensity of mean number percent with respect to 
hydrodynamic size and peak width was analyzed (Figure 4.8 B). The results revealed that 
NaOH concentration was critical for the synthesis of a higher population of AgNP with less 
than 20 nm and low polydispersity. When NaOH concentration was below a critical value (i.e. 
less than 5 mM), the larger particles were produced. However, increasing NaOH concentration 
from 5 to 6 mM, it produced AgNP with a smaller size (10-20 nm). To monitor the stability of 
the suspension, when zeta potential was measured, we found that the stability was highest at 
NaOH concentration of 5 and 6 mM (-25 to -20 mV) (Figure 4.8 C). Therefore, the overall 
experimental results indicated that for obtaining reduced size with high stability, the critical 
concentration of NaOH was required. Nisimura et al. [164] reported that increasing NaOH play 
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crucial role in nucleation ionization rate of silver nanoparticle. In our study, we also observed 
that increasing NaOH increased the rate of AgNP synthesis.  
4.5.2 The effect of starch concentration 
Further, we wanted to know the role of starch in controlling AgNP size when other parameters 
were kept constant (1.0 mM AgNO3, 5 mM NaOH, and reaction temperature at 90 ⁰C). Figure 
4.9 showed that the variation in starch concentration also affects SPR and subsequently the 
size of NP, which was further confirmed by color variation and DLS data (Figure 4.9 A & B). 
The SPR analysis also revealed that at a lower concentration, larger particles was synthesized 
(shown by brown color for 0.2% starch concentration). With the increase of starch 
concentration i.e., from 0.2 to 3%, AgNP solution turned pale yellow from dark brown color, 
indicates the synthesis of AgNP. When SPR was analyzed between starch concentrations of 
0.2 to 2%, it showed a red shift in SPR for both lower (0.2%) and higher (2%) concentration 
of starch (Figure 4.9. A), However, SPR shift remained constant for 0.5, and 1% of starch 
(Figure 4.9. A).  
Further, we also analyzed the hydrodynamic size distribution of AgNP samples with different 
starch concentration (0.2-2%). The results showed that variation in starch concentration of 1.0, 
and 2% decreased the hydrodynamic size of AgNP while 0.2% and 0.5% starch produced 
larger particles (Figure 4.9 B). However, we also found that increasing starch concentration 
from 0.2% to 0.5% increased the zeta potential of AgNP from -12 mV to -26 mV, indicated 
higher stability while increasing the starch concentration to 1% and 2% decreased the zeta 
potential to -19 mV and -17 mV (Figure 4.9 C). 
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Figure 4.8 The effect of NaOH concentration (3, 4, 5, 6, and 7 mM) on AgNP synthesis. (A) SPR shift 
(B) hydrodynamic size of AgNP, (C) zeta potential analysis of AgNP.  
We found that both lower concentration (below 0.5% w/v) and higher concentration (above 
1% w/v) of starch was unable to stabilize the AgNP. Vigneshwar et al. [165] used starch as a 
reducing as well as capping agent in synthesis of AgNP in autoclave. Sharma et al. [166] in a 
review on green synthesis of AgNP also reported the role of starch as a capping agent. From 
these reports and our finding, it was observed that starch can be use as capping agent while 
modification of starch by chemical and physical method convert inert starch into active 
reducing agent. 
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Figure 4.9 The effect of starch concentration (0.2, 0.5, 1, 2% w/v) on AgNP synthesis. (A) SPR shift 
(B) hydrodynamic size of AgNP, (C) zeta potential analysis of AgNP.  
4.5.3 The effect of silver nitrate concentration 
The effect of various concentration of gold salts was also analyzed when other parameters were 
unchanged (1% starch, 5 mM NaOH, and reaction temperature at 90 ⁰C). The results showed 
that SPR of various AgNP solutions varied with AgNO3 concentration. It was observed that 
increasing silver salt concentration from 0.2 to 1 mM also enhanced the SPR peak significantly 
while at 0.2 mM concentration showed broad peak that signifies formation of polydispersed 
particles while higher concentration produced more amount of NP (Figure 4.10 A). Further, 
DLS analysis showed that 0.5 mM silver salt produced AgNP of the equivalent hydrodynamic 
size of 12-18 nm (Figure 4.10 B) with narrow peak while for 0.2 and 1 mM silver salt produced 
larger NP. The zeta potential analysis also showed the stability of AgNP was highest for 
following precursor composition and reaction temperature: 0. 5 mM AgNO3 with 1% starch, 5 
mM NaOH and 90 ⁰C. AgNP sample produces by using 0.5 mM silver salt showed zeta 
potential approximately of -24 mV (Figure 4.10 C). 
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Figure 4.10 The effect of AgNO3 concentration (0.2, 0.5, 1 mM) on AgNP synthesis. (A) SPR shift (B) 
hydrodynamic size of AgNP, (C) zeta potential analysis of AgNP.  
4.5.4 Effect of reaction temperature  
To understand the role of reaction temperature, we also performed the reaction at room 
temperature (RT i.e. 25 ⁰C), 60 ⁰C, 70 ⁰C, and 90 ⁰C (Figure 4.11 A, B, and C), when other 
parameters were constant (1.0 mM auric chloride, 1% starch, and 6 mM NaOH). When we 
performed the reaction at RT and below 50 ⁰C for more than 1.0 h, we found that the solution 
became transparent after addition of NaOH (5 mM), and become dark brown after 24 h of 
incubation. However, when the reaction was performed at 60 0C, and 70 0C, the solution was 
initially found transparent, however, turned light brown thereafter, indicated the synthesis of 
silver oxide (AgO2) (Figure 4.11. A).When we plotted the SPR, we found that at RT and below 
90 ⁰C , the SPR analysis showed broad peak and redshift in SPR (see appendix Figure 4.11 A) 
while reaction at 90-100 ⁰C showed the disappearance of brown color and formation of pale 
yellow color. The SPR analysis showed a narrow peak at 401 nm (Figure 4.11 A). DLS analysis 
showed a larger particle of more than 100 nm average size (Figure 4.11 B) with high 
polydispersity index.  
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 From here, it was observed that reaction below 90 ⁰C produced polydispersed NP, which 
contains both AgNP and AgO2 mixture. Therefore, it is essential to perform the reaction 
between 90-100 ⁰C to get smaller AgNP with less polydispersity. Moreover, zeta potential 
measurement of AgNP suspension showed that reaction at a higher temperature (i.e. 90-100 
⁰C) produced more stable AgNP (-24 mV) while reaction at lower  temperature formed a larger 
particle with less stability and more AgO2 (Figure 4.11 C). Jiang et al. [167] also reported that 
reaction temperature play crucial role in particle growth, shape, and size. The variation in 
reaction temperature influence the rate of the reaction and the particle size. Kasture et al. [168] 
reported that AgNP synthesis at lower temperature produce highly polydispersed nanoparticles 
while at higher temperature smaller nanoparticle with narrow size distribution. Therefore, these 
reports further verify our finding on AgNP synthesis. 
4.5.5 Electron microscopic analysis 
FESEM analysis of AgNP under various conditions and TEM imaging of the AgNP sample 
with the various condition was performed (Figure 4.12 A-F). We observed that AgNP 
synthesized using 0.5 % starch (other parameter remain constant e.g. AgNO3 (0.5 mM), 
temperature 90 ⁰C, 5 mM NaOH), produced larger particles with polydispersity (Figure 4.12 
A). The results showed that AgNP synthesized from 0.5 mM of AgNO3 contains smaller 
particles (Figure 4.12 B). However, when NaOH concentration was increased from 5 to 7.0 
mM, the AgNP image revealed the formation of large particles with high polydispersity and 
irregulars shape (Figure 4.12 C). When AgNP was prepared at lower temperature like RT 
(Figure 4.12 G), and 60 ⁰C (Figure 4.12 H), it produced larger particles while at reaction at 80 
⁰C produced more amount of small particles than larger aggregates (Figure 4.12 I).  
4.5.6 X-Ray diffraction analysis 
XRD analysis was performed to observe the characteristic crystallite size and the effect of 
various parameters on the growth of AgNP crystallite size (Figure 4.13). The peak broadening 
and peak shift of AgNP signified the decrease in the particle size to the nanoscale. The data 
were analyzed by background subtraction and fitting of peaks. From Figure 4.13, we observed 
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that the lattice plane were located at (111), (200), (220), (311) lattice positions with some peak 
shift and peak broadening. 
 
Figure 4.11 The effect of reaction temperature (room temperature (RT), 60, 70, and 90 ⁰C) on AgNP 
synthesis. (A) SPR shift (B) hydrodynamic size distribution, (C) zeta potential analysis of AgNP.  
These lattices were matched with JCPDS card No 40784, which confirmed the face centered 
cubic structure of the sample. The peak broadening at various positions indicated the formation 
of nanosize AgNP. The sample with a different concentration of NaOH (4, 5, and 7 mM) 
showed peak broadening which varies with the concentration of NaOH (Figure 4.13 A, D, & 
G) and showed crystallite size of 12.7, 9.3, and 15.67 nm, respectively. Moreover, we also 
analyzed the effect of various temperatures (70, 80, and 100 ⁰C) on the AgNP crystallite size 
(Figure 4.13 D, E, & F) that showed crystallite size of 13.17, 14.91, 9.3 nm, respectively. We 
found that AgNP produced at higher temperature demonstrated broad peaks, which signified 
the synthesis of smaller particles.  
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Figure 4.12 FE-SEM images of AgNP. Image (A) and (B) showed effect of NaOH (5, & 7 mM) 
concentration on AgNP. (C) and (D) showed effect of 0.5% and 2% starch, (A) and (E) showed 0.5, 
and 0.2 mM AgNO3. The effect of temperature on AgNP ((G) at 70 ⁰C, (H) 80 ⁰C, (I) 90 ⁰C showed 
the effect of temperature. 
Furthermore, we also analyzed the effect of various concentration of starch (0.5, and 1 %) 
(Figure 4.13 C & D) which showed AgNP crystallite size of 10.28, 9.3 nm, respectively and 
silver salt (Figure.4.13 B & D) (0.5, and 1 mM) that showed AgNP crystallite size of 10.66, 
and 9.3, respectively. The crystallite size of AgNP samples were analyzed using Scherrer’s 
formula: D = 0.94λ /β (1/2 Cosθ); where λ is the wavelength of X-ray (1.54 A), β is line 
broadening, θ is Bragg’s angle.  
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Figure 4.13 XRD analysis of AgNPST samples XRD scanning was performed in the range of 25-90⁰. 
We proposed a plausible mechanism of AgNP synthesis involving heat-mediated modification of starch 
in the presence of NaOH.  
AgNO 3 + NaOH
 60-100  0 C
+ Starch (reduced) Ag-Nucleus
Ag-Nucleus + Ag +Starch AgNP (starch capped)
 60-100  0 C
 60-100  0 C
 
Further, we also synthesized PEG capped AgNP of equivalent size by using 0.5% v/v PEG and 
by maintaining same reaction condition. The synthesized starch capped AgNP (AgNPST), and 
PEG capped AgNP (AgNPPEG) were observed by TEM imaging (Figure 4.14 A and B). SPR 
analysis showed that AgNPST and AgNPPEG showed SPR peak at 402 and 417 nm, respectably 
(Figure 4.14 C). 
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Figure 4.14 TEM images of (A) AgNPST and (B) AgNPPEG. (C) Surface plasmon resonance analysis 
of NP. (D) Zeta potential; (E) Hydrodynamic size distribution of AgNPPEG (10 nm) and AgNPST (15 
nm). 
The Zeta potential analysis showed that PEG capping increased the solution stability of AgNP 
(-34 mV) compared to starch capped AgNP (-24 mV) (Figure 4.14 D), while hydrodynamic 
size analysis showed the AgNPST size of 15 nm and AgNPPEG of 10 nm (Figure 4.14 E). XRD 
analysis of both the NP sample showed the peak broadening and crystallite size of 13.7 nm and 
9.09 nm, respectively (Figure 4.15 A & B), which also matched with the results of TEM and 
DLS 
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Figure 4.15 XRD analysis of AgNPST and AgNPPEG in the range of 25-90⁰. The data were processed, 
and Gaussian peak fitting was performed. (A) AgNPST sample, (B) AgNPST sample.  
4.7 Characterization of ZnONP 
The initial reaction was carried out at room temperature so that Zn (NO3)2.6H2O and NaOH 
reaction can be performed at a slow rate and resulted in the formation of Zn (OH)2. The heating 
of starch (amylose and amylopectin) at 60-65 ⁰C increase their solubility in water and expands 
the structure of amylopectin. Hence, we proposed here that the NP could assemble with 
expanded form of amylopectin of starch. We also used calcination temperature of 60, 70, and 
80 ⁰C for overnight with an aim to achieve a complete conversion of Zn(OH)2 to ZnO. 
4.6.1 UV-VIS spectroscopic analysis  
UV-VIS spectroscopy analysis of different ZnONP samples showed absorbance peak shift with 
varying starch concentration, calcination temperature, and Zn(NO3)2.6H2O concentration. 
ZnONP [10 mM Zn(NO3)2.6H2O] prepared with 0.5, 1, 2, and 3 % (w/v) starch showed 
absorbance peak at 384, 349, 358, and 360 nm, respectively (Figure 4.16 C). It showed that at 
low concentration of starch (0.5%), the amount of absorbed light was more compared to other 
samples (1%, 2%, and 3%). We also found that absorption peak of ZnONP prepared with 0.5% 
starch was broader compared to other samples. This fact indicated that varying starch 
concentration also affect the amount and wavelength of light absorbed by ZnONP. This may 
be due to more exposed surface of ZnONP than other samples.  
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Furthermore, when we analyzed the effect of calcination (Figure 4.16 B) temperature on the 
absorption spectra of ZnONP prepared with (50 mM) Zn(NO3)2.6H2O, it was found that 
calcination temperature of various sample also affects the amount and wavelength of light 
absorption and consequently the morphology and size of ZnONP. Goh et. al. [169] reported 
that UV absorption by ZnONP depends on the size of ZnONP. They observed that UV 
absorption of ZnONP increased with NP size, but larger NP showed a decrease in absorption. 
It was also observed that ZnONP prepared at a calcination temperature of 60 ⁰C showed no 
sharp absorbance peak while calcination at 70 ⁰C showed a peak at 359 nm. However, 
calcination at 80 ⁰C showed a blunt absorbance peak with maxima at 328 nm. Furthermore, 
the different concentration of Zn (NO3)2.6H2O like 5, 10, 20, and 50 mM was used with 1% 
starch, and the calcination process was performed at 70 ⁰C. These samples showed the 
absorbance at 352 nm, 349 nm, 358 nm, and 359 nm, respectively. Figure.4.16 A showed that 
the amount and wavelength of light absorbed by ZnONP also vary with zinc nitrate 
concentration. It indicated that size and surface of nanoparticle also vary with zinc nitrate used 
in the reaction, when other parameters were constant (i.e. 1% starch, and calcination at 70 ⁰C). 
The shift in the absorption peak signifies the change in particle size with varying concentration 
of starch (0.5-3%), zinc salt (5-50 mM) and calcination temperature [169]. It showed that low 
concentration of starch like 0.5 % (w/v) was unable to stop the growth of the particle and 
caused self-aggregation, but higher concentration caused absorption of excess starch on 
ZnONP surface and increased particle size (Figure 4.16 C). The reason may be the separation 
of the boundary between assembled particle and some shrinkage of starch at a higher 
temperature as well as evaporation of water that vary the size and surface morphology of the 
particles. The sample produced by calcination at 60 ⁰C showed no sharp peak, which may be 
due to the lower conversion rate of Zn (OH)2 to ZnONP and structural variations in ZnONP. 
Moreover, we have also calculated the energy of the absorption peak using equation E=hc/λ 
(Table.4.1).  
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Figure 4.16 UV/VIS spectra of ZnONP; (A) UV/VIS spectroscopic analysis of ZnONP synthesized 
with 1% (w/v) starch using 5-50 mM of Zn(NO3)2.6H2O and at a calcination temperature of 70 ⁰C; (B) 
UV/VIS spectra of ZnONP prepared with 1% (w/v) starch by using 50 mM of Zn(NO3)2.6H2O and 
calcination temperature of 60, 70, and 80 ⁰C. (C) UV/VIS spectra of ZnONP prepared with 0.5-3% 
(w/v) starch, 10 mM of Zn(NO3)2.6H2O and a calcination temperature of 70 ⁰C.  
4.6.2 Hydrodynamic size and stability analysis of ZnONP 
The hydrodynamic size and stability analysis of ZnONP suspension in water was studied using 
Malvern zeta sizer (ZS-Nano) (Figure 4.17). The effect of zinc salt, starch concentration, and 
calcination temperature on particle size was studied. When zinc nitrate concentration was 
increased from 5 mM to 10 mM with a starch concentration of 1% w/v and calcination 
temperature 70 ⁰C, hydrodynamic average size measured was 230 nm and 153 nm, 
respectively. When ZnONP sample was prepared using 50 mM zinc nitrate at a calcination 
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temperature of 80 ⁰C caused a reduction in the hydrodynamic size of the particle up to 143 nm 
with the broadening of peak and polydispersity. Moreover, the increasing starch concentration 
from 1%-3% (w/v) caused reduction of particle size with increased in the polydispersity. The 
result was further confirmed by the UV spectroscopic measurement.  
Table 4.1 The energy for respective wavelength of absorption maxima (E=hc/λ; h is plank constant, c 
is velocity of light, λ is wavelength of absorption maxima in nm) and crystallite size calculated by 
Scherrer method [(Dp=Kλ / β½ Cosθ), K= 0.94, λ is X-ray wavelength (1.54 nm), β is linear broadening 
in degree, θ is Bragg angle]. 
 
 
 
 
 
 
Zn(NO3)2.6H2O 
(mM) 
Calcination 
(⁰C) 
Starch 
(w/v)% 
Absorption 
maxima, nm  
(energy, eV) 
Crystallite size 
(nm) 
5 70 1.0 352 (3.52 eV) 9.4 
10 70 1.0 349 (3.55 eV) 8.3 
20 70 1.0 358 (3.46 eV) 8.6 
50 70 1.0 359 (3.45 eV) 8.9 
10 70 0.5 384 (3.23 eV) 7.3 
10 70 2.0 358 (3.46 eV) 7.8 
10 70 3.0 360 (3.44 eV) 10.1 
50 60 1.0 358 (3.46 eV) 7.8 
50 80 1.0 328 (3.78 eV) 9.5 
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When we analyzed the effect of size on the stability of particle by measuring zeta potential, 
ZnONP showed approximately -12 mV zeta potential value when prepared with 5 mM and 10 
mM zinc nitrate concentration. The sample calcinated at 80 ⁰C and with 3% starch showed -
10 mV zeta potential. The fact indicated that excess starch reduced the charge on the surface 
of the particle and hence, sample stability. Moreover, the results revealed that hydrodynamic 
size, polydispersity, and zeta potential were dependent on starch and zinc nitrate concentration. 
Further, it also showed a low level of polydispersity and high zeta potential for ZnONP, 
prepared with 10 mM zinc nitrate, 1% of starch and calcination temperature of 70 ⁰C. Such 
fact indicated that for a particular stoichiometry ratio of primary ZnONP and starch, ZnONP 
assembly was more homogenous and showed high stability. The reason may be the limited 
number of available sites in starch to accommodate the nanoparticles, which was synthesized 
due to the heating starch molecule. This fact also triggers the opening of amylopectin as flower 
or branch and interact using its own hydroxyl group with ZnONP during calcination and the 
reaction induces the self-assembly. 
 Furthermore, the zeta potential of various samples were plotted with respect to starch and 
Zn(NO3)2 concentration and calcination temperature (see appendix, Figure S8. A). It was 
observed that zeta potential of ZnONP was decreased from -12.5 mV to -8.0 mV when 
Zn(NO3)2 concentration was increased from 5 mM to 20 mM, however, further increasing of 
Zn(NO3)2 concentration to 50 mM showed zeta potential of -12.1 mV (see appendix Figure S8. 
B). Here, it was possible that when other parameters (starch 1%, and calcination 70 ⁰C) were 
constant the increasing concentration of Zn(NO3)2 also produced larger ZnONP while 
synthesis of a polydispersed particle in the case of 50 mM sample provide zeta potential of -
12.1 mV. When we have analyzed the effect of starch concentration on the zeta potential of 
ZnONP it was clearly shown that increasing starch concentration also decrease the zeta 
potential of the particle (see appendix Figure S8. C). It confirmed that starch act as a 
passivizing agent on the surface of ZnONP. Zeta potential of ZnONP (50 mM) samples 
prepared by calcination at 60, 70, and 80 ⁰C were also performed (see appendix Figure S8. D). 
The results showed calcination at 60 and 80 ⁰C causes a reduction in zeta potential of the 
nanoparticle. The reason may be variation in structure and surface morphology of ZnONP 
while NP prepared by calcination at 70 ⁰C showed zeta potential of 12.1 mV.  
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4.6.3 X-ray diffraction analysis 
X-Ray diffraction analysis revealed peak position of ZnONP crystal with a broadening in peak 
and intensity of different peak under varying parameter (Figure 4.18). Full width of half 
maxima (FWHM) value of each peak was calculated, and crystallite size of the nanostructure 
was determined using Scherrer equation (Table.4.1). 
 
Figure 4.17 DLS and zeta potential of a different aqueous solution of ZnONP. The size and stability 
of ZnONP under varying Zn(NO3)2.6H2O, starch concentration, and calcination temperature were 
analyzed. DLS analysis showed that the average hydrodynamic size of particles was more than 100 nm 
for all the cases.  
The peak position of each crystal was compared with JCPDS database. Here, we found that 
increasing starch concentration (0.5-3 %) caused narrowing the peaks, which signifies the fact 
that the increase of starch concentration could increase the size of ZnONP from 7.3 nm to 10 
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nm. However, the increase of Zn(NO3)2.6H2O concentration (10 mM) showed the formation 
of smaller crystallite size (8.3 nm) in comparison to other samples with different concentration 
(5, 20, 50 mM) of Zn (NO3)2.6H2O (Table.1). Here, we found that the use 10 mM of Zn (NO3)2 
showed smaller crystallite size than others. The lattice planes (100), (002), (101), (102), (110), 
(103), and (200) of all spectra matched with ZnO of JCPDS card NO 361451. Moreover, 
increased calcination temperature showed an increase of crystallite size from 7.8 to 9.5 nm. 
This fact further indicated the role of temperature and starch concentration on the growth of 
the particles. It was also found that the sample produced by using 5 mM and 20 mM of Zn 
(NO3)2.6H2O concentration and 0.5 and 3% starch concentration and with a calcination 
temperature of 80 ⁰C showed less intensity for (002)-lattice plane. The reduction of the aspect 
ratio of (002) to 101 in comparison to bulk form indicated the exposed surface of the crystallite 
[17]. It signifies that (002)-lattice plane exposed the surface of ZnO.  
 
Figure 4.18 XRD analysis of all ZnONP samples performed in the range of 25-90⁰. Baseline correction 
of obtained data was done and compared with ZnO crystal structure.  
4.6.4 Electron microscopy analysis 
The FESEM analysis of samples was prepared to observe the shape and size of the 
nanostructures. It revealed that the sample prepared with 10 mM Zn(NO3)2.6H2O showed 
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mono-dispersed self-assembled nanostructure with an average size of 100 nm, but other 
samples also showed larger size or nanostructure with less homogenous nature. The samples 
prepared with 5 mM of Zn(NO3)2 and 0.5% starch showed agglomeration of two assemblies. 
However, the samples prepared with 50 mM Zn(NO3)2 or 2%, or 3% starch showed 
heterogeneous population. From Figure 4.19, we found that the sample calcinated at 60 ⁰C 
showed cubic and random shape particles while both the samples calcinated at 80 ⁰C and 70 
⁰C showed particle population of small. However, the calcination at 80 ⁰C caused 
heterogeneous size distribution. FESEM analysis also supports the polydispersity and particle 
size results obtained by DLS analysis for both the ZnONP samples prepared using 3% starch 
and higher calcination temperature. Furthermore, we analyzed the primary particle of ZnONP 
that participate in self-assembly using TEM, which confirmed that the average size of the 
nanoparticle was 7 nm and shape of the particle was spherical in nature. 
Furthermore, the growth mechanism of ZnONP assembly was analyzed by collecting the 
sample at the interval of 0 h, 1 h (at Room temperature), 1h (at 60 ⁰C), 2h (at 60 ⁰C), and after 
calcination at 70 ⁰C. All the sample were deposited on silica wafer and analyzed by FESEM. 
The FESEM observation showed that at 0 h there were random large structures were deposited 
(Fig. 4.20 I), which was modified to a small particle-like structure after 1h of reaction at RT 
(Figure 4.20 II). When the reaction was further performed at 60 ⁰C (after 1 h), the randomly 
oriented branched structure was observed (Figure 4.20 III). Furthermore, the observation of 
sample after 2 h, the branched structures were showed now in spherical orientation (Figure 
4.20 IV). After completion of the reaction, the sample was centrifuged to obtain the precipitate, 
and the sample was calcinated at 70 ⁰C and observed by FESEM. The calcinated sample 
showed starched assembled ZnONP structure (Figure 4.20 V).  
From here, we can propose a growth mechanism of how ZnONP assembly was made. Starch 
is made up of amylose (20-30%, linear chain) and amylopectin (70-80%, branch chain). The 
chemical formula of amylopectin is C30H52O26 [linear bonding α(1→4) glycosidic bonds and 
Branching with α(1→6) bonds) and amylose is (C6H10O5)n [α(1→4) glycosidic bonds]. During 
the reaction Zn(NO3)2 was reduced to Zn(OH)2 particles. Further, the reaction temperature was 
increased to 60 ⁰C that causes the branched amylopectin to open like flower, which then 
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interacted with Zn(OH)2 particles. After completion of the reaction, the white gel was separated 
and calcinated at 70 ⁰C. The calcination process completely converts the Zn(OH)2 to ZnO and 
produces the self-assembled ZnONP structure. 
 
Figure 4.19 FESEM analysis of different samples. (A)-(C) ZnONP prepared with different 
concentration of Zn(NO3)2.6H2O like 5 mM, 10 mM, 50 mM with 1% (w/v) starch. (D)- (F) Sample 
prepared with 10 mM Zn(NO3)2.6H2O prepared with 0.5, 2, 3% (w/v) of starch and calcinated 
temperature of 70 ⁰C for overnight. (G)-(H) Samples prepared with 10 mM Zn(NO3)2.6H2O and 1% 
starch and calcination at 60 ⁰C, 80 ⁰C were shown. (I) Primary ZnONP of average size 7.0 nm analyzed 
by TEM analysis.  
Further, we also synthesized the starch capped ZnONP (ZnONPST) at room temperature using 
10 mM Zn(NO3)2.6H2O and 1% w/v starch. After 2 h of reaction, the sample was centrifuged 
at 8000 rpm for 10 min and washed three times. Similarly, uncapped ZnONP was also 
synthesized without starch in similar condition. All the ZnONP samples were calcinated at 70 
⁰C for overnight to convert Zn(OH)2 to ZnO. The electron microscopic study showed that 
ZnONPuncap, ZnONPST, and ZnONPassmb were spherical in shape (Figure 4.21 A, B, & C). 
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Figure 4.20 Time-dependent growth mechanism of ZnONP was analyzed using FESEM by collecting 
sample after 0 h, 1.0 h (RT), 1.0 h (at 60 ⁰C), and 2.0 h (at 60 ⁰C) and after calcination. (I) random 
structure of precursor molecules during 0 h. (II) embedded small particle on the starch surface after 1 
h reaction at RT. (III) showed branched amorphous structure randomly oriented after 1 h of reaction at 
60 ⁰C. (IV) Annular arrangement of branched structure after 2 h of reaction at 60 ⁰C. (V) Self-assembly 
of ZnONP after overnight calcination of the sample at 70 ⁰C. (see Appendix Figure S7). 
 Further, the DLS analysis showed that hydrodynamic size of ZnONPuncap was 12 nm, 
ZnONPST was 30 nm, and ZnONPassmb was 163 nm (Figure 4.21 D, E, and F). The zeta potential 
analysis showed ZnONPuncap value is -19 mV, ZnONPST is -29.8 mV, and ZnONPassmb is -15.2 
mV (Figure 4.21 G). Therefore, it was revealed that starch-based capping increased the 
stability of ZnONP while the formation of larger assembly reduced the stability. Zamiri et al. 
[170] and Becheri et al. [171] reported the starch capped ZnONP synthesis. The results showed 
that variation in starch concentration influence the size and stability of ZnONP. Therefore, 
starch play crucial role in size control synthesis of ZnONP.  
XRD analysis of these samples showed the characteristic peak for wurtzite crystal structure for 
ZnO. The crystallite size analysis by Scherr’s equation showed the crystallite size of 10.2 nm 
for ZnONPST, 13 nm for ZnONPuncap, and 7.10 nm for ZnONPassmb (Figure 4.22 A, B, & C).  
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Figure 4.21 Electron microscopy images of (A) ZnONPuncap, (B) ZnONPST and (C) ZnONPassmb. 
Hydrodynamic size distribution of (D) ZnONPuncap (15 nm), (E) ZnONPST (30 nm), and (F) ZnONPassmb 
(163 nm). (G) Zeta potential of ZnONPuncap, ZnONPST, and ZnONPassmb. 
The characterization of ZnONP showed that starch capped ZnONP produced less 
polydispersed NP of 30 nm size with higher stability, while NP produced by the formation of 
a larger assembly and without capping, were less stable in solution. 
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Figure 4.22 XRD analysis of (A) ZnONPST, (B) ZnONPuncap, and (C) ZnONPassmb in the range of 25-
90⁰ was performed. The data were processed, and Gaussian peak was fitted.  
4.6.5 Analyzing the surface activity of NP 
4.6.5.1 Heavy metal sensing 
The order to study surface the interaction of NP with proteins, it is required to conform the 
active surface properties of our synthesized NP. Hence, we wanted to evaluate the surface 
activity of our synthesized AuNPST and AgNPST (size 7-10 nm, Figure 3F) in the sensing of 
six heavy metals using optical properties (colorimetric and SPR). Colorimetric sensing and 
SPR analysis with 50 ppm of Cu2+, Ni2+, Zn2+, Pb2+, Hg2+, and As2+ revealed that starch capped 
AuNPST (100 μM) was most sensitive with Pb2+ and Cu2+ (Figure 4.23 7 A and B) and less or 
insensitive to other four metals. However, AgNPST showed highest sensitivity to Hg
2+
 (Figure 
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4.24 A & B) and less/ no sensitivity to other heavy metals. When different concentration of 
Pb2+ (1-20 ppm), Cu2+ (10-50 ppm), and Hg2+ (1-10 ppm) were mixed with 100 μM of AuNPST 
and AgNPST solution and incubated for 10 min, the change in color from pink to dark ruby red 
for Pb2+, violet color for Cu2+, and color yellow color of AgNPST become colorless for Hg
2+. 
Further, the SPR shift and peak broadening was also observed for all tested heavy metals with 
AuNPST and AgNPST, which signified the formation of larger particles (Figure 4.23 A and B, 
and Figure 4.24 A and B). Therefore, in this study, we found that our AuNPST and AgNP 
demonstrated sensitivity to heavy metal ions Cu2+ , Pb2+, and Hg2+. Moreover, AgNPST also 
showed H2O2 sensing ability.  
 
Figure 4.23 The effect of AuNPST with different concentration of heavy metal in ppm level was 
analyzed. (A) The effect of AuNPST with Cu2+. (B) with Pb2+. 
4.6.5.2 Photocatalytic degradation of methyl green and rhodamin-B 
The photocatalytic degradation ability of ZnONP self-assembly was tested with methyl green 
(MG) and rhodamine-B (Rho-B) dye. The absorption spectra of dye were measured in the 
range of between 450 to 700 nm with a 2 h time interval. The photocatalytic degradation of 
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methyl green (Figure.7 A and C) in UV-C showed that the primary absorption peak height for 
MG dye decreased, and the new secondary peak emerged. It indicated the degradation of MG 
dye was decreased with time. Moreover, a similar experiment with RhoB was performed, and 
absorption data was collected with 2 h interval up to 12 h by incubating the sample in UV-C. 
The decrease in the absorption peak with time obtained that indicated the photo-degradation 
of Rho-B dye (Figure 4.25 B and D). 
 
Figure 4.24 The effect of AgNPST with different concentration of heavy metal in ppm level was 
analyzed. (A) The effect of AgNPST with 50 ppm of all metals. (B) with Hg2+ (1-10 ppm)  
From, surface activity analysis of AuNP, AgNP by analysis of heavy metal sensing and photo-
catalytically degradation of dye by ZnONP clearly indicated that the surface of our synthesized 
NPs was highly active. 
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Figure 4.25 Photolytic degradation of dye by ZnONP analyzed by absorption spectroscopy. (A) and 
(C) Methylene green (MG); (B) and (D) Rhodamine-B  
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CHAPTER 5 
STUDY OF THE INTERACTION BETWEEN 
NANOPARTICLES AND PROTEINS 
5.1 Materials and methods 
The detail of nanoparticle synthesis and characterization was described in chapter-4. 
5.2 Characterization of NP-protein conjugate 
All the NP and protein were mixed in different molar ratios (1:20, 1:10, 1:5, 1:2, 1: 1.5, and 
1:1) and were incubate at room temperature for 2 h (to get equilibrium). The formation of NP-
protein conjugate was monitored by UV-Vis and tryptophan (Trp) fluorescence spectroscopy 
of protein (λex 280 nm) while stability and hydrodynamic size analysis of conjugate was also 
observed using DLS analyzer attached with a zeta sizer (ZS-nano series, Malvern Pvt. Ltd).  
5.2.1 Fluorescence spectroscopy 
The conformational change of protein due to interaction with nanoparticles was analyzed by 
exciting 7 μM of protein at 295 nm and recording variation in intrinsic fluorescence emission 
in the range of 300 to 400 nm. Fluorescence spectroscopic analysis was performed by using 
Cary eclipse fluorescence spectrometer (Agilent Pvt. Ltd.) when emission and excitation slit 
width was fixed at 5 and 10 nm, respectively. The baseline correction was performed with 
respect to buffer and nanoparticle concentration.  
5.2.2 Circular dichroism spectroscopy measurement 
The secondary structural contents of BLA and HEWL were measured using circular dichroism 
(CD) spectroscopy (Jasco 815) under constant N2 purging. Protein concentration of 14 μM 
was used in sodium phosphate buffer (pH 7.4, 20 mM) with different molar ratio of NP to 
protein (1:1, 1:2, 1:4, 1:8, and 1:10). The effect of different concentration of NP was analyzed 
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in the range of 200-260 nm. The PMT voltage of below 600 V during analysis. The data 
obtained was average of three scans of data collected with 1 nm interval. The obtained data 
was converted to molar residual ellipticity using following equation: 
𝑴𝑹𝑬 =  
𝑶𝒃𝒔𝒆𝒓𝒗𝒆𝒅 [𝜽] ·  𝟏𝟎𝟔
𝒏 ·  𝒄 ·  𝒍
− − − − − − − (𝟏) 
Here, n is a number of amino acids, ‘c’ is the concentration of protein in μM, ‘l’ is path length 
in mm. 
5.2.3 Lysozyme activity assay 
The lysozyme activity was analyzed by the method as suggested by Shugar [172] with some 
modification. The decrease in turbidity of 0.01 per minute was a measurement at 450 nm, at 
25 ⁰C and pH 7.4, as one unit of enzyme activity. For analysis of enzyme activity, Micrococcus 
lysodeikticus cells of 18 mg were prepared in phosphate buffer, and volume was made up to 
30 ml. For 3 ml enzyme assay, 2.9 ml of lysodeikticus solution was prepared by adding 1.5 ml 
from stock and 100 μl of protein was added from 3 mg/ml lysozyme solution. The variation in 
turbidity at 450 nm was measured up to 10 min with 1 min interval and the activity of lysozyme 
was calculated by using following equation: 
𝑼𝒏𝒊𝒕/𝒎𝒈 =  
∆𝑨𝟒𝟓𝟎 𝒏𝒎 ·  𝟏𝟎𝟎𝟎
𝒎𝒈 𝒆𝒏𝒛𝒚𝒎𝒆
− − − − − − − (𝟐) 
Here, ΔA is OD difference of sample between two times intervals, enzyme activity expressed 
in unit/mg.  
5.2.4 Effect of guanidine hydrochloride: 
Guanidine hydrochloride (GdnHCl) is strong denaturant used to study protein unfolding. The 
change of protein conformation was analyzed by tryptophan fluorescence analysis and circular 
dichroism (CD) spectroscopy analysis. For the unfolding study, 10 μM of protein was 
incubated at room temperature for 2 h in different concentrations of GdnHCl (0, 1, 2, 4, 6 M). 
For the refolding study, the 700 μM protein sample was incubated in 8 M GdnHCl for 2 h. The 
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solution was further diluted by 70 fold and incubated for 2 h in similar condition and refolding 
was measured. The samples were analyzed using Trp fluorescence, and CD spectra.  
5.2.5 Analyzing the thermal stability of protein 
Thermal stability of protein was analyzed by incubating the protein and NP (complex) at 
different temperature (25-60 ⁰C) with a step size of 5 ⁰C during heating and cooling with 
stabilization time 10 min after each step. The variation in Trp fluorescence and CD spectra was 
analyzed by fluorescence and CD spectroscopy, as described above. 
5.2.6 Surface hydrophobicity analysis 
The surface hydrophobicity of NP-protein complex was analyzed by 8-anilino naphthalene 
sulfonic acid (ANS) binding assay. The protein samples (10 μM) (both free and NP-protein 
complex) (1:2 molar ratio) and 300 μM of ANS were incubated in sodium phosphate buffer 
(pH 7.4) for 30 min and samples were analyzed by exciting at 350 nm. The emission was 
recorded between 400-650 nm with excitation and emission slit width of 5 and 10 nm, 
respectively.  
5.2.7 Proteinase-K digestion assay  
To study the effect of proteinase K (PK) digestion of BLA and HEWL in NP conjugate (NP: 
5 μM; BLA: 1.6 mg/ml), we incubated the conjugate solution with a various concentration of 
PK (0, 1, 3, 5, 7 μM). All the samples were incubated at RT for 10 min, and the reaction was 
stopped by adding 20 μM of PMSF. The samples were loaded onto 15% SDS-PAGE gel. The 
Biorad electrophoretic mini-gel apparatus was used, while the image was collected by Biorad 
gel doc instrument. All experiments were independently performed, and an equal amount of 
protein (20-40 μg) was loaded in each well.   
Further, test tube base ANS assay was also performed with BLA and HEWL with NP. All the 
samples were incubated at RT for 10 min, and the reaction was stopped by using 20 μM of 
phenylmethane sulfonyl fluoride (PMSF). The samples were further diluted so that final protein 
concentration becomes 10 μM and incubated with 400 μM ANS for 20 min. The sample was 
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excited at 350 nm and emission was collected in the range of 400-600 nm with fixed slit width 
of 10 nm. To, analyze the susceptibility of protein towards PK, we calculated the final ANS 
fluorescence using following equation:     
𝐅𝐧𝐞𝐭 =  𝐅𝐏𝐍𝐊 − (𝐅𝐏 − 𝐅𝐊 − 𝐅𝐍) − − − − − − − (𝟑) 
Here, Fnet is ANS fluorescence due to exposure of new hydrophobic sites. FPNK is ANS 
fluorescence of test sample, FP is ANS fluorescence of control sample without proteinase-K, 
FK is ANS fluorescence of PK, FN is ANS fluorescence of NP. The Fnet fluorescence was 
plotted with respect to proteinase-K (PK) concentration. The hypothesis was digestion of 
protein by PK exposed the new hydrophobic sites of proteins, which will increase/decrease 
with variation in protein susceptibility with various concentration of PK.  
5.3 Results and discussion 
5.3.1 Analyzing the interaction of protein with nanoparticles 
5.3.1.1 UV-Vis spectroscopic analysis 
Surface plasmon analysis (SPR) is a very sensitive method to study the interaction of metal 
nanoparticles with biomolecules because SPR depends on the surface properties of the metal 
NP, and surface properties of NP vary with the change in size, shape, local environment and 
dielectric properties of NP [2]. We incubated different concentration of BLA and HEWL (10, 
20, and 40 μM) with fixed concentration of both the NP (20 μM) in sodium phosphate buffer 
at RT for 2 h to reach equilibrium, which was shown by no further shift in SPR after 2 h. 
The starch capped gold nanoparticle (AuNPST) was scanned in the range of 400-700 nm, while 
starch capped silver NP (AgNPST) was scanned between 300-700 nm. The results showed that 
the interaction of AuNPST and BLA causes a red shift in surface plasmon resonance (SPR) (1-
3 nm) (Figure 5.1 A) while the interaction of BLA with AgNPST showed the SPR shift of 5-8 
nm (Figure 5.1 B). 
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Figure 5.1 BLA and NP interaction monitored by Spectroscopy. The shift in UV-Vis absorption peak 
due to BLA interaction was monitored. (A) AuNPST-BLA, (B) AgNPST-BLA, (C) ZnONPST-BLA. 
 A shift in absorption maxima of NP indicates the molecules induced alteration over NP [3]. 
Further, it was observed that the interaction of AuNPST and AgNPST with HEWL in similar 
condition causes 10-15 nm (Figure 5.2. A) and 8-10 nm shift (Figure 5.2. B), respectively. This 
fact clearly confirmed the interaction of AuNPST and AgNPST with BLA and HEWL. 
 63 
 
 
Figure 5.2 Interaction of HEWL was analyzed with various NP (AuNPST, AgNPST, and ZnONPST). The 
shift in UV-Vis absorption peak due to HEWL interaction was monitored. (A) AuNPST-HEWL, (B) 
AgNPST-HEWL, (C) ZnONPST-HEWL. 
The band gap analysis of starch capped zinc oxide nanoparticle (ZnONPST) with different 
concentrations (10, 20, and 40 µM) of BLA and HEWL was performed in sodium phosphate 
buffer. We found that interaction of BLA causes a reduction in UV absorption of ZnONPST 
while interaction with a similar amount of HEWL reduces the UV absorption in greater extent 
(Figure 5.2 C). The UV-Vis spectra of ZnONPST with different concentration of BLA and 
HEWL showed quenching in UV absorption perhaps due to the formation of protein corona 
over NP. 
From SPR shift and band gap analysis of tested NP, when surface capping agent was same, 
indicated that SPR of AuNPST was more sensitive to interaction, and SPR shift clearly varies 
with the type of protein at the interface of NP. It showed higher SPR shift when a protein with 
opposite zeta potential (i.e. HEWL) interact with AuNPST (Figure 5.1 A and Figure 5.2 A). 
Band gap analysis of ZnONPST also showed that the UV absorption was affected to a greater 
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extent by the interaction of opposite net charge of protein (Figure 5.1C and Figure.5.2 C). 
However, AgNPST showed a slight difference in SPR with two proteins and only showed a 
shift of 5-8 nm with BLA, and 8-10 nm with HEWL, respectively.  Metal nanoparticle showed 
highly sensitive surface plasmon resonance (SPR), which can be utilize for biomolecule 
detection such as protein, and nucleic acid. You et al. [173] synthesized the fluorescence AuNP 
for detection of protein. Nath and Chilkoti utilized colorimetric sensing and SPR of gold 
nanoparticle for biomolecular detection [6]. Nam et al. [174] used antibody capped gold 
nanoparticle for identification of various proteins. Lee and El-Sayed also reported the effect of 
size, shape, and metal composition of gold and silver nanoparticle in sensing and imaging [4]. 
Therefore, SPR shift due to biomolecular interaction confirm the interaction of protein with 
nanoparticle. The variation in SPR shift and band gap due to interaction with BLA and HEWL 
also indicated that UV-Vis spectra shift also vary with protein on the nanoparticle surface. 
5.3.1.2 Hydrodynamic size analysis 
DLS size analysis was performed to analyze the hydrodynamic size distribution of NP, pure 
protein (BLA, and HEWL) and NP-protein (BLA, and HEWL) complex. Hydrodynamic size 
analysis showed that major population of BLA and HEWL were 2.2 nm and 1.5 nm size. 
Further, analyzing the hydrodynamic size of NP and protein conjugates showed that AuNPST 
and AgNPST formed highly poly-dispersed protein-NP conjugate (Figure 5.3 A & B, and Figure 
5.4 A & B) while ZnONPST showed less poly-dispersed conjugate with the size of below 100 
nm (Figure 5.3. C and Figure 5.4. C). 
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Figure 5.3 Hydrodynamic size distribution of NP-protein conjugates. (A) AuNPST-BLA, (B) AgNPST-
BLA, (C) ZnONPST-BLA  
 
Figure 5.4 Hydrodynamic size analysis of AuNPST, AgNPST, and ZnONPST and their conjugates with 
HEWL. Hydrodynamic size distribution of (A) AuNPST-HEWL (B) AgNPST-HEWL, (C) ZnONPST-
HEWL conjugates.  
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The results showed that ZnONPST of 30 nm produces larger conjugates of NP-HEWL. The 
DLS analysis of conjugates showed that the size of NP-HEWL conjugate varies with the 
variation of NP core material and protein. BLA formed smaller NP-protein conjugate with 
higher polydispersity while HEWL having a net positive surface charge trigger to form larger 
NP-protein conjugates (Figure 5.4). However, AuNPST showed polydispersed conjugates with 
both the proteins (Figure 5.3 A and Figure 5.4 A).  
5.3.1.3 FESEM analysis of conjugates 
The field emission scanning electron microscopy (FESEM) was performed in cryo-mode to 
visualize the morphology, shape, and size of conjugates. The results revealed the presence of 
both small and larger aggregate of the random shape of BLA (Figure 5.5 A). The FESEM 
analysis also showed that AuNPST-BLA conjugate produced the very small size of conjugates 
with only a few larger aggregates (Figure 5.5 B) indicated a thick layer of BLA over AuNPST. 
The AgNPST-BLA and ZnONPST-BLA conjugates showed both larger and smaller aggregates 
of spheroidal and random shape (Figure 5.5 C & D). It was observed that ZnONPST formed a 
more spherical shaped particle of larger size (Figure 5.5 D).  
FESEM analysis of HEWL showed uniformly distributed spheroidal shape particles with some 
larger aggregates (Figure 5.6 A). The AuNPST and ZnONPST with HEWL revealed random 
shape conjugates (Figure 5.6 B & D) while AgNPST-HEWL conjugates showed both larger 
and smaller spherical particles with some aggregates (Figure 5.6 C). 
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Figure 5.5 FESEM analysis of BLA and its conjugate with different NP (Au, Ag, ZnO). (A) BLA 
(random aggregates), (B) AuNPST-BLA, (C) AgNPST-BLA, (D) ZnONPST-BLA conjugate. 
 
Figure 5.6 FESEM analysis of HEWL and its conjugate with different NP (Au, Ag, ZnO). (A) HEWL, 
(B) AuNPST-HEWL, (C) AgNPST-HEWL, (D) ZnONPST-HEWL. 
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From FESEM image of conjugates, it was clear that HEWL interaction with all three NP 
formed larger particles, which indicates the formation of a multilayer of protein over NP 
surface. However, BLA formed smaller conjugates but showed more poly-dispersity. The 
shape of conjugate also varies with NP and protein as HEWL with AgNPST formed spherical 
particle while HEWL formed random shape structure with other two NP. It was also revealed 
that AuNPST forms the smallest conjugate with BLA. Therefore, our DLS and FESEM analysis 
confirmed the formation of NP-protein conjugates with different size, shape, and 
polydispersity. The amount of protein adsorbed on the surface of NP depends on the core 
material of NP and type of protein interacting with NP.   
5.3.1.4 Surface zeta potential of conjugate 
Further, we wanted to analyze the stability of different NP-protein conjugates in the sodium 
phosphate buffer. Therefore, the zeta potential of NP-protein conjugates was analyzed. Surface 
zeta potential of BLA (-15.1 mV) with AuNPST (-20.6 mV), AgNPST (-24.2 mV), and ZnONPST 
(-26.9 mV) showed zeta potential of -16.4 mV, -11.6 mV, and -14.04 mV (Figure 5.7) while 
conjugate with HEWL (+6.09 mV) showed zeta potential of -14.6 mV, -6.37 mV, and -16.7 
mV (Figure 5.8), respectively. The zeta potential analysis of NP, proteins, and NP-protein 
conjugates showed that stability of conjugate decreased with respect to NP and protein, but it 
varies with the core material of NP and protein. From zeta potential analysis, it was revealed 
that AgNPST produced conjugates with the low stability of both the proteins while AuNPST-
BLA and ZnONPST-HEWL produced conjugates with the high stability.  
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Figure 5.7 Effect of AuNPST, AgNPST, and ZnONPST on the colloidal stability of NP-protein 
conjugates. Zeta potential analysis of various NP-BLA conjugates. 
The solution stability of NP-protein conjugate decreased in biological solution; therefore, there 
were higher chances of larger particle formation. Another important point is the stability of 
conjugate depends on the core material of NP. The decrease in zeta potential also indicated 
that interaction of NP and protein is electrostatic in nature because BLA has both negative and 
positively charged patches, which showed a decrease in zeta potential. Similarly, HEWL 
showed net negative zeta potential due to electrostatic interaction of positively charged patches 
of HEWL and negatively charged NP surface. Therefore, HEWL conjugate with all NP showed 
negative zeta potential. Surface zeta potential play crucial role in stability of colloidal solution, 
and protein in aqueous environment. Jiang et al. [175] higher surface charge help to prevent 
aggregation of nanoparticle. Patil et al. [176] reported that protein adsorption and cellular 
uptake of nanoparticle depends on the surface zeta potential. Moreover, Zhang et al. [177] 
reported that surface zeta potential play crucial role in cellular uptake. Therefore, higher zeta 
potential of colloidal solution not stabilize the conjugate but also play important role in 
biological uptake and disease cell killing. 
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Figure 5.8 Effect of AuNPST, AgNPST, and ZnONPST on the colloidal stability of NP-protein conjugate. 
Zeta potential analysis of different NP-HEWL conjugates. 
5.3.1.5 Surface hydrophobicity analysis 
The surface hydrophobicity of protein plays an important role in the stability of protein in 
solution [178, 179]. It interaction of NP with protein altered the protein structure and might 
expose or protect the hydrophobic surfaces in protein; hence, it affects the stability of proteins. 
For surface hydrophobicity, analysis of 10 μM of BLA and HEWL was used. The surface 
hydrophobicity analysis of BLA showed that interaction of AgNPST and ZnONPST (NP: 
protein, 1:2 molar ratio) decrease the surface hydrophobicity of BLA while AuNPST interaction 
with BLA increased the surface hydrophobicity of protein (Figure 5.9 A). ANS binding assay 
showed that interaction of AgNPST and ZnONPST with BLA protect the hydrophobic surface 
of protein, therefore, reduces the chances of hydrophobic interaction while AuNPST causes 
exposure of the hydrophobic surface of BLA; which increased the chance of hydrophobic 
interaction leading to protein aggregation. 
Moreover, a similar study was performed with HEWL and NP showed that AuNPST and 
ZnONPST increased the surface hydrophobicity of protein while AgNPST reduced the surface 
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hydrophobicity of protein. Therefore, AuNPST and ZnONPST interaction with HEWL increased 
the chance of hydrophobic interaction and formation of larger particles while AgNPST prevents 
such kind of interactions (Figure 5.9 B). For this analysis, the effect of NP and ANS binding 
and ANS (without NP) were also analyzed (Figure S14). The result showed that the emission 
spectra of ANS with and without NP showed insignificant difference. 
 
Figure 5.9 Effect of AuNPST, AgNPST and ZnONPST on the surface hydrophobicity of NP-protein 
conjugate. (A) BLA with NP, (B) HEWL with NP. 
Zeta potential and surface hydrophobicity analysis showed that interaction of NP with protein 
vary with the change in nanoparticle material and type of protein interacting with NP, which 
is responsible for the colloidal stability of NP-protein complex in solution. The protein surface 
hydrophobicity plays important role in stability and protein-protein interaction and ultimately 
aggregation. The interaction of protein hydrophobic site at the interface prevent hydrophobic 
interaction while exposed of hydrophobic surface reduces the protein stability in aqueous 
environment. Vegenede et al. [180] glycerol interact with the large patches of protein 
hydrophobic surface; therefore, prevent aggregation of protein in solution. Chi et al. [181] 
reported the various factors such as pH, salt, and surfactant concentration in stability of protein 
structure. The salt and pH help to maintain surface charge while variation in surface 
hydrophobicity also paly crucial role in aggregation of proteins.  
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5.3.1.6 Fluorescence spectroscopy of protein 
Tryptophan fluorescence spectra were recorded to get the information regarding protein 
conformational changes. Trp fluorescence is highly sensitive to its microenvironment and other 
weak interactions. The exposure of Trp towards polar environment causes a red shift in 
emission intensity; similarly, movement toward non-polar environment exhibit blue shift in 
Trp fluorescence [182-184]. BLA contain four tryptophan buried in protein [185] and HEWL 
has six tryptophan (three buried and three in active site of protein) [186]. Therefore, analyzing 
the Trp fluorescence intensity provides valuable information about interaction and 
conformational changes in protein.   
Therefore, the effect of different concentration of AuNPST, AgNPST, and ZnONPST on intrinsic 
fluorescence of BLA and HEWL was analyzed. The NP were mixed with fixed amount of 
protein (7 μM) in different molar ratio such as 1:20, 1:10, 1:5, 1:2, 1: 1.5, and 1:1 and the 
samples were incubated for 2 h to get the equilibrium at room temperature (25 ⁰C) (See Figure 
S8-S13 and Figure 5.10). Further, all the samples were analyzed by the exciting sample at 295 
nm when excitation and emission slit width was fixed at 5 nm and 10 nm, respectively. The 
result showed the quenching of overall emission spectra of both the proteins, which indicates 
the interaction of NPST with proteins in different extent with shift in emission spectra.  
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Figure 5.10 Trp fluorescence quenching of BLA and HEWL with different concentration of NP 
(AuNPST, AgNPST and ZnONPST). (A), (B), and (C) Trp fluorescence quenching of BLA, (D), (E), and 
(F) Trp fluorescence quenching of HEWL was plotted in the range of 300-420 nm. The result showed 
the different extent of fluorescence quenching due to interaction with NP. 
BLA interaction with AuNPST and ZnONPST causes quenching of Trp fluorescence to a greater 
extent (Figure 5.10 A and C). Moreover, BLA with AuNPST showed a red shift in Trp emission 
peak (328 nm to 333 nm); however, ZnONPST showed a blue shift in Trp fluorescence. 
Therefore, the fluorescence quenching in AuNPST-BLA might be due to the exposure as well 
as the interaction of BLA with NP. However, blue shift (328-326 nm) with greater extent of 
quenching of Trp with ZnONPST might be due to movement of Trp towards the non-polar 
environment and interaction of ZnONPST (Figure 5.10 C). BLA interaction with AgNPST also 
exhibit Trp fluorescence quenching (less quenching than AuNPST, ZnONPST) with a blue shift 
in emission (328-324 nm) indicated the alteration in BLA structure that might cause movement 
of Trp to the non-polar environment (Figure 5.10 B). 
Further, we also performed a similar experiment with another protein hen egg white lysozyme 
(HEWL), which is homologous to BLA protein but have net positive surface charge. It was 
observed that interaction of AgNPST with HEWL causes quenching and blue shift (3 nm) in 
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Trp fluorescence (i.e. 344 to 342 nm) (Figure 5.10 E) while ZnONPST showed quenching with 
red shift (344 to 349 nm) in Trp fluorescence (Figure 5.10 F). Trp fluorescence analysis 
indicated that interaction of AgNPST shifts the Trp towards the non-polar environment, which 
might be due to AgNPST-HEWL interaction but simultaneous quenching in Trp fluorescence 
(Figure 5.10 E) was also observed. However, it was observed from Trp fluorescence analysis 
with different concentration of AuNPST that the NP quenched the Trp fluorescence in a higher 
extent than AgNPST and ZnONPST but also showed the red shift in Trp fluorescence (344 to 
347) (Figure 5.10 D). The red shift and quenching in Trp fluorescence indicated the movement 
of Trp towards the polar environment. Some previous reports earlier demonstrated the 
fluorescence quenching of ZnONP (uncapped) and AuNP (citrate-capped) by interacting with 
BSA, HEWL, and BLA [187-189]. Therefore, we concluded that interaction of AuNPST and 
ZnONPST might alter the BLA structure and Trp fluorescence quenching might be due to both 
exposures of the Trp to polar environment and interaction with NP. However, AgNPST 
interaction with BLA might shift the Trp toward non-polar environment or interact near Trp to 
protect it from the polar environment.  
5.3.1.7 Circular dichroism of proteins 
Further, we also analyzed the secondary structure variation by circular dichroism spectroscopy. 
The obtained data converted to molar residual ellipticity (MRE) by using equation given in 
“method” section. MRE value at 222 nm represents variation in the α-helix content of protein 
[190] while at 218 nm indicates β-sheet content [191]. The interaction study with BLA and all 
three NP showed that increasing concentration of NP causes an increment of the α-helix 
content of BLA (Figure 5.11 A-C), and the highest effect is shown by AuNPST. Analyzing the 
circular dichroism (CD) data using online server CAPITO [192] showed the gain of α-helix 
(32% to become 53%) and loss of β-sheet (22% to 9%) in BLA (Figure 5.11 A). The gain of 
α-helix and simultaneous drop in of β-sheet made the protein structure highly flexible due to 
NP-protein interaction. 
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Figure 5.11 CD spectra of BLA with different concentration of (A) AuNPST, (B) AgNPST, and (C) 
ZnONPST; CD spectra of HEWL with (D) AuNPST, (E) AgNPST, (F) ZnONPST.  
When, we analyzed the effect of various concentrations of AuNPST, AgNPST, and ZnONPST on 
HEWL secondary structure, it was observed that interaction of these NP (AuNPST and AgNPST) 
with HEWL causes a substantial increase of β-sheet content with increasing NP concentration. 
(Figure 5.11 D-F). However, HEWL showed increment in α-helix content (41% to 54%) with 
ZnONPST at the expense of β-sheet. The interaction between HEWL and all three NP revealed 
that the β-sheet content was increased by almost to two folds when the concentration of metal 
NP such as AuNPST and AgNPST were increased, perhaps at the expense of α-helix content 
(Figure 5.11 D-F), However, the ZnONPST causes increase in α-helix content of both BLA and 
HEWL. Therefore, it was observed that interaction of AuNPST and AgNPST increased the 
flexibility in BLA by increasing α-helix content while increasing the rigidity in HEWL by 
increasing β-sheet content. However, it clearly indicated that ZnONPST tends to increase the 
α-helix content of both BLA and HEWL (Figure 5.11 A -F). Further, we observed that 
increasing NP concentration initially altered the protein secondary structure; however, after 
approaching certain concentration ratio (10:1 to onward) there was no change in CD spectra 
shape, which indicated that nanoparticle-protein interaction depends on the availability of free 
protein in the solution. However, in absence of free protein for interaction, NP not able to alter 
the structure but either quench or enhance the CD spectra (Figure 5.11 A-F).  
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5.3.1.8 Effect of NP interaction on HEWL activity 
From activity assay, it was observed that interaction of NP causes loss of enzyme activity of 
lysozyme. It clearly showed that AgNPST causes the highest loss in enzyme activity (~30%) of 
HEWL (Figure 5.12) while ZnONPST causes least. This fact also indicated that the structural 
change also altered the catalytic site of HEWL, which must be due to overall conformational 
changes of the protein. 
 
Figure 5.12 The enzyme activity analysis of HEWL after the interaction with different NPs. 
5.3.1.9 Effect of NP on unfolding and refolding of proteins  
The guanidine hydrochloride (GdnHCl) is a strong denaturant used to analyze the unfolding of 
various model proteins. Here, we analyzed the unfolding and refolding of both the proteins (10 
μM). To analyze the unfolding of BLA and HEWL, different concentration of guanidine 
hydrochloride (0-6 M) was used. All the protein samples were incubated at 25 ⁰C for 2 h to 
attain unfolding equilibrium. In an another experiment, protein stock solution (700 μM) was 
incubated in 8 M guanidine hydrochloride solution for 2 h and followed by dilution (70 folds) 
with buffer to make 10 μM in 6-1 M guanidine hydrochloride solution. Refolding solution was 
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further incubated for 2 h before analysis (See Appendix Figure S15-S18 for BLA and Figure 
S21-S22 and S24-S25 for HEWL).  
To analyze the effect of GdnHCl on protein tertiary and secondary structure, the protein 
solution was analyzed using tryptophan fluorescence spectroscopy, and circular dichroism 
(CD) spectroscopy, respectively. The fluorescence spectroscopy showed that free BLA showed 
Trp fluorescence drop during refolding with a red shift in emission wavelength but at 1 M of 
GdnHCl, both unfolding and refolding states were reached to an identical state (Figure 5.13 
A). However, BLA complex with AuNPST (2:1 molar ratio) showed a large gap in unfolding 
and refolding state of protein at all GdnHCl concentration (0-6 M) (Figure 5.13 B). It was also 
observed that BLA in refolding clearly showed a visible shift in a fluorescence spectrum in the 
presence of different concentration of GdnHCl (Figure 5. 13 C & D).  
 
Figure 5.13 Effect of Guanidine hydrochloride (0-6 M) on BLA refolding. Unfolding and refolding of 
BLA with (A) none (B) AuNPST, (C) AgNPST, (D) ZnONPST. (See Trp fluorescence spectra in Appendix 
Figure S16-S19, Figure S25). 
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CD spectroscopy is an important tool to analyze the secondary structure of protein. Moreover, 
molar residual ellipticity (MRE) at 222 nm indicated the α-helix content of protein while 
absorption at 218 nm represents β-sheet content. Analyzing the CD peak of free BLA at 222 
nm and 218 nm showed that with increasing GdnHCl concentration causes a loss in α-helix 
and β-sheet but during refolding it formed more β-sheet (Figure 5.14 A). When we analyzed 
refolded BLA in the presence of NP, it was observed that BLA contain a lower percentage of 
α-helix and β-sheet than free BLA in similar condition. This indicated that AuNPST resists the 
regain of secondary structure, therefore compromise structural flexibility and rigidity (Table 
5.3). We observed that AgNPST showed less effect on the secondary structure of refolded BLA 
compared to AuNPST. Therefore, both in unfolding and refolding condition there was very 
lower loss in α-helix and β-sheet contents compared to free BLA (Table 5.1). Further, it was 
observed that BLA with ZnONPST protects the content during refolding while contains more 
amounts of β-sheet (Table 5.1). Further, we have analyzed the variation in secondary structure 
during unfolding and refolding by utilizing CD spectra at 222 nm and fitting normalized 
absorption peak at 222 nm (Figure 5.14 A-D). the result showed that BLA without NP (Figure 
5.14 A) showed similar unfolding and refolding pathway while administration of NP in BLA 
altered the folding pathway (Figure 5.14 B-D). The administration of AuNPST and AgNPST 
resist the unfolding while altered the refolding facilitate folding (Figure 5.14 B-C). Moreover, 
the ZnONPST showed less effect on the folding pathway of BLA (Figure 5.14 D)  
The fluorescence spectroscopy analysis showed that AgNPST and ZnONPST cause less effect 
on the protein tertiary structure during refolding process. However, AuNPST showed drastic 
change the refolding state of HEWL. It was found that during refolding process, Trp 
fluorescence of HEWL showed a drop of fluorescence with AgNPST, and ZnONPST (Figure 
5.15 A, B, D), indicated some larger extent of unfolding and exposure of Trp to polar 
environment. However, Trp fluorescence was enhanced when similar experiment performed 
with AuNPST, the enhancement in fluorescence intensity the movement of Trp toward the non-
polar environment probably the core of protein that causes enhancement of fluorescence  
(Figure 5.15 C).  
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Figure 5.14 BLA chemical denaturation in different concentration of guanidine hydrochloride 
(GdnHCl) (0-6 M). CD spectra of 222 nm were normalized and fitted by non-linear curve fitting (R2 
value range 0.98-0.99). BLA with (A) none, (B) AuNPST, (C) AgNPST, (D) ZnONPST.  
The analysis of secondary structure of HEWL sample showed that free protein regains its 
secondary structure during the refolding process with a certain difference in secondary 
structure (Table 5.2). From CD spectroscopic data, it was clear that AuNPST and AgNPST cause 
a little gain of HEWL secondary structure during the refolding process (Table 5.4). However, 
ZnONPST protected the changes in HEWL secondary structure and showed less variation in 
absorption peak at 222 nm and 218 nm (Table 5.2). Therefore, it was clear that ZnONPST 
protects the HEWL structure at the tertiary structure and secondary structural level while 
AuNPST causes drastic changes in HEWL structure during refolding process.  
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Figure 5.15 Unfolding and refolding of HEWL with (A) None, (B) AuNPST, (C) AgNPST, (D) 
ZnONPST. (See Trp fluorescence spectra in Appendix Figure S21, Figure S23, Figure S25). 
Further, we have analyzed the variation in secondary structure of HEWL during unfolding and 
refolding by utilizing CD spectra at 222 nm and fitting normalized absorption peak at 222 nm 
(Figure 5.16 A-D). the result showed that BLA without NP (Figure 5.16 A) showed almost 
identical two step unfolding and refolding pathway while administration of NP in BLA altered 
the folding pathway (Figure 5.16 B-D). The administration of AuNPST showed less effect on 
the unfolding and refolding of HEWL (Figure 5.16 B). However, AgNPST and ZnONPST resist 
the unfolding while altered the refolding pathway drastically and facilitate folding (Figure 5.16 
C-D). The Fluorescence spectroscopy and CD spectra analysis showed that AuNPST altered the 
tertiary structure of protein more drastically but has less effect on the secondary structure 
during unfolding and refolding. While AgNPST and ZnONPST showed less effect on the tertiary 
structure but showed high impact on the protein secondary structure during chemical 
denaturation. Chakroborti et al.[187, 188] investigated the effect of ZnONP on the structure 
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and unfolding of BLA and HEWL. It was reported that ZnONP stabilize the folded form of 
HEWL while BLA retain tertiary structure but secondary structure showed significant changes. 
 
Figure 5.16 HEWL chemical denaturation in different concentration of guanidine hydrochloride 
(GdnHCl) (0-6 M). CD spectra of 222 nm were normalized and fitted by non-linear curve fitting (R2 
value range 0.98-0.99). HEWL with (A) none, (B) AuNPST, (C) AgNPST, (D) ZnONPST.  
 
5.3.1.10 Effect of NP on heat-induced unfolding and refolding of proteins  
Thermal unfolding and refolding were observed by incubating both the protein between 25-60 
⁰C with an increment of 5 ⁰C. Protein samples were incubated for 20 min at each temperature, 
and Trp fluorescence spectra and MRE of protein was measured. Analyzing the Trp 
fluorescence and CD spectra of BLA (Figure 5.17 and Figure 5.18) showed that thermal 
unfolding and refolding in the presence of all three NPs drastically changed the BLA tertiary 
and secondary structure. It was observed that Trp fluorescence of BLA over AuNPST-BLA and 
ZnONPST-BLA complex initially decreased up to 40 ⁰C temperature and afterward showed 
enhancement and red shift (Figure 5.17 B & D). This indicated initial unfolding of BLA protein 
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and exposure of Trp to polar environment, however, increasing the temperature causes 
movement of Trp toward the non-polar environment and showed enhancement. 
Table 5.1 Effect of Guanidine hydrochloride (0-6 M) on BLA secondary structure. The data was 
measured and percentage secondary structure contents were analyzed by CAPITO online server. (See 
CD spectra in Appendix Figure S20-S21, Figure S24, and Figure S27) 
 
GdnHCl 
(M) 
β-Sheet (%) 
 BLA BLA -AuNPST BLA -AgNPST BLA -ZnONPST 
 Unfolding Refolding Unfolding Refolding Unfolding Refolding Unfolding Refolding 
0 22.5 22.5 9 9 9 9 9 9 
1 42 44.5 40.5 44.5 39 40.5 43 40.5 
2 52 49 39 39.5 33 33 39.5 33 
4 39.5 39.5 39.5 37.5 37 39 39.5 39.5 
6 39.5 38 39.5 40 36 36 38 39.5 
 
Table 5.2 Effect of Guanidine hydrochloride (0-6 M) on HEWL secondary structure. The data was 
measured, and Percentage secondary structure contents were analyzed by CAPITO online server. (See 
CD spectra in Appendix Figure S20-S21, Figure S24, and Figure S27) 
 
GdnHCl 
(M) 
β-Sheet (%) 
 
HEWL HEWL -AuNPST HEWL -AgNPST HEWL -ZnONPST 
Unfolding Refolding Unfolding Refolding Unfolding Refolding Unfolding Refolding 
0 11.5 11.5 21.5 21.5 21.5 21.5 20.5 20.5 
1 24 27.5 24 23.5 24 24 24 23.5 
2 24 24 42.5 36.5 31 26 31 29 
4 36 36 39.5 38 39.5 39.5 39.5 39.5 
6 46 46 46 46 46 46 42 41 
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Figure 5.17 Thermal unfolding and refolding on BLA. (A) Trp fluorescence of BLA during thermal 
unfolding and refolding, (B) AuNPST-BLA, (C) AgNPST-BLA, (D) ZnONPST-BLA. (See Trp 
fluorescence in Appendix Figure S28-S30). 
Moreover, AgNPST causes exposure of Trp to the more polar environment (Figure 5.17 C). 
Therefore, Trp fluorescence analysis showed that AuNPST and ZnONPST cause a shift of 
hydrophobic Trp to the core of protein while AgNPST exposed it to the polar environment 
indicated the unfolded state of BLA. However, CD spectroscopy analysis of BLA showed that 
NP effect is at tertiary structure level while secondary structure analysis showed at 222 nm 
there was an equivalent amount of secondary content in BLA during thermal refolding (except 
AuNPST) (Figure 5.15 A-D) but showed alteration secondary structure between 35-50 
0C.  
Further, the HEWL structural changes at tertiary and secondary structure level by analyzing 
variation in Trp fluorescence and MRE variation at 222 nm showed that all three NP causes 
drastic changes in HEWL tertiary structure (Figure 5.16 B-D). Free HEWL showed good 
refolding ability during thermal unfolding and refolded process (Figure 5.16 A). It was 
observed that Trp fluorescence during refolding was higher than the unfolding fluorescence 
with emission wavelength shift for HEWL conjugated with NP. Therefore, the interaction of 
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HEWL with NP decreased the stability of its tertiary structure and protein was unable to regain 
its native tertiary structure in the presence of all three NP.  
Moreover, secondary structure analysis of HEWL showed variation during refolding (Figure 
5.17 A). Moreover, it was also observed that all the tested NP altered the unfolding and 
refolding pathway of the HEWL secondary structure and showed fewer amounts of α-helix and 
β-sheet after refolding (Figure 5.17 B). However, it was cleared that AgNPST and ZnONPST 
showed protection in the HEWL secondary structure during thermal refolding, which was 
shown by less shift in absorption peak at 222 nm and 218 nm during refolding of HEWL at 
different temperature (Figure 5.17 C & D).  
 
Figure 5.18 Thermal denaturation of BLA at different temperature (25-60 0C). BLA with (A) none, (B) 
AuNPST, (C) AgNPST, (D) ZnONPST.  
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Figure 5.19 Analyzing the thermal unfolding and refolding on HEWL. (A) Trp fluorescence of HEWL 
during thermal unfolding and refolding, (B) AuNPST-HEWL, (C) AgNPST-HEWL, (D) ZnONPST-
HEWL. (See Trp fluorescence spectra in Appendix Figure S35-S37). 
 
Figure 5.20 Thermal denaturation of HEWL at different temperature (25-60 ˚ C). HEWL with (A) none, 
(B) AuNPST, (C) AgNPST, (D) ZnONPST.  
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This fact clearly indicated that interaction of AgNPST and ZnONPST protect the HEWL 
secondary structure during thermal denaturation and help to regain it structure during their 
folding process while a similar amount of AuNPST unable to do so.  
The BLA has high degree of homology with HEWL, four disulphide bond occupied same 
position. However, BLA and HEWL showed opposite net surface charge in physiological pH 
[193]. The chemical and thermal unfolding with AuNP, AgNP, ZnONP showed that the effect 
of NP on the protein vary with nature of interaction complex. The secondary structure as well 
as tertiary structure variation and denaturation of protein also vary with interaction of different 
NP. 
5.3.1.11 Analyze the folding Model and Free energy of folding 
Further, we analyzed the chemical and thermal denaturation data for calculation of folding 
fraction of both the proteins (i.e. BLA and HEWL) and calculated the free energy of folding 
using method reported by Fersht [194] and Greenfield [195]. The understanding the energetics 
by calculation of free energy will help to understand the energetics of protein folding and the 
effect of tested NP during chemical and thermal denaturation and renaturation. Bovine α-
lactalbumin (BLA) and hen egg white lysozyme (HEWL) are monomeric proteins. Therefore, 
thermal denaturation study using circular dichroism spectroscopy will be done by using 
following equations: 
                           K = [F]/[U]--------------------------------------------(5.1) 
Here, K is equilibrium constant for folding. If, the fraction folded at given temperature is α. 
                             K= α/(1- α) -------------------------------------------(5.2) 
                             α = K/(1+K) -------------------------------------------(5.3)  
The free energy of folding will be calculated using following equation: 
                              ΔG = -nRTlnK---------------------------------------- (5.4) 
ΔG is free energy of folding and R is gas constant (1.98 cal/mol) 
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Figure 5.21 Thermal denaturation (25-60 ˚C) and renaturation (60-25 0C) of BLA was performed and 
fraction of protein in the folding state was calculated with (A) none, (B) AuNPST, (C) AgNPST, (D) 
ZnONPST. The non-linear curve fitting was performed using originPro2016. The R2 value for the fitted 
curve in the range of 0.94-0.988. 
The folding fraction of BLA (without and with NP) (Figure 5.21 A-D) showed that BLA 
interaction with all the tested NP shift the TM (temperature when half of the protein in folded 
state) toward higher temperature (i.e.50 0C <). However, AgNPST showed lower amount of 
folding fraction compared to AuNPST and ZnONPST (Figure 5.21 C and D). Moreover, it was 
observed that BLA- AgNPST and BLA alone showed higher amount of folding fraction up to 
the TM however, below TM AgNPST showed less amount of folded state compared to BLA-
AuNPST while BLA-ZnONPST showed lower amount of folding fraction throughout the 
thermal denaturation and renaturation (Figure 5.21 D). Hiraoka and Suqai [196] reported the 
thermal denaturation of BLA is two state folding and energetic of apo and holo form of BLA 
and observed that both the proteins follow similar pattern. Vanderheeren and Hanssens [197] 
performed the thermal denaturation of apo-BLA and reported that thermal denaturation 
exposes the hydrophobic sites while calcium binding in apo-BLA make it stable.  
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Table 5.3 Calculation of folding constant (K), Free energy of folding (ΔG Kcal/mol) during thermal 
denaturation and renaturation of BLA, BLA-AuNPST, BLA-AgNPST, and BLA-ZnONPST. 
 
Temperature 
(˚C) 
BLA 
(unfold/refold) 
BLA-AuNPST 
(unfold/refold) 
BLA-AgNPST 
(unfold/refold)) 
BLA-ZnONPST 
(unfold/refold) 
 K ΔG  
 
K ΔG  
 
K ΔG  
 
K ΔG  
 
30 7.6/ 
30.2 
 
-1.2/ 
-2.0 
 
2.0x103/ 
0.1x103 
 
-4.6/ 
-2.8 
 
7.6/ 
93.4 
 
-1.2/ 
-2.7 
 
72.1/ 
37.5 
 
-2.6/ 
-2.2 
 
35 5.4/ 
10.9 
 
-1.0/ 
-1.4 
 
18.2/ 
13.1 
 
-1.8/ 
-1.6 
 
5.4/ 
58.8 
 
-1.0/ 
-25 
 
10.3/ 
5.2 
 
-1.4/ 
-1.0 
 
40 3.5/ 
4.4 
 
-0.8/ 
-0.9 
 
5.5/ 
10.2 
 
-1.1/ 
-1.4 
 
3.5/ 
3.7 
 
-0.8/ 
-0.8 
 
8.8/ 
2.4 
 
-1.3/ 
-0.5 
 
45 1.9/ 
3.0 
 
-0.4/ 
-0.7 
 
6.7/ 
4.6 
 
-1.2/ 
-1.0 
 
1.9/ 
3.1 
 
-0.4/ 
-0.7 
 
3.9/ 
2.7 
 
-0.9/ 
-0.6 
 
50 1.0/ 
1.6 
 
0.003/ 
-0.3 
 
3.3/ 
1.2 
 
-0.8/ 
-0.1 
 
1.0/ 
1.2 
 
0.003/ 
-0.1 
 
1.9/ 
1.9 
 
-0.4/ 
-0.4 
 
55 0.3/ 
0.3 
 
0.7/ 
0.8 
 
0.7/ 
0.4 
 
0.2/ 
0.6 
 
0.3/ 
0.2 
 
0.7/ 
1.1 
 
0.4/ 
0.4 
 
0.5/ 
0.7 
 
 
Further calculating the free energy of folding using equation 5.1 to 5.4 showed thermal 
unfolding/refolding free energy become negative to positive, which indicated that increasing 
temperature causes unfolding of protein and formation folded state become difficult. 
Therefore, folding is unfavorable at higher temperature while at lower temperature folding is 
favorable, which was shown by negative free energy (Table 5.3). We analyzed folding of BLA 
with AuNPST, AgNPST, and ZnONPST at different temperature and calculated the free energy 
of folding. The result clearly showed that BLA-AuNPST sample higher amount of negative 
folding free energy compared to AgNPST and ZnONPST (Table 5.3). The thermal folding 
analysis of BLA and free energy calculation showed that although AuNPST showed higher 
amount of alteration in tertiary structure but favored the folding of BLA compared to AgNPST 
and ZnONPST. 
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Figure 5.22 Thermal denaturation (25-60 0C) and renaturation (60-25 0C) of HEWL was performed 
and fraction of protein in the folding state was calculated with (A) none, (B) AuNPST, (C) AgNPST, (D) 
ZnONPST. The non-linear curve fitting was performed using polynomial-4 function. The R2 value for 
the fitted curve in the range of 0.95-0.96. 
Further, we also analyzed the thermal unfolding of HEWL wth and without NP and folding 
fraction as well as free energy of folding were calculated. Analyzing the thermal unfolding and 
refolding showed that HEWL has high efficiency of refolding (Figure 5.22 A). When, we 
analyzed the folding fraction of HEWL with AuNPST, it was revealed that interaction of HEWL 
altered the refolding fraction of HEWL (Figure 5.22 B). The results showed that TM value for 
HEWL was reduced to below 45 ˚C with all the tested NP. The folding fraction analysis also 
showed that HEWL showed negligible difference in folding fraction during thermal unfolding 
and refolding with AuNPST (Figure 5.22 B).  
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Table 5.4 Calculation of folding constant (K), Free energy of folding (ΔG Kcal/mol) during thermal 
denaturation and renaturation of HEWL, HEWL-AuNPST, HEWL-AgNPST, and HEWL-ZnONPST. 
 
Temperature 
(0C) 
HEWL 
(unfold/refold) 
HEWL-AuNPST 
(unfold/refold) 
HEWL-AgNPST 
(unfold/refold)) 
HEWL-ZnONPST 
(unfold/refold) 
 K ΔG K ΔG  K ΔG  K ΔG  
30 2.1 
/ 
6.3 
-0.5 
/ 
-1.1 
6.7/ 
25.7 
 
-1.1/ 
-19.5 
 
0.8/ 
2.9 
 
0.2/ 
-0.6 
 
3.4/ 
5.5 
 
-0.7/ 
-1.0 
 
35 1.2 
/ 
4.0 
-0.1 
/ 
-0.8 
7.7/ 
1.8 
 
-1.3/ 
-0.4 
 
0.7/ 
0.6 
 
0.3/ 
0.3 
 
1.2/ 
3.1 
 
-0.1/ 
-0.7 
 
40 0.4 
/ 
4.9 
0.5 
/ 
-0.9 
2.8/ 
2.2 
 
-0.6/ 
-0.5 
 
1.3/ 
0.8 
 
-0.2/ 
0.1 
 
0.3/ 
0.8 
 
0.7/ 
0.1 
 
45 0.5 
/ 
4.5 
0.4 
/ 
-0.9 
1.1/ 
1.1 
 
-0.6/ 
-0.8 
 
0.1/ 
0.7 
 
1.5/ 
0.2 
 
0.2/ 
0.01 
 
1.1/ 
2.7 
 
50 0.5 
/ 
7.2 
0.4 
/ 
-1.3 
0.2/ 
0.6 
 
0.9/ 
0.3 
 
0.02/ 
0.2 
 
2.3/ 
0.9 
 
0.7/ 
1.2 
 
0.2/ 
-0.1 
 
55 0.2 
/ 
3.1 
0.9 
/ 
-0.7 
0.2/ 
0.002 
 
1.0/ 
3.8 
 
0.01/ 
0.5 
 
2.8/ 
1.9 
 
0.1/ 
0.04 
 
1.4/ 
2.1 
 
 
Blumlein and McManus [198] reported that thermal denaturation of HEWL reversible and 
irreversible denaturation in low ionic pH solution. The results showed that increase in TM was 
not correlated with reversibility of folding. Chang and Li [199] reported that HEWL is highly 
thermostable and showed stability up to 55 0C. Therefore, variation in thermal stability during 
denaturation is altered by tested NP. 
When we analyzed the free energy of folding using folding constant obtained utilizing equation 
5.1 to 5.3 and free energy was calculated using equation 5.4. The results showed that AuNPST 
highest amount of negative free energy (ΔG = -19 kcal/mol) while AgNPST showed least 
amount of negative free energy of folding. When increased the temperature it was observed 
that all the tested NP not favored the folding of HEWL at higher temperature compared to free 
HEWL (Table 5.4). form free energy analysis it is cleared that NP favored the HEWL folding 
at lower temperature but inhibit the folding at higher temperature. 
 91 
 
Further, we analyzed the unfolding and refolding of BLA and HEWL using different 
concentration of guanidine hydrochloride (0-6 M). The CD absorption peak at 222 nm was 
utilized for calculation of folding fraction of BLA and HEWL using following equation:  
fraction folded α is calculated by using following equation: 
                                    α= (ϴob - ϴU)/ (ϴF - ϴU)----------------------------------(5.5) 
Here, ϴob is molar residual ellipticity at given temperature; ϴU unfolded protein; ϴF folded 
protein. 
The curve is plotted between α and GdnHCl concentration and fitted, 
Thermodynamics of protein folding using denaturants: 
                                        K= α/ (n*[C]n-1) * (1- α) n----------------------------------- (5.6) 
[C] is a concentration of monomeric protein; n is 1, 2, 3, and 4. 
                                            ΔG = -nRTlnK----------------------------------------------(5.7) 
ΔG value is the free energy of folding in the presence of chemical denaturant  
 
Figure 5.23 Chemical denaturation of BLA in the presence of guanidine hydrochloride (0-6 M) and 
folding was calculated with (A) none, (B) AuNPST, (C) AgNPST, (D) ZnONPST. The non-linear curve 
fitting was performed using originPro2016. The R2 value for the fitted curve in the range of 0.96-0.99. 
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The Chemical denaturation of BLA and BLA-NP showed that folding fraction of BLA reduced 
with AuNPST. It was revealed that CM (concentration of GdnHCl when half protein in folded 
state) value increased for refolding of BLA-AgNPST and BLA-ZnONPST while CM value 
reduced for BLA-AuNPST. Therefore, folding fraction analysis revealed that AuNPST unable 
to protect folding fraction of BLA while AgNPST and ZnONPST protect against chemical 
denaturant efficiently. Ikeguchi et al.[200] reported that BLA and lysozyme showed two state 
chemical denaturation and found that similar folding intermediate observed in both the 
proteins. Kuwajima et al. [201] reported that both the proteins showed similar folding fraction 
at early stage of folding and intermediate has similar structure during folding. 
Table 5.5 Calculation of folding constant (K), Free energy of unfolding (ΔG Kcal/mol) during 
Chemical denaturation and renaturation of BLA, BLA-AuNPST, BLA-AgNPST, and BLA-ZnONPST. 
 
 
When, we calculate the free energy of folding in presence of various concentration of GdnHCl; 
it was revealed that all the tested NP with BLA showed higher amount of negative free energy 
of folding (Table 5.5). This revealed that folding favored in terms of free energy with all tested 
NP while folding fraction vary with different NP with BLA. Therefore, protein folding fraction 
analysis, free energy calculation, and fluorescence spectroscopy clearly indicated that 
interaction of BLA with NP altered the tertiary and secondary structure of BLA to different 
extent. It was further revealed that AuNPST was unable to protect BLA structure in presence of 
GdnHCl while facilitate the folding of protein while AgNPST and ZnONPST significantly 
protected the BLA structure in presence of GdnHCl and favored the folding state of BLA. 
GdnHCl  
[M] 
BLA 
(unfold/refold) 
 
BLA-AuNPST 
(unfold/refold) 
 
BLA-AgNPST 
(unfold/refold) 
 
BLA-ZnONPST 
(unfold/refold) 
 
 K ΔG  K ΔG  K ΔG  K ΔG  
1 
0.7/ 
0.7 
0.2/ 
0.2 
0.7/ 
0.3 
0.2/ 
0.7 
0.6/ 
1.5 
0.3/ 
-0.2 
0.9/ 
1.6 
0.03/ 
-0.3 
2 
2.8x104/ 
1.3x105 
 
-6.0/ 
-7.0 
22.6x103
/ 
9.4x103 
-5.9/ 
-5.4 
10.2x103/ 
53.1x103 
-5.4/ 
-6.4 
22.8x103/ 
52.4x103 
-5.9/ 
-6.4 
 
4 
4.2x1013/ 
6.7 x1013 
-18.5/ 
-18.7 
6.4x1013/ 
4.8x1012 
-18.7/ 
-17.2 
4.7x1011/ 
1.4x1014 
-15.9/ 
-19.2 
5.3x1013/ 
4.9x1014 
-18.6/ 
-19.9 
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Figure 5.24 Chemical denaturation of HEWL in the presence of guanidine hydrochloride (0-6 M) and 
folding was calculated with (A) none, (B) AuNPST, (C) AgNPST, (D) ZnONPST. The non-linear curve 
fitting was performed using originPro2016. The R2 value for the fitted curve in the range of 0.96-0.99. 
 
HEWL denaturation and renaturation in presence of GdnHCl was performed (Figure 5.24 A-
D). the analysis of folding fraction showed that there is very less alteration in folding fraction 
of HEWL by tested NP during unfolding and refolding analysis. Moreover, free energy 
calculation also showed that interaction of AuNPST, AgNPST, and ZnONPST unable to 
drastically altered the unfolding and refolding of HEWL in the presence of different 
concentration of GdnHCl (Table 5.6). The CD spectra, and fluorescence spectra analysis with 
free energy calculation clearly indicated that all the tested NP altered the tertiary as well as 
secondary structure of HEWL protein to different extent; however, neither of tested NP able 
to drastically facilitated or inhibited the HEWL unfolding and refolding in the presence of 
GdnHCl. Ahmad and Bigelow [202] reported that free energy of folding of HEWL for 
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guanidine hydrochloride is 1.25 to 4.22 Kcal/mol*M while with urea it is 0.88 to 2.08 
kcal/mol*M. The free energy of chemical denaturation also depends on the pH, ionic strength 
and temperature of solution. Moreover, interaction of protein with NP also affect folding of 
HEWL and variation in free energy. 
Table 5.6 Calculation of folding constant (K), Free energy of folding (ΔG Kcal/mol) during chemical 
denaturation and renaturation of HEWL, HEWL-AuNPST, HEWL-AgNPST, and HEWL-ZnONPST. 
 
 
5.3.1.12 Proteinase-K digestion assay 
To understand the vulnerability of NP-bound protein to PK, we performed PK digestion assay 
of BLA and HEWL with AuNPST, AgNPST, and ZnONPST complex. Proteinase K (PK) is a 
broad-spectrum serine protease whose activity is greatly increased by the addition of 
denaturing agents that expose the PK digestion sites [105-106, 172, [203]], indicating that the 
unfolding of the substrates helps PK to degrade them. Protein interaction with NP causes 
perturbation in protein structure that was already demonstrated by fluorescence and CD spectra 
measurement. 
Hence, it was anticipated that the interaction should make the non-native protein more 
susceptible to PK. Here we performed 15% SDS-PAGE analysis and ANS hydrophobicity 
analysis experiment with both the proteins (BLA and HEWL). The samples were incubated 
with different concentration of PK (0, 1, 3, 5, 7 μM) and the reaction was stopped using PMSF. 
For ANS assay, 500 μM of ANS was added and incubated for 10 min. PMSF of 50 μM was 
added in the solution to stop the reaction and further incubated for 20 min. The digestion 
GdnHCl  
[M] 
HEWL 
(unfold/refold) 
HEWL-AuNPST 
(unfold/refold) 
HEWL-AgNPST 
(unfold/refold) 
HEWL-ZnONPST 
(unfold/refold) 
 K ΔG K ΔG) K ΔG K ΔG  
 
1 
1.4x102/ 
14.3 
-2.9/ 
-1.6 
19.7/ 
66.4 
-1.8/ 
-2.5 
35.7/ 
10.8 
-2.1/ 
-1.4 
71.8/ 
3.6x102 
-2.5/ 
-3.5 
 
2 
1.1x107/ 
6.6x106 
-9.6/ 
-9.3 
9.7x106 
/10.3 x106 
-9.5/ 
-9.5 
3.4x107/ 
4.6x106 
-10.2/ 
-9.0 
11.0x107/ 
11.5x106 
-10.9 
-9.6 
4 
1.0x1016/ 
8.3x1014 
-21.8/ 
-20.3 
2.1x1016/ 
5.6x1015 
-22.2/ 
-21.4 
2.1x1015/ 
5.4x1014 
-20.8/ 
-20.0 
1.8x1015/ 
6.3x1015 
-20.7/ 
-21.5 
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produced new fragments that reduced the band size. Moreover, for ANS assay, our hypothesis 
was that the digestion of protein by PK produced more amounts of hydrophobic fragments and 
this fragment when interacted with ANS causes enhancement of fluorescence. All samples 
were baseline corrected, and final data were plotted by subtracting the ANS fluorescence of 
native protein and respective fluorescence of PK.  
 
Figure 5.25 Proteinase-K digestion assay of various AgNPST-BLA conjugates, 20 μl of all  
loading sample contains 20 μg of BLA.  
The result clearly revealed that BLA and HEWL when in pure form, were highly susceptible 
to PK (above 3 μM of concentration completely digested fragments by PK-treatment) (Figure 
5.25, Figure 5.26) while BLA in AgNPST-BLA (Figure 5.25, and Figure 5.26 A) showed 
protection against PK digestion to higher extent but protein complex with other NP (AuNP and 
ZnONP) showed (Figure S41.A & C, Figure 5. 26 B) susceptibility under the same condition. 
Such PK-resistance of protein molecules in the protein corona over AgNP has utter 
significance. The use of NP in the biological system thus might trigger the protein into highly 
PK-resistant, which could prevent its normal degradation process in cells and resulted in the 
accumulation of non-functional proteins in cells. 
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Figure 5.26 Proteinase-K digestion assay was performed by ANS based fluorescence spectroscopy 
method. (A) PK digestion assay with different concentration of PK (1, 3, 5, 7 μM) with 0.2 mg/ml BLA; 
(B) PK digestion assay with different concentration of PK (1, 3, 5, 7 μM) with 0.2 mg/mL HEWL. 
5.3.1.13 Effect of surface capping 
Further, we also analyzed the effect of starch capping on the NP by variation in surface capping 
agent. For analysis, polyethylene glycol capped AuNP and AgNP of equivalent size were 
prepared and uncapped and starch self-assembled ZnONP was synthesized. The protein and 
NP were mixed in sodium phosphate buffer in 10:1 molar ratio and incubated for 2 h. The 
variation in Trp fluorescence and circular dichroism (CD) spectra was analyzed to analyze the 
effect of NP on protein structure (Figure 5.27 and Figure 5.28). The Trp fluorescence 
spectroscopy analysis showed that PEGylation of AuNP and AgNP weaken the NP-based 
quenching of BLA and HEWL indicated that interaction of both the NP was weaker than starch 
capped NP (Figure 5.27 A-D). Moreover, the interaction of uncapped and assembly of ZnONP 
with BLA showed that uncapped ZnONP weakly interacts with BLA while ZnONP assembly 
showed higher quenching, signifies stronger interaction than ZnONPST (Figure 5.27 E). 
However, the interaction of HEWL with uncapped and assembly ZnONP showed no 
significant difference in Trp fluorescence quenching and equivalent amount Trp fluorescence 
quenching as with ZnONPST and HEWL interaction (Figure 5.27 F).   
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The secondary structure analysis of these BLA and HEWL were also performed to analyze the 
effect of variation of capping on the secondary structure of both the proteins. The results were 
analyzed with respect to variation in absorption peak at 222 nm (indicate α-helix) and at 218 
nm (indicate β-sheet) (Figure 5.28). NP and protein were mixed in 1:2 molar ratios and 
incubated for 2 h at room temperature. The absorption peak analysis at 222 nm and 218 nm for 
various BLA-NP samples showed that PEGylation showed less effect on the secondary 
structure of BLA while starch capped AuNP and AgNP showed higher extent of secondary 
structure alteration, which was shown by higher amount of circular dichroic light absorption 
at 222 nm, therefore more amount of α-helix formation (Figure 5.28 A & C). Moreover, 
uncapped ZnONP (ZnONPuncap) and self-assembly of ZnONP (ZnONPassmb) also showed less 
effect on the secondary structure of BLA due to interaction (Figure 5.21 E).  
The CD spectra at 222 nm and 218 nm showed that the interaction of HEWL with AuNPST 
over AuNPPEG showed no significant difference in peaks. Therefore, PEGylation of AuNP 
showed the similar effect as shown by AuNPST (Figure 5.28 B), which indicated that the effect 
of AuNP on HEWL secondary structure was due to the core material of NP. Moreover, a 
similar analysis with PEGylated AgNP (AgNPPEG) also showed a similar effect in CD spectra, 
but fluorescence spectra showed that PEGylation reduced the conformational changes in 
HEWL by AgNP (Figure.5.28 D). Moreover, uncapped ZnONP (ZnONPuncap) and self-
assembly of ZnONP (ZnONPassmb) showed higher amount circular dichroic light absorption at 
222 nm and 218 nm than ZnONPST indicated a higher amount of secondary structure alteration 
and reduction in α-helix and β-sheet content Figure 5.28 F). Therefore, Trp fluorescence and 
CD spectroscopy analysis showed that variation of surface properties by capping agent and 
alteration surface structure of NP (e.g. formation of assembly) altered the interaction strength 
and different extent of secondary structure, which depends on the type of protein and NP.  
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Figure 5. 27 Trp fluorescence analysis of different BLA and HEWL sample (A) AuNP-HEWL (starch 
and PEG capped), (B) AuNP-HEWL (starch and PEG capped), (C) AgNP-BLA (starch and PEG 
capped), (D) AgNP-HEWL (starch and PEG capped), (E) ZnONP-BLA (starch, assembly and 
uncapped), (B) ZnONP-HEWL (starch, assembly and uncapped). 
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Figure 5.28 CD spectroscopic analysis of different conjugate of NP with BLA and HEWL sample (A) 
AuNP-HEWL (starch and PEG capped), (B) AuNP-HEWL (starch and PEG capped), (C) AgNP-BLA 
(starch and PEG capped), (D) AgNP-HEWL (starch and PEG capped), (E) ZnONP-BLA (starch, 
assembly and uncapped), (B) ZnONP-HEWL (starch, assembly and uncapped). 
5.3.1.14 Lysozyme activity 
The enzyme assay of various NP-protein complexes showed that starch and PEG capped AuNP 
and AgNP were unable to retain the free HEWL enzyme activity. The enzyme activity analysis 
showed that AuNPST and AuNPPEG cause loss in activity of 40% and 33%, respectively. 
Moreover, AgNPST and AgNPPEG showed 39% and 33.9% loss, respectively. This indicated 
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that PEGylation of AuNP and AgNP showed reduced the loss in enzyme activity compared 
starch capped NP. 
 
Figure 5.29 Enzyme activity of different HEWL (0.1 mg/ml) sample with HEWL-AuNP (starch and 
PEG capped), HEWL-AgNP (starch and PEG capped), BLA-ZnONP (starch capped, assembly and 
uncapped). 
When we analyzed the effect of starch-capped (ZnONPST), uncapped (ZnONPuncap), and self-
assembly (ZnONPassmb) of ZnONP on HEWL activity, the result indicated the structural 
changes in protein due to interaction causes a loss in enzyme activity. The results showed that 
ZnONPST causes 21% loss in enzyme activity while ZnONPuncap and ZnONPassmb showed 
46.9% and 39.4% loss in enzyme activity. Therefore, the enzyme activity analysis showed that 
self-assembly and uncapped ZnONP reduced the enzyme activity of protein (Figure 5.29) by 
altering the HEWL structure more severally than ZnONPST. Therefore, it is confirmed that 
variation in surface capping and its effect also vary the function of NP. However, the variation 
is mostly governing by core material because variation in surface is capping unable to protect 
the loss but can reduce the effect.  
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CHAPTER 6 
EFFECT OF GOLD AND SILVER NANOPARTICLE ON THE 
INHIBITION OF HEN EGG LYSOZYME AMYLOID FIBRILLATION 
AND ITS CELLULAR TOXICITY 
6.1 Materials and methods 
6.1.1 Materials  
Hen egg white lysozyme (HEWL) (EC 3.2.1.17), DMEM media, and Fetal bovine serum (FBS) 
were obtained from Sigma-Aldrich (Germany). Hydrochloric acid (HCl), potassium 
dihydrogen phosphate (KH2PO4), sodium chloride (NaCl), thioflavin-T (ThT), and potassium 
chloride (KCl) were purchased from Himedia (India). Mice neuroblastoma cell line, N2a and 
human keratinocyte cell line, HaCaT were procured from NCCS, Pune, India. All glassware 
was rinsed by aqua regia and washed using double distilled water and dried in hot air oven 
before use. All the experiments were performed using Milli-Q water. 
6.2 Methods 
 6.2.1 Synthesis of gold and silver nanoparticle  
For this study, starch and polyethylene glycol (PEG) capped gold and silver nanoparticles 
(AuNP and AgNP) were synthesized by the wet chemical method and characterized by 
standard techniques for size, shape, and stability analysis. Detail protocol was already 
described in chapter-4.  
6.2.2 Preparation of amyloid 
Hen egg white lysozyme (HEWL) solution was prepared as described by Liu and Wang with 
slight modification [118]. Protein (70 μM) samples were prepared in hydrochloric acid (pH 
2.0), which contain 2.7 mM KCl, 137 mM NaCl, and 0.01% (w/v) NaN3. The solutions (20 
mL) were incubated in a shaker incubator at 58 ⁰C temperature and at a shaking speed of 100 
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rpm. Further, amyloid samples were analyzed by various standard methods such as thioflavin-
T fluorescence assay and electron microscopy. 
6.2.3 Electron microscopic imaging of amyloid samples  
The amyloid growth was observed by atomic force microscopy (AFM) (Agilent 5500) and 
field emission scanning electron microscopy (FESEM) (Nova Nano-SEM) at 5 kV voltage, 
and TEM (CM 200, Phillips). For AFM analysis, samples were deposited by drop casting 
method, dried under vacuum and analyzed in tapping mode. For FESEM analysis, the sample 
was drop cast on silica wafer and dried under vacuum for overnight and gold coated for 1 min 
using sputtering of the sample. For TEM analysis, the sample was deposited on a copper grid 
of 300 meshes, negatively stained with uranyl acetate and dried in a vacuum drier for overnight 
before analysis. 
6.2.4 Analyzing the effect of AuNP and AgNP 
The effect of ZnONP (uncapped, starch capped, and self-assembly) on the HEWL amyloid 
growth was analyzed. A fixed concentration of three types of NP (10 μM) was administered to 
70 μM protein samples at 0 h and incubated at 58 ⁰C for 72 h, and amyloid growth kinetics 
was monitored by Thioflavin-T fluorescence assay performed at an interval of 12 h up to 120 
h. Moreover, the effect of different concentration of AuNPST and AgNPST (0.1, 0.2, 0.5, 1, 2, 
5, 10, and 20 μM) on the growth and structure of amyloid was also analyzed after 72 h of 
incubation. The effect of NP on the different phases of growth such as lag, log phase, and 
stationary phase was also monitored by adding optimized NP sample. Moreover, the surface 
hydrophobicity was studied by protein-bound ANS fluorescence assay. The ζ-potential and 
hydrodynamic size distribution were analyzed by a zeta sizer (Nano-ZS, Malvern Pvt.). The 
structural change of amyloid was monitored by measuring Tryptophan (Trp) fluorescence 
spectra (Cary Eclipse, Agilent Pvt.) and secondary structural analysis was performed by 
Circular dichroism (CD) (Jasco-815) spectroscopy. The surface morphology and assembly of 
amyloid was observed by electron as well as atomic force microscopy using TEM (Jeol), AFM 
(Agilent), and FESEM. 
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6.2.5 Thioflavin-T (ThT) fluorescence measurement  
The amyloid samples were diluted to 7 μM concentration and ThT was added such that the 
final concentration of ThT was 20 µM in sodium phosphate buffer, pH 7.4. The solutions were 
incubated for 20 min before spectrofluorometric (Cary eclipse, Agilent) analysis. The 
excitation was set at 440 nm and emission was recorded between 460-600 nm. The excitation 
and emission slit width were set at 5.0 and 10 nm, respectively. The growth of amyloid fibers 
was analyzed by ThT fluorescence at a different time interval (0, 24, 36, 48, 60, 72, 84, 96, 
108, 120 h), and emission was recorded. The amyloid growth curve was plotted with time (h), 
using the area under the curve of ThT emission spectra. The contribution of free ThT was 
subtracted before analysis. 
6.2.6 1-Anilinonaphthalene-8-sulfonic (ANS) assay 
The protein-bound ANS fluorescence assay was performed in 3 mL sodium phosphate buffer 
(20 mM). The amyloid sample was diluted to make the final concentration of protein and ANS 
of 7 µM and 150 µM, respectively. The solution was incubated for 30 min before measuring 
ANS fluorescence. The samples were excited at 350 nm and emission spectra were recorded 
between 400 and 600 nm by a Cary eclipse fluorescence spectrophotometer (Agilent Pvt. Ltd.). 
The excitation and emission slit width were adjusted at 5 and 10 nm, respectively 
 6.2.7 Dynamic light scattering and ζ-potential analysis  
The hydrodynamic size distribution of amyloid samples was analyzed by a zeta sizer (Malvern 
Nano-ZS series). Moreover, Aggregation index (AI) was also calculated to monitor the larger 
aggregate formation by protein. The size of protein aggregates was also monitored using DLS 
particle size analysis in dual angle mode. Aggregation index (AI) was calculated using the 
following equation: 
𝑨𝑰 =  
(𝒁𝒂𝒗𝒆𝒓𝒂𝒈𝒆 𝒇𝒐𝒓𝒘𝒂𝒓𝒅)
 (𝒁𝒂𝒗𝒆𝒓𝒂𝒈𝒆 𝒃𝒂𝒄𝒌𝒘𝒂𝒓𝒅)
− 𝟏 − − − − − − − (𝟏) 
 104 
 
Zaverage forward is hydrodynamic size analyzed at a forward angle, and Zaverage backward is 
hydrodynamic size at a backward angle. 
The ζ-potential of amyloid samples was analyzed by the zeta sizer (Malvern Nano-ZS series) 
connected with a DLS particle size analyzer. The samples were diluted five times with distilled 
water, and ζ-potential of samples was estimated in a disposable cuvette. 
6.2.8 Circular Dichroism (CD) analysis 
 CD spectra of lysozyme amyloid samples (14 μM) were analyzed in the range of 200-260 nm. 
The baseline correction of the sample was performed. The mean residual ellipticity was plotted, 
and percentage β-sheet was estimated by using CAPITO online server [192]. All the data were 
converted to molar residue ellipticity (MRE) by using following equation: 
𝑴𝑹𝑬 =  
𝑶𝒃𝒔𝒆𝒓𝒗𝒆𝒅 [𝜽] ·  𝟏𝟎𝟔
𝒏 ·  𝒄 ·  𝒍
− − − − − − − (𝟐) 
   Here, n is a number of amino acids, c is the concentration of protein in μM, ‘l’ is path length 
in mm. 
 6.2.9 Intrinsic fluorescence analysis  
Tryptophan (Trp) fluorescence of protein samples was also measured by exciting the sample at 
295 nm and recording emission in the range of 300-400 nm, with an excitation and emission slit 
width of 5 and 10 nm, respectively. 
6.2.10 Effect of surface capping 
We have also used the polyethylene glycol (PEG-400) capped AuNP and AgNP of equivalent 
size of different concentration (0.1, 0.2, 0.5, 1 μM) in amyloid formation condition. The Th-T 
binding assay, surface hydrophobicity and zeta potential, secondary structure analysis, 
hydrodynamic size, morphology, and intrinsic fluorescence were analyzed and compared with 
starch capped AuNP of equivalent concentration.  
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6.2.11 Analyzing cytotoxicity of amyloid  
The cytotoxicity of amyloid produced with all NP was also analyzed, in mice neuroblastoma 
N2a cells and normal skin HaCaT cells. The cell lines were procured from the repository in 
NCCS, Pune. The obtained cells were cultured in Dulbecco's modified Eagle's medium 
(DMEM) with 10% fetal bovine serum. The obtained cells were counted using cell counter and 
2000 cells/ well were inoculated in each well of 96 well plate at 37 ⁰C and 5% of CO2 humidity 
maintained for 24 h. Both the NP, amyloid and amyloid with NP was first washed using sterile 
water then resuspended in culture media. The 5, 10, 50 μM of the sample were inoculated, and 
highest concentration (50 μM) was reported. The cells were treated with MTT (0.5 mg/ml) after 
24 h of administration of samples and after 2 h of incubation; the undissolved MTT was 
solubilized by using DMSO. Further, the cells were analyzed at 595 nm, and cell viability was 
calculated by dividing the absorbance of treated cells with control cells, Mean±SD, n. =3. 
Cell viability (%) = (ODtreated / ODcontrol) x 100 
Here, ODtreated is OD 595 of amyloid treated cell; ODcontrol is OD 595 of untreated cells. 
6.3 Results and discussion 
The synthesis and characterization of nanoparticles were described in chapter-4. 
6.3.1 Monitoring the amyloid growth 
The in vitro monitoring of amyloid formation was performed using enhancement of thioflavin-
T (ThT) fluorescence emission due to specific binding of ThT with cross β-sheet [204, 205]. 
The ThT assay was performed to quantify the amyloid growth at every 12 h of time interval 
up to 120 h. Further, the variation in surface zeta potential, hydrophobicity, intrinsic 
fluorescence (tryptophan, and tyrosine), and secondary structure were also monitored.  
AuNPST and AgNPST (10 μM) were administered at 0 h of amyloid formation, and ThT binding 
assay was performed by the exciting sample at 440 nm, when excitation and emission slit width 
was 5 and 10 nm, respectively. The ThT area under the curve was plotted with regard to time 
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(Figure 6.1 A). The ThT binding assay showed that administration of AuNPST and AgNPST 
caused the inhibition of amyloid growth. Here, we analyzed that addition of NP slowed down 
the growth of amyloid compared to control (amyloid formed without NP). When an equal 
amount of NP at 0 h of growth was administered, AuNPST showed higher amyloid inhibition 
potential than AgNPST. Further, we also analyzed the time-dependent variation in surface 
properties by zeta potential, and surface hydrophobicity measurement of both control and test 
samples of amyloid with NP. 
6.3.2 Surface zeta potential  
Change of surface zeta potential with time was analyzed using Malvern zeta sizer. The HEWL 
(1 mg/ml) was incubated in acidic buffer (pH 2.2), and high temperature (58 ⁰C) for 120 h and 
zeta potential of samples were analyzed at every 12 h of the interval. It was observed that the 
zeta potential of native HEWL in phosphate buffer (pH 7.4) was +6.14 mV, which was reduced 
to +1.89 mV for amyloid (with none) after 2 h, while amyloid with AuNPST showed -0.679 
mV and +1.66 mV with AgNPST. From here, it was cleared that initially, all three protein 
samples (i.e. amyloid, amyloid-AuNPST, and amyloid-AgNPST) lost the solution stability due 
to reducing surface charge. However, after 36 h of incubation, amyloid samples showed 
enhanced zeta potential of +29.8 mV, +33.6 mV, +33 mV for amyloid, amyloid-AuNPST, and 
amyloid-AgNPST, respectively.  
6.3.3 Surface hydrophobicity  
Surface hydrophobicity of a protein plays an important role in the kinetics of amyloid growth. 
The formation of a higher amount of hydrophobic surface also promotes the assembly of 
protein during aggregation and amyloid formation [206]. Therefore, the presence of higher 
amount of hydrophobic amino acid on the protein surface enhances the assembly of protein by 
hydrophobic interactions. Here, we observed that amyloid sample (without NP) showed higher 
surface hydrophobicity up to 48 h of incubation; however, hydrophobicity start decreasing 
thereafter. Moreover, amyloid samples treated with both NP showed lower surface 
hydrophobicity than amyloid without NP (Figure 6.1 C) throughout the growth analysis. 
However, it was observed that during maturation phase of growth surface hydrophobicity of 
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pure amyloid start decreasing; the reason might be the interaction of hydrophobic surfaces and 
amyloid assembly (Figure 6.1 C). 
 
Figure 6.1 The growth profile of amyloid in the presence of AuNPST and AgNPST. The amyloid growth 
monitored by (A) ThT binding fluorescence (B) surface zeta potential, (C) surface hydrophobicity 
(ANS fluorescence) (D) MRE value at 218 nm (correspond to β-sheet).  
The time-dependent surface hydrophobicity, zeta potential, ThT analysis showed that amyloid 
assembly depends on the hydrophobicity and charge of the amyloid surface. The Higher 
positive charge might inhibit the assembly process due to repulsion force between similar 
charges while higher surface hydrophobicity facilitates the same and subsequently formation 
of amyloid fibers. Marshell et al. [207] , reported that hydrophobic, aromatic, and electrostatic 
interactions play an important role in amyloid fibril formation as well as stability. Moreover, 
Raman et al. [208] reported that the amyloid fibril growth and stability highly depends on the 
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critical balance of electrostatic and hydrophobic interactions. The hydrophobicity and charge 
analysis showed that NP, which reduced the surface hydrophobicity but increases the surface 
zeta potential of proteins showed inhibition of amyloid fibers assembly. 
6.3.4 Atomic force microscopic analysis of amyloid morphology 
We applied atomic force microscopy (AFM) to analyze the morphology of amyloid formed 
after 120 h of incubation under different conditions. AFM analysis showed that HEWL formed 
thin and long fibers by the assembly of protofibrils (Figure 6.2. A); However, administration 
of AuNPST and AgNPST (20 μM each), inhibited the fibrillar growth. It was further observed 
that AuNPST was able to completely inhibit the amyloid fibril assembly and formed the 
amorphous protein aggregates of smaller size (Figure 6.2 B).  
 
Figure 6.2 AFM analysis of amyloid fibrils in different conditions. Amyloid prepared with (A) none, 
(B) AuNPST, (C) AgNPST  
Moreover, AFM analysis of amyloid with AgNPST showed that AgNPST was able to form larger 
aggregates of proteins (Figure 6.2. C). From AFM analysis, it was clear that different metal 
nanoparticles of equivalent size and similar surface capping agent could affect the growth of 
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amyloid fiber assembly and structure and prevent the amyloid formation to a different extent 
and developed the different morphology of protein aggregates.  
6.3.5 CD measurement 
The secondary structure analysis of HEWL samples (without and with NP) using CD 
measurement showed that administration of AuNPST (10 μM) causes reduction of β-sheet 
production of HEWL. The results showed that after 72 h of incubation pure amyloid showed 
68% of β-sheet formation (Figure 6.1 D), but HEWL produced with AuNPST (Figure 6.3 D), 
and AgNPST (Figure 6.1 D) showed much-reduced amount of β-sheet i.e. 39% and 47%, 
respectively. Such drastic reduction of β-sheet was perhaps associated with the inhibition of 
amyloid fiber formation.  
6.3.6 Intrinsic fluorescence 
The variation in intrinsic fluorescence is an important tool to analyze the conformational 
changes in the protein. It was observed that fluorescence quenching and a shift in emission 
wavelength indicate the variation in the microenvironment of the protein [182-184]. Therefore, 
variation in protein tryptophan fluorescence with time was analyzed by exciting samples at 
295 nm and emission was recorded between 300-400 nm using fixed excitation and emission 
slit width of 5 and 10 nm, respectively. Both the amyloid sample (with none, and AuNPST) 
showed equivalent fluorescence quenching, but amyloid prepared with AgNPST showed a 
higher amount of quenching up to 48 h of incubation (Figure 6.3). However, at 60 h of growth 
of amyloid (produced with AuNPST and AgNPST) showed less amount of quenching than pure 
amyloid. Moreover, after 72 h, amyloid prepared with both NP showed less fluorescence 
quenching than pure amyloid (Figure 6.3). The time-dependent Trp fluorescence analysis 
showed the continuous tertiary structure transition in during amyloid growth. The pure amyloid 
sample showed quenching in Trp fluorescence with a red shift in emission peak this fact 
indicated that during amyloid formation Trp and hydrophobic core of protein exposed to the 
polar environment. However, the later state of growth, assembly of fibrils showed the 
movement of Trp toward non-polar environment with some blue shift in emission.  
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Figure 6. 3 Tryptophan fluorescence spectra of amyloid prepared with (A) none, (B) AuNPST, (C) 
AgNPST. 
Moreover, Trp fluorescence analysis of an amyloid sample prepared with NP showed 
fluorescence quenching with a blue shift in emission indicated that fluorescence quenching 
was related with the interaction of amyloid with NP. It was also revealed that intrinsic 
fluorescence and conformational changes vary with the type of NP administered in amyloid 
solution, which causes variation in exposure of Trp residue to polar environment and 
subsequently the amyloid growth.  
6.3.7 Effect of NP dose 
To analyze the effect of different doses of AuNPST and AgNPST in amyloid formation, we used 
a wide range of NP concentration i.e. 0.1, 0.2, 0.5, 1, 5, 10, and 20 μM with 1 mg/ml of HEWL 
protein and incubated up to 120 h. Further, ThT binding assay, surface hydrophobicity analysis 
by ANS binding, zeta potential analysis, aggregation index (AI) analysis, Trp fluorescence 
analysis, and TEM analysis were performed. 
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The ThT analysis showed that binding of ThT with amyloid cross β-sheet structure 
continuously decreased with an increment of both the NP concentration up to the 20 μM 
(Figure 6.4 A and Figure 6.5 A). However, it was observed that increment of AuNPST showed 
higher effect than AgNPST of similar concentration. The ThT emission analysis clearly 
indicated that AuNPST was more effective to inhibit the amyloid fibrillar assembly than 
AgNPST of similar concentration.  
Further, we analyzed the effect of different concentration of NP in the structure of HEWL 
amyloid by circular dichroism (CD) and fluorescence spectroscopic analysis. The CD analysis 
of different amyloid sample showed that addition of both NP causes inhibition of β-sheet 
formation with AuNPST showed the highest effect. The pure amyloid sample showed 68% of 
β-sheet formation from 19% of native HEWL. However, incubation of HEWL with different 
concentration of AuNPST and AgNPST causes the formation of 57 to 40% of beta-sheet content 
with AuNPST (Figure 6.4 B), however, AgNPST showed 62- 51% beta- sheet for the same 
concentration of NP (Figure 6.6 B). Further, we have analyzed the effect of NP concentration 
on the surface hydrophobicity of amyloid protein (Figure 6.4 C and Figure 6.5 C). Here, we 
observed that increment of AuNPST concentration causes a reduction in surface hydrophobicity 
compared to amyloid without NP (Figure.6.4 A). However, we also observed that similar 
amount of AgNPST showed the insignificant effect on the surface hydrophobicity of amyloid 
(Figure 6.5 C). 
Moreover, analyzing the zeta potential of NP treated amyloid sample showed that increasing 
the AuNPST concentration up to 20 μM causes increment of zeta potential from 30 mV to 40 
mV (Figure 6.4 D). When we have analyzed the zeta potential of AgNPST treated sample, the 
results showed that increment of AgNPST concentration up to 10 μM causes an increment of 
zeta potential to 38 mV but further increment causes saturation of zeta potential to 39 mV 
(Figure 6.5 D). Zeta potential analysis showed that stability of amyloid and its assembly vary 
with the type of NP and concentration added in solution. Here, we observed that AuNPST 
showed higher potential to inhibit amyloid growth, which was shown by reduced ThT 
fluorescence, and CD spectroscopy.  
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Figure 6.4 The effect of different concentration of AuNPST (5, 10, 20 μM) in amyloid fibrils formation. 
(A) ThT binding assay, (B) CD analysis, (C) surface hydrophobicity analysis by ANS binding 
fluorescence, (D) zeta potential analysis, (E) Trp fluorescence variation.  
Further, we analyzed the surface properties of amyloid samples by surface hydrophobicity 
analysis and net surface charge by zeta potential analysis. The surface hydrophobicity analysis 
was performed using ANS, samples were excited at 350 nm, and emission was recorded at 481 
nm (Figure 6.4 C & D and Figure 6.5 C & D). The results showed that amyloid sample with 
AuNPST and AgNPST showed decreased in surface hydrophobicity and enhanced positive zeta 
potential with increasing NP concentrations. From ANS binding fluorescence and zeta, the 
potential analysis showed that administration of different concentrations of NP enhanced the 
solution stability of protein-NP conjugates and reduced the amyloid formation. 
Here, we observed that AuNPST cause a reduction in surface hydrophobicity (Figure 6.4 C) 
while AgNPST was unable to change the surface hydrophobicity significantly (Figure 6.5 C); 
however, both NPs increase the zeta potential.  
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Figure 6.5 The effect of different concentration of AgNPST (5, 10, 20 μM) on amyloid fibril formation. 
(A) ThT binding assay, (B) CD analysis, (C) surface hydrophobicity analysis by ANS binding 
fluorescence, (D) zeta potential analysis, (E) Trp fluorescence variation. 
This indicated that although AgNPST increased the surface zeta potential but simultaneously it 
was less efficient to protect the hydrophobic patches evolved during amyloid formation. 
Moreover, AuNPST not only reduced the surface hydrophobicity but also increased the surface 
zeta potential at higher concentrations. Analyzing the dose-dependent effect of NP on amyloid 
formation clearly indicated that amyloid formation and assembly depends on both zeta 
potential and surface hydrophobicity of protein and the NP that were able to reduce the 
hydrophobicity and increased zeta potential, which indicates higher inhibition potential.    
Further, we analyzed the Trp fluorescence by exciting protein sample at 295 nm. The 
administration of different doses of AuNPST and AgNPST (5, 10, 20 μM) and analyzing the 
variation in Trp fluorescence to study the variation in tertiary structure (Figure 6.4 E) and 
(Figure 6.5 E). Here, we observed that administration of different dose of AuNPST enhanced 
the Trp fluorescence to a greater extent than amyloid produce with none (i.e. 10 μM)  
(Figure 6.4 E); this indicated the movement of Trp toward the non-polar environment. 
However, amyloid with AgNPST showed a gradual decrease in Trp fluorescence with 
increasing NP concentration (Figure 6.5 E), which indicated that during interaction Trp was 
expose to the more polar environment and causes quenching in fluorescence. It was also 
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observed that amyloid sample prepared with AuNPST showed the different extent of blue shift 
(2-10 nm) in Trp fluorescence, while redshift (5-10 nm) was observed in the case of AgNPST. 
Trp fluorescence analysis indicated structural changes in amyloid also depends on the 
concentration of administered NP. Moreover, some other reports also observed the similar type 
of phenomenon. Medina et al. [209] reported that adsorption of protein on NP surface and 
aggregation of NP-protein complex highly depends on the NP to protein molar ratio. Radic et 
al. [210] in their simulation study reported that the effect of NP on amyloid growth varies with 
the variation of NP to protein molar ratio and strength of interaction. Therefore, our 
observation also supports this observation and revealed that variation in NP to protein ratio 
causes variation in amyloid structure.  
 
Figure 6.6 Analysis of amyloid Aggregation index (AI) of amyloid samples produced with different 
concentration of AuNPST and AgNPST of 0-20 μM.(The calculation of AI value was given in “Method 
section 6.1.7” of this chapter.) 
TEM and aggregation index (AI) analysis of amyloid sample showed that increasing the NP 
concentration inhibited the assembly of fibrils assembly and subsequently inhibited the 
formation of long fibers (Figure 6.6, and Figure 6.7). Therefore, both the results confirmed that 
administration of starch capped AuNP and AgNP not only inhibited the amyloid β-sheet 
formation to a different extent but also prevented the assembly of formed amyloid fibrils and 
produced fragmented amyloid fibers with small aggregates (Figure 6.6, Figure 6.7 B & C and 
Figure 6.7 D &E), respectively. The Figure 6.7 (A) and (D) are amyloid sample without NP. 
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Figure 6.7 TEM analysis of amyloid samples formed with different concentration of AuNPST and 
AgNPST. amyloid formed with (A) with none, (B) 5 μM (C) 10 μM of AuNPST; (D) with none, (E) 5 
μM and (F) 10 μM of AgNPST.  
6.3.8 Effect of administration time  
Most of the reports on the effect of NP on amyloid growth ignored that variation in efficacy of 
NP on a different state of amyloid growth. Therefore, it is essential to observe the effect of NP 
on the different states of amyloid growth. Here, we used AuNPST, and AgNPST of 10 μM to 
observe the role of the NP administration time on amyloid growth. Therefore, we administered 
both the NP at the beginning of the amyloid growth (0 h), the intermediate state of growth (36 
h) and a later phase of growth (48 h). The amyloid growth was analyzed by ThT binding assay 
and CD spectroscopy by quantifying the β-sheet contents. 
The ThT binding analysis showed that administration of both the NP was most effective when 
we administered the NP at the beginning of amyloid growth (0 h) (Figure 6.8 A & B). The 
reason might be the interference of NP in amyloid nucleation during growth while 
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administration of NP during later phase might inhibit the assembly of precursor molecule, 
secondary nucleation, and growth. However, we also observed that administration of both the 
NP showed less effect on the amyloid growth when administered in the intermediate phase (36 
and 48 h), which is a well-known fact for the formation of small fibrils by the assembly of the 
nucleus. The reason might be the bulk amount of nucleus formed during initial phase and 
interaction of NP with nucleus might act as a solid support for amyloid nucleus and 
unavailability free NP for further interaction during intermediate phase might promote fibril 
formation and secondary growth. However, the addition of NP after the initial state of growth 
might inhibit the assembly of nucleus and protofibril to form long fibrils due to the availability 
of free NP to interact.  
 
Figure 6.8 ThT analysis of amyloid produced with AuNPST and AgNPST administered at 0, 36, 48 h. 
Amyloid prepared with (A) AuNPST (B) AgNPST. 
Further, the effect of both the NP administration time on Trp fluorescence of amyloid (Figure 
6.8 A & B) was analyzed. The result showed that administration of AuNPST during 
intermediated and final phase of growth causes quenching of intrinsic fluorescence (Figure 6.8 
A). However, the addition of AuNPST during the early phase of growth showed the lower extent 
of quenching of fluorescence compared to amyloid with none. Different extent of Trp 
fluorescence quenching due to the administration of NP in different time indicated the different 
conformational state of amyloid. Moreover, AgNPST administration during a different phase 
of amyloid growth showed quenching in Trp fluorescence in all cases but the different extent 
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of red shift. This fact indicated that AgNPST administration causes exposure of Trp to the polar 
environment due to different extent of conformational changes (Figure 6.9 B). 
 
Figure 6.9 Trp fluorescence spectra of various amyloid samples when NP administered at different 
time (0, 36, 48 h) (A) amyloid with AuNPST (B) amyloid with AgNPST . 
Further, it was observed that the addition of NP during 0 h showed highest zeta potential of 45 
mV while administration at 36 h and 48 h reduce the zeta potential to 33 mV and 27 mV (Figure 
6.10 A), respectively. Moreover, AgNPST administration at 0 h and 36 h showed higher zeta 
potential of 40 and 34 mV indicated the higher stability of amyloid solution (Figure 6.10 B). 
Therefore, it was observed that administration time also affect the stability of amyloid solution 
and subsequently the assembly of fibrils. 
 
Figure 6.10 Stability of various amyloid samples when NP administered at different time (0, 36, 48 h) 
(A) amyloid with AuNPST (B) amyloid with AgNPST .  
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The ANS fluorescence measurement of amyloid samples showed that the administration time 
of NP also affects the exposure of hydrophobic surface (Figure 6.11). The AuNPST 
administration at 0, 36, and 48 h showed the lower amount of exposure of hydrophobic surface 
compared to amyloid samples. When NP was administered at 48 h (Figure 6.11 A), showed 
more amount of hydrophobic surface compared to 0 and 36 h amyloid samples but lower than 
amyloid with none during amyloid formation. Moreover, the addition of AgNPST at 48 h also 
showed the exposure of more hydrophobic surfaces compared to an amyloid sample formed 
by the addition of AgNPST (administered at 0 h and 36 h) (Figure 6.11 B). Therefore, ANS 
analysis also revealed that administration time also could affect the surface hydrophobicity and 
subsequently the stability of amyloid samples, which is essential for amyloid β-sheet formation 
and assembly of amyloid precursor to form long fibers. 
However, it was observed that higher surface potential might prevent the amyloid formation 
and assembly even for a sample having higher surface hydrophobicity, which was cleared by 
ThT assay.  
Further, CD spectroscopy analysis was performed to analyze the effect of NP administration 
time on the secondary structure of amyloid (Figure 6.12 A & B). The obtained data were 
analyzed using CAPITO server [192] for CD data analysis. The CD analysis showed that 
administration of both NP at 0 h and 36 h drastically reduced the formation of β-sheet; 
however, administration of NP at 48 h showed the least effect on the amyloid growth. It was 
observed that administration of 10 μM of AuNPST and AgNPST at 0 h produces 40% and 46% 
of β-sheet compared to pure amyloid (68%). 
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Figure 6.11 ANS fluorescence of amyloid samples produced with AuNPST and AgNPST when 
administered at 0, 36, and 48 h (A) AuNPST (B) AgNPST.  
Moreover, administration of NP at 48 h showed the least effect and produced the 57% and 59% 
of β-sheet. However, administration of NP at 36 h showed 48% and 52% of β-sheet for AuNPST 
and AgNPST. Here, we concluded that reduced amyloid growth due to the administration of 
NP might be due to the inhibition of amyloid protofibrils assembly and further nucleus 
formation and subsequent growth of amyloid fibers. However, a higher amount of amyloid 
formation due to the administration of NP at 48 h compared to 0 and 36 h might be due to the 
availability of nucleus and protofibrils and subsequently amyloid assembly. Therefore, we 
concluded that our NP was unable to effectively inhibit or slow down the protofibrils and 
assembly formation but affect the nucleation amyloid. Various reports on the effect of NPs and 
active surfaces on amyloid growth also reported the various effects of tested surface on a 
different state of amyloid growth. Lines et al. [37] reported that co-polymer NP, cerium oxide 
NP, quantum dots, and carbon nanotubes promote the nucleus formation of β2-microglobulin. 
Moores et al. [211] reported that variation in surface charge and hydrophobicity of surfaces 
also vary the amyloid formation. Moreover, Zhu et al. [212] reported that mica surface 
enhances the protofibril formation and subsequent amyloid assembly compared to free protein. 
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Figure 6.12 CD spectroscopy of amyloid produced with AuNPST and AgNPST when administered at 0, 
36, 48 h (A) AuNPST (B) AgNPST . 
 6.3.9 Effect of capping 
Further, we analyzed the effect of the capping agent on amyloid growth. Since polyethylene 
glycol-400 (PEG-400) has been reported as non-toxic and used as a capping agent to reduce 
the protein absorption on the NP surface [213] and to develop NP with stealth properties 
against immune system [56, 214]. We also used different concentrations (0.1-1 μM) of PEG 
capped AuNP and AgNP of equivalent size in HEWL amyloid forming condition. The ThT 
assay results showed that PEG capped NP showed a lesser amount of amyloid than starch 
capped NP (Figure 6.13. A & B) and (Figure 6.14 A & B), which is demonstrated by reduced 
ThT binding fluorescence.  According to previous reports on PEGylated NP and protein 
interaction, PEGylation reduced the protein adsorption on NP surface. Therefore chances of 
formation of hard corona on NP surface is less with PEGylated NP. Hence, the interaction of 
PEGylated nanoparticles might have disturbed the equilibrium of amyloid growth in solution 
by dynamic interaction on NP surfaces. Radic et al. [210] showed by their analysis that 
dynamic interaction disturbed the amyloid growth by continued depletion of the precursor from 
solution. It was also revealed these type of NP amyloid interaction showed inhibition in 
amyloid at a lower concentration of NP to protein ratio. This fact clearly indicated that reducing 
the protein absorption on the NP surface using PEG as a capping agent might facilitate the 
other type of interactions with NP and showed the enhanced potential of amyloid inhibition by 
PEGylated NP.  
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Figure 6.13 Effect of different concentrations (0.1-1 μM) of (A) starch and (B) PEG capped gold 
nanoparticles on the amyloid formation by the thioflavin-T binding assay. 
 
Figure 6.14 Effect of different concentrations (0.1-1 μM) of (A) starch and (B) PEG capped silver 
nanoparticles on the amyloid formation was analyzed by the thioflavin-T binding assay. 
 The Trp fluorescence analysis of amyloid produced with starch and PEGylated AuNP and 
AgNP at various concentration (Figure 6.15 A & B for AuNP), (Figure 6.16 A & B for AgNP) 
was studied. It was observed that PEGylated AuNPST showed concentration-dependent 
quenching of Trp fluorescence while AuNPST did not show such effect (Figure 6.15). This fact 
indicated that at lower concentration (0.1-1 μM) of starch capped AuNP showed a lesser effect 
in Trp fluorescence (Figure 6.15 A) while the similar concentration of PEGylated AuNP 
showed concentration-dependent quenching of Trp fluorescence (Figure 6.15 B). However, a 
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higher amount of AuNPST (5-20 μM) showed significant variation in Trp fluorescence (Figure 
6.5 E).  
 
Figure 6.15 Effect of different concentrations (0.1-1 μM) of (A) starch and (B) PEG capped gold 
nanoparticles on the amyloid samples monitored by Trp fluorescence spectroscopy.  
Further, analyzing the effect of PEGylated AgNP on Trp fluorescence showed that variation 
in Trp fluorescence is less compared to pure amyloid sample, while administration of similar 
amount of AgNPST (0.1-1 μM) showed significant variation in Trp fluorescence. This fact 
indicated that the lower concentration quenched the Trp fluorescence to different extent while 
showed less shift (blue or red shift) Trp fluorescence compared to pure amyloid (Figure 6.16 
A); however, PEGylated AgNP showed less quenching of Trp fluorescence but showed 
simultaneous blue shift in emission, indicated the movement of Trp toward non-polar 
environment (Figure 6.16 B). Therefore, PEGylated AgNPST affects the tertiary structure more 
drastically than AgNPST. 
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Figure 6.16 Effect of different concentrations (0.1-1 μM) of (A) starch and (B) PEG capped AgNP on 
the amyloid samples monitored by Trp fluorescence spectroscopy.  
 
Figure 6.17 Effect of different concentrations (0.1-1 μM) of (A) starch and (B) PEG capped AuNP on 
hydrodynamic size variation. (C) Amyloid surface zeta potential same sample. 
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Further, we analyzed the hydrodynamic size and surface zeta potential of amyloid samples 
treated with starch and PEGylated AuNP and AgNP (Figure 6.17) and (Figure 6.18). The DLS 
analysis showed that addition of PEGylated NP produced smaller fibers while starch capped 
AuNP showed multiple peaks; indicates the formation of poly-dispersed NP-protein aggregates 
(Figure 6.16 A & B). Zeta potential analysis showed that increasing the AuNPST concentration 
also increase the zeta potential of amyloid (46 mV) while AuNPPEG of same concentration 
showed less effect on the amyloid zeta potential (39 mV) (Figure 6.17 C). Therefore, starch 
capped and PEG capped AuNP produced highly stable amyloid suspension.  
 
Figure 6.18 Hydrodynamic size and surface zeta potential of amyloid, when the different concentration 
of (A) starch AgNP (B) PEG capped AgNP on hydrodynamic size variation. (C) surface zeta potential 
amyloid with AgNPST and AgNPPEG. 
We analyzed hydrodynamic size distribution and zeta potential of the amyloid samples 
prepared with the different concentration of AgNPST and AgNPPEG (Figure 6.17). The DLS 
analysis showed that AgNP (starch and PEGylated) produced highly poly-dispersed protein 
aggregates (Figure 6.18 A & B). Moreover, the result showed that although AgNP increased 
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the zeta potential of the amyloid solution and above 0.2 μM causes drastic enhancement of zeta 
potential in case of both starch capping and PEGylated AgNP and both samples showed zeta 
potential more than > 40 mV. Hydrodynamic size and zeta potential analysis showed that even 
PEGylation produced a more stable amyloid solution and therefore, reduced the chance of 
assembly of amyloid protein precursors.   
 
Figure 6.19 Effect of different concentrations (0.1-1 μM) of starch and PEG capped gold nanoparticles 
on the amyloid surface hydrophobicity.  
Further, we analyzed the effect of capping agent on the surface hydrophobicity of amyloid 
samples (Figure 6.19 and Figure.6.20). The results showed that addition of different 
concentration of PEGylated AuNP reduced the surface hydrophobicity of amyloid solution 
while starch capped AuNP showed less effect at lower concentrations (Figure 6.19 A & B) and 
found that increasing the concentration of AuNPPEG from 0.5 μM to 1 μM causes drastic 
reduction in surface hydrophobicity (Figure 6.19 B); however, similar concentration of 
AuNPST showed less effect. Further, analyzing the effect of PEGylated AgNP showed the 
similar kind of effect (Figure 6.20). AgNPPEG showed a reduction in surface hydrophobicity 
more drastically than amyloid samples with AgNPST of similar concentrations.  
Therefore, surface hydrophobicity analysis indicated that PEGylation of AuNP and AgNP 
reduced the exposer of hydrophobic patches and subsequent hydrophobic interaction of 
proteins while higher zeta potential of amyloid samples prepared with PEGylated NP; further, 
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inhibit the assembly of amyloid by similar charge repulsion force, therefore, inhibit the 
amyloid formation and assembly.  
 
Figure 6.20 Effect of different concentrations (0.1-1 μM) of starch and PEG capped silver nanoparticles 
on the amyloid surface hydrophobicity.  
Further, CD spectroscopy analysis of amyloid samples showed that the reduced ThT 
fluorescence was closely correlated with decreased in β-sheet formation. It was observed that 
increasing the AuNPPEG and AuNPST concentration from 0.1 to 1 μM also reduced the β-sheet 
content of amyloid sample; however, PEGylation of AuNP causes higher amount of reduction 
in β-sheet from 68%- 38% (Figure 6.21 A, Tab 6.1) while similar amount of AuNPST produced 
49% of β-sheet (Figure 6.22 A). The result showed that AgNPST and AgNPPEG inhibit beta-
sheet content of 17%, and 30%, respectively (Figure 6.22 A & B, and Table-6.2). The results 
clearly indicated that PEGylation of AgNP enhance inhibition of cross-beta-sheet formation in 
HEWL during amyloid growth even at a lower concentration of AgNP than starch capped NP.  
 127 
 
 
Figure 6.21 Effect of different concentrations (0.1-1 μM) of starch and PEG capped gold nanoparticles 
on the amyloid secondary structure.  
 
Figure 6.22 Effect of different concentrations (0.1-1 μM) of starch and PEG capped silver nanoparticles 
on the amyloid secondary structure. CD spectra were performed, and MRE was measured. 
TEM analysis of AuNPPEG and AgNPPEG was analyzed and compared the effect of similar 
amount AuNPST and AgNPST (Figure 5.23 A & B and Figure 5.24 A & B). The results showed 
close correlation with our ThT analysis. We observed that both AuNPPEG and AgNPPEG 
produced less amount of amyloid fibers than respective starch capped NP. Therefore, TEM 
analysis further validated that PEGylation of metal NP enhanced the amyloid inhibition 
potential and showed high impact even at a lower concentration.  
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Table 6.1 The effect of different concentrations (0.1-1 μM) of AuNP (PEG and starch capped) on the 
secondary structure of amyloid samples 
 
Sample α-helix% β-strand% 
Amy 10 68 
AuNPPEG-Amy (0.1 μM) 11.6 58 
AuNPPEG-Amy (0.2 μM) 12 39 
AuNPPEG-Amy (0.5 μM) 13 38 
AuNPPEG-Amy (1 μM) 13 38 
AuNPST-Amy (0.1 μM) 7 62 
AuNPST-Amy (0.2 μM) 7 41 
AuNPST-Amy (0.5 μM) 6 40 
AuNPST-Amy (1 μM) 6 49 
 
Table 6.2 The effect of different concentrations (0.1-1 μM) of AuNP (PEG and starch capped) on the 
secondary structure of amyloid samples 
 
Sample %α-helix %β-strand 
Amy 10 68 
AgNPPEG-Amy (0.1 μM) 11 48 
AgNPPEG-Amy (0.2 μM) 12 39 
AgNPPEG-Amy (0.5 μM) 13 38 
AgNPPEG-Amy (1 μM) 13 30 
AgNPST-Amy (0.1 μM) 7 58 
AgNPST-Amy (0.2 μM) 7 54 
AgNPST-Amy (0.5 μM) 6 51 
AgNPST-Amy (1 μM) 6 51 
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Figure 6.23 Effect of different concentrations (1 μM) of starch and PEG capped AuNP on the amyloid 
growth. 
 
Figure 6.24 Effect of different concentrations (1 μM) of starch and PEG capped AgNP on the amyloid 
growth.  
Therefore, the results showed that AuNP and AgNP both have the potential to inhibit the 
amyloid growth to a different extent while amyloid growth inhibition potential can be enhanced 
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by variation in nanoparticle material, surface properties using a various capping agent, dose, 
and administration time.  
6.3.10 Effect of amyloid in cellular toxicity 
It was already reported that amyloids cause ROS generation that might be the reason behind 
high toxicity to cells [117, 215, 216]. To analyze the toxicity of amyloid prepared with NP, we 
measured the cellular toxicity of amyloid samples in N2a (mice neural cell line) and HaCaT 
(human keratinocyte) cells. The cell viability assay was performed by standard MTT assay 
after 24 h post administration and expressed as percentage cell viability. We observed that pure 
amyloid caused 78% and ~80% cell death in HaCaT and N2a cells, respectively, while amyloid 
formed with different AuNP (starch and PEG capped) showed a cell death of 21 %, and 19%, 
respectively in N2a cells (Figure 6.25 A) and 19%, 18%, respectively in HaCaT cells (Figure 
6.26 A). A similar assay was also performed with 50 μM (optimized concentration) of AgNPST 
and AgNPPEG, which showed cellular death in both the cells of 28% and 18% in N2a cells and 
16 % and 18% in HaCaT (Figure 6.26. A and Figure 6.27. A) respectively. Therefore, it was 
clearly proved that AuNP and AgNP not only reduced the quantity and changed the structure 
of amyloid but also reduced their cytotoxicity. The results also supported our previous 
observation that protein aggregates produced with NP results lower amount of cross β-sheet 
and fragmented fibrillar bodies, which were perhaps the reasons of causing reduced level of 
toxicity. 
The above results also support our earlier observations of reduced cross β-sheet amount and 
fibrillar bodies of protein amyloids produced with both AuNP and AgNP, which were perhaps 
the reasons of causing reduced level of toxicity. Bieschke et al.[217] reported that mature α-
synuclein and its fibrils are toxic to the PC12 cells while polyphenol (-)-epi-gallocatechine 
gallate (EGCG) treatment reduces the cellular toxicity by remodeling of fibrils and reducing 
β-sheet formation. Therefore, here perhaps lack of formation of mature fibrils reduced cellular 
toxicity. Moreover, capping of AuNP and AgNP with PEG showed a reduced cellular toxicity 
for HaCaT and N2a cells, respectively. The reason was perhaps having the biocompatibility of 
PEG capped NP, which enhanced the anti-amyloid potential and reduced cellular toxicity and 
hence, amyloid-mediated cellular toxicity. 
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Moreover, we already observed that amyloid sample possessed high surface hydrophobicity. 
The reason is the misfolding of the protein which exposes hydrophobic residues on its surface 
that further trigger aggregation through hydrophobic interaction. Here, in our present study, 
we observed that samples are having a lower amount of surface hydrophobicity showed a 
reduced ROS generation and cellular death. In fact, Mannini et al.[218] recently reported that 
cellular toxicity of amyloid sample varies with surface hydrophobicity of protein oligomers .  
 
Figure 6.25 Cellular viability analysis of amyloid samples in (A) N2a cells (B) N2a in the presence of 
5 mM NAC, amyloid samples were prepared in the presence of different AuNP (starch and PEG 
capped), AgNP (starch and PEG capped). Gallic acid was used as positive control for analysis of ROS 
based death. Percentage error was within 5%. 
 
Figure 6.26 Cellular viability analysis of amyloid samples in (A) HaCaT cells (B) HaCaT in the 
presence of 5 mM NAC, amyloid samples were prepared in the presence of different AuNP (starch and 
PEG capped), AgNP (starch and PEG capped). Gallic acid was used as positive control for analysis of 
ROS-based death. Data were produced in triplicate and error is within 5%. 
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Further, to estimate ROS generation by cells, we administered N-acetyl cysteine (NAC), an 
ROS inhibitor and gallic acid (ROS-mediated apoptosis inducing agent) a positive control in 
cell culture. When, we administered NAC (5 mM) at 0 h in cells, and cell viability assay was 
performed after 24 h, the MTT assay demonstrated a cell death within 10% in both cells for 
pure amyloid while gallic acid showed only 16% cell death (Figure 6.25 B for N2a and Figure 
6.26 B for HaCaT) after 24 h post administration. These results indicated that amyloid and 
gallic acid predominantly caused ROS-mediated apoptotic cell death. However, when NAC 
was administered, all the NP samples showed the ignorable level of cellular toxicity in both 
cells indicated that the cell death by pure NPs was caused by ROS generation. Rest 10-12% 
cell death, was perhaps due to other kinds of cell death mechanism. Therefore, from our cell 
viability assay, we demonstrated that HEWL amyloid was highly toxic to both N2a cells and 
HaCaT cells and such toxicity was predominantly caused by ROS generation. However, when 
amyloid was produced in the presence of AuNPST and AgNPST, such toxicity was reduced 
significantly, while AuNPPEG and AgNPPEG demonstrated minimum cell death (10%) (Figure 
6.26 A, & C). Such drop of toxicity was perhaps associated with the interaction of both the NP 
with amyloid forming HEWL molecules (probably through hydrophobic interaction), which 
further produced higher amount of thin, shorter fibers and loose aggregates rather than long 
and thick (toxic) fibers, which also reduced the ROS-dependent toxicity of both NP and 
amyloid.  
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CHAPTER 7 
NANO ZINC OXIDE EFFECT ON FIBRILLAR GROWTH OF 
LYSOZYME AMYLOID AND ITS CELLULAR TOXICITY  
7.1 Methods 
7.1.1 ZnONP synthesis and characterization 
For this study, uncapped zinc oxide nanoparticles (ZnONP) was synthesized and 
characterization method described in detail in chapter 4 (section 4.3 & 4.4). 
7.1.2 Preparation of amyloid and Characterization 
 Described in detail in chapter 6 (section 6.1.2-7.1.10).  
7.1.3 Cytotoxicity assay  
To study the cytotoxicity of HEWL amyloid samples prepared under different conditions, we 
applied them to two different cell lines; mice neuroblastoma (N2a) cells and human 
keratinocyte (HaCaT) cells. Cells were cultured in Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% fetal bovine serum. The cells (2000 cells/well) were 
inoculated in a 96-well plate at 37 0C for 24 h. Various amyloid samples prepared with 
ZnONPuncap, ZnONPST, and ZnONPassmb (50 μM), were applied in triplicates and cytotoxicity 
was estimated after 24 h of administration. After incubation, MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyl-2H-tetrazolium bromide) assay was performed as described by Risset et al. 
[219] using MTT kit (Himedia). MTT was added to a final concentration of 0.5 mg/ml and 
cells were incubated for 2 h. The excess formazan was dissolved in DMSO, and the absorbance 
was measured at 570 nm within 1 h and viability percentage was calculated by dividing the 
absorbance of treated cells with control cells. To analyze the ROS-dependent cell death, we 
administered 5 mM of N-acetyl cysteine (NAC) at 0 h in the cell culture, and cell viability was 
analyzed. Gallic acid (50 µM) was also used as positive control after 24 h post-administration.  
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7.2 Results and Discussion 
7.2.1 ZnONP synthesis and characterization 
ZnONPs were synthesized as per the protocol described in the ‘Materials and methods’ section. 
The synthesized NPs were found to be spherical in shape (Figure S1. A, B, and C) as revealed 
by electron microscopy and average hydrodynamic size of ZnONPuncap, ZnONPST, and 
ZnONPassmb were estimated to be 15, 30, and 163 nm, respectively. Zeta potential values were 
also estimated to be -19.6 (ZnONPuncap), -26.9 (ZnONPST) and -15.5 mV (ZnONPassmb), which 
concluded that ZnONPST possessed the highest stability among all (see Figure 4.17 and 4.21 in 
chapter-4). 
7.2.2 Amyloid formation with ZnONP 
 In order to obtain the size distribution of amyloid samples, we performed DLS analysis of all 
the samples. It showed two independent peaks; one was around 100 nm, and another broad 
peak was at 600 nm (See Appendix Figure S42). It signified the presence of both small as well 
as large aggregates (See Appendix Figure S42). Further, we analyze the effect of all three 
forms of ZnONP on the amyloid formation using various biophysical techniques. When 
samples were analyzed by tryptophan (Trp) fluorescence spectroscopy, we observed that the 
fluorescence intensity of amyloid was quenched drastically for all the samples. Further, the 
fluorescence spectra showed red shift for ZnONPST and ZnONPassmb while amyloid formed 
with ZnONPuncap and none showed a slight blue shift of λmax (Figure 7.1 A). All these results 
indicated the drastic change of environment around Trp residue due to the interaction with NP, 
which might also be associated with fluorescence quenching by ZnONP. 
The amyloid formation of all HEWL (7 μM) samples was monitored using Thioflavin-T (ThT) 
(10 μM) fluorescence. The protein samples were excited at 440 nm and emission was analyzed 
at 488 nm. We also observed that HEWL amyloid (formed with none) exhibited highest 
fluorescence intensity; however, amyloid formed with all ZnONP showed reduced 
fluorescence intensity while ZnONPST showed maximum fluorescence drop (Figure 7.1 B). 
The protein bound ThT fluorescence is normally considered an indicative of cross β-sheet 
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contents in amyloid, hence, the results revealed that the administration of ZnONP caused the 
inhibition of forming cross β-sheet structure. The secondary structure of amyloid samples was 
also analyzed by CD spectroscopy to quantify the β-sheet formation (original spectra in Figure 
S3). Amyloid samples prepared with ZnONPuncap and ZnONPassmb showed 57% and 54% β-
sheet structure, while the amount of β-sheet in amyloid formed with ZnONPST was estimated 
only 44% and the value was indeed lowest among all amyloid samples (Figure 7.1 C) (see CD 
spectra in Appendix Figure S43). Moreover, when we measured the surface charge of amyloid 
samples, we found that zeta (ζ)-potential of amyloid formed with ZnONP showed much higher 
(>30 mV) values than pure amyloid while ZnONPST showed the highest stability (see Figure 
7.1 D). It is assumed that the ζ-potential with a value of more than 30 shows high stability; 
hence, the sample showed the strong stability of amyloid sample when to interact with 
ZnONPST. The results also indicated a lower chance of further reaction of fiber formation in 
the presence of ZnONP due to higher charge repulsion. 
 
Figure 7.1 The effect of ZnONPuncap, ZnONPST, and ZnONPassmb on the HEWL amyloid formed after 
72 h. The ZnONP was administered at t=0 h. (A) Tryptophan fluorescence, (B) Thioflavin-T 
fluorescence, (C) % β-sheet contents of various samples estimated from Circular dichroism spectra, (D) 
zeta (ζ)-potential, (E) ANS fluorescence, of various amyloid samples. 
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Further, we analyzed the effect of three different forms of ZnONP on the stability of amyloid 
by analyzing the surface hydrophobicity. We found that amyloid formed without NP showed 
the highest hydrophobicity, while amyloid samples formed with all three ZnONP showed 
lower hydrophobicity (Figure 7.1 E) (ZnONPST showed the lowest hydrophobicity). Vetri et 
al. [120] reported that during the amyloid formation process, new hydrophobic regions are 
spontaneously formed for fast interaction. Therefore, here ZnONP perhaps interacted with 
hydrophobic sites of proteins and subsequently inhibits the amyloid growth. 
7.2.3 Microscopic analysis of amyloid formation 
 The AFM images showed the formation of amyloid fibers under different conditions (Figure 
7.2 A-D). It showed that amyloid formed with ZnONPuncap and ZnONPassmb consists of loose 
aggregates with a small fraction of fiber production (Figure 7.2 B & D) while amyloid sample 
formed with ZnONPST demonstrated reduced amount of protein aggregates and almost no fiber 
formation (Figure 7.2 C). The overall result proved that ZnONP prevented the formation of 
fibrillar structure/amyloid to a different extent. Moreover, the growth of amyloid depends on 
the surface property of ZnONP used (ZnONPuncap, ZnONPST, and ZnONPassmb) that interact 
with the protein under the same conditions. 
7.2.4 Effect of nanoparticle doses on amyloid formation  
Further, we analyzed the effect of different concentrations of ZnONP on amyloid formation. 
We administered 1.0, 2.0, 5.0, 10, and 20 μM of NP with 70 μM of protein and incubated for 
72 h at 58 ⁰C. We found that with the increase of NP concentration, the ThT fluorescence 
intensity was decreased (Figure 7.3 A-C) with ZnONPST caused the maximum effect. Further, 
secondary structural components were estimated using CD spectroscopy, which revealed a 
reduction in β-sheet of all samples while amyloid formed with ZnONPST showed the maximum 
drop (68% to 39%) (Figure 7.3 D-F). 
This finding further generated curiosity that why ZnONPuncap and ZnONPassmb demonstrated 
lower potential to prevent amyloid formation compared to ZnONPST under same concentration. 
Since NP and protein interaction is an interfacial phenomenon and can change the surface 
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properties of protein, it is essential to know the factors that are responsible for the 
concentration-based effect on amyloid growth. Hence, we further analyzed the surface 
hydrophobicity, zeta (ζ)-potential and aggregation index of amyloid samples for all the 
concentration of NP.  
 
Figure 7.2 The effect of ZnONPuncap, ZnONPST, and ZnONPassmb on the HEWL amyloid growth until 
72 h. The ZnONP was administered at t=0 h. Amyloid formed in the presence of (A) none (B) 
ZnONPuncap, (C) ZnONPST, and (D) ZnONPassmb. Scale bar is equal to 0.5 µm. 
Figure 3G showed that increase of ZnONP (uncap/assembly) concentration caused an initial 
increase in positive ζ-potential of amyloid but decrease at higher concentrations (> 10 μM) 
except ZnONPST that showed an increase of ζ-potential with increasing NP concentration. 
However, when we increase the concentration of ZnONPuncap and ZNONPassmb, it demonstrated 
reduction of surface hydrophobicity (Figure 3H) and such decrease was highest for an amyloid 
sample formed with ZnONPST. A similar effect was also observed when we measured 
aggregation index (AI) by dual angle analysis of dynamic light scattering (DLS) and calculated 
the AI. Here ZnONPST also demonstrated maximum reduction of AI compared to other 
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amyloid samples formed with ZnONPuncap and ZnONPassmb (Figure 7.3 I), collectively, 
indicates strong inhibition potential of amyloid formation. 
 
Figure 7.3 Thioflavin-T fluorescence assay of amyloid samples produced in the presence of different 
concentrations (1-20 μM) of ZnONP: (A) ZnONPuncap, (B) ZnONPST, and (C) ZnONPassmb. (D)-(F) 
showed CD spectra of the same samples. The change in β-sheet contents was also reported in the plot. 
(G) ζ-potential analysis of amyloid samples with different concentration of ZnONP (uncap, capped, 
and assembly). (H) Surface hydrophobicity analysis of amyloid samples using ANS. (I) Aggregation 
index of amyloid samples with different concentration of NP. 
Galvagnion et al. [179 ] and Radic et al. [187] already reported that NP and protein interaction 
reduced the free protein concentration in solution [210, 220] Therefore, when the interaction 
between NP and protein is strong, NP inhibits the amyloid growth both in solution and on NP 
surface at all NP concentrations. However, when interaction is relatively weak, amyloid 
formation depends on the concentration of NP administrated in the solution. Here, we observed 
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a concentration-dependent inhibition of amyloid growth by all ZnONP; however, highest 
amyloid inhibition was observed by ZnONPST. 
In order to observe the amyloid fibrillar structure under three different concentrations of 
ZnONP (5, 10 and 20 µM), we analyzed TEM images of different amyloid samples (Figure 
7.4). Amyloid formed with ZnONPuncap and ZnONPassmb showed less number of thicker and 
shorter fibers when NP concentration was increased from 5 to 20 µM (Figure 7.4 A-A2 & C-
C2). However, the amyloid formed in the presence of ZnONPST revealed thin fibers at 5 µM, 
however predominantly non-fibrillar aggregates at 10 and 20 µM (Figure 7.4 B, B1 & B2). All 
above results collectively established that the administration of ZnONPST inhibited the 
formation amyloid fiber most efficiently. 
7.2.5 Growth kinetics of amyloids 
Further, we also analyzed the growth kinetics of amyloid by ThT, ANS fluorescence, ζ-
potential and CD spectroscopy analysis. The amyloid formation in the presence of NP 
(ZnONPuncap, ZnONPST, and ZnONPassmb) was analyzed at the interval of 12 h until 120 h. The 
area under the curve in ThT spectra (original ThT spectra in Appendix Figure S44) was plotted 
with respect to growth time up to 120 h. The results showed that amyloid formed with 
ZnONPuncap and ZnONPassmb demonstrated shorter lag phase and longer log phase (Figure 7.5 
A) than amyloid formed with ZnONPST; however, all ZnONP showed longer lag phase than 
amyloid formed without NP (Figure 7.5 A), which was observed by lower protein bound ThT 
fluorescence intensity. Here, it was also found that all ZnONP were able to reduce the amyloid 
formation with maximum effect demonstrated by ZnONPST (Figure 7.5 A), which indeed also 
supported our previous results 
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Figure 7.4 TEM image showed the effect of three different concentrations (5, 10 and 20 μM) of ZnONP 
on amyloid formation. (A)-(A2) ZnONPuncap; (B)-(B2) ZnONPST; (C)-(C2) ZnONPassmb. 
When we analyzed the time dependent surface ζ-potential at an interval of 12 h, we found that 
the surface charge reached a maximum at 48 h, which was indeed matching with the end of 
amyloid growth phase. ZnONPST demonstrated constant ζ-potential value after 48 h unlike 
other samples, indicates no further significant change of amyloid or its surface structure 
(Figure 7.5 B). 
We further analyzed the quantity of β-sheet in different amyloid samples during the growth 
process. We found that the formation of β-sheet was rapid during nucleation phase; however, 
slowed down afterward (Figure 7.5 C). Amyloid sample formed with ZnONPST was found to 
have lower percentage β-sheet contents (47%) and containing more irregular secondary 
structural components compared to other amyloid samples (β-sheet contents are 63% & 56% 
 141 
 
for amyloid formed with ZnONPuncap and ZnONPassmb) (Figure 7.5 C) while amyloid produced 
without NP showed 68% of β-sheet. Therefore, it was also concluded that inhibition of amyloid 
formation also associated with the drop of the β-sheet formation. 
Further analysis of FESEM also demonstrated that after 2 h of amyloid growth both amyloid 
formed without NP and with ZnONPST had shown smaller aggregates (Figure 7.6 A and C) but 
amyloid samples formed with ZnONPuncap and ZnONPassmb showed larger and more poly-
dispersed aggregates (Figure 7.6 B& D). After 36 h of growth, we observed that all samples 
formed amorphous (unstructured/loose) aggregates (Figure 7.6 A1, B1, C1, & D1). However, 
at 48 h, samples in the presence of ZnONPuncap showed denser fibers while ZnONPassmb showed 
both fibers and amorphous (unstructured/loose) aggregates (Figure 7.6 A2, B2, C2, & D2). In 
contrary, pure amyloid showed long fiber formation (Figure 7.6 A2). 
 
Figure 7. 5 Plot of (A) ThT fluorescence intensity at 488 nm. (B) zeta (ζ)-potential, (C) % β-sheet of 
amyloid samples with a time of amyloid growth. The measurement was taken after 72 h of amyloid 
growth. (See ThT and CD spectra in Appendix Figure S43 and Figure S44, respectively).  
However, amyloid sample formed in the presence of ZnONPST results in higher amount of 
loose aggregates and fewer fibers (Figure 7.6 A2). After 72 h of amyloid growth, we found 
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that all samples except amyloid formed with ZnONPST showed dense fibers but amyloid 
formed with ZnONPST showed predominantly non-fibrillar (Figure 7.6 A3, B3, C3 & D3), 
which are also indicative of an inhibitory potential of ZnONPST in amyloid growth of HEWL. 
 
Figure 7.6 FESEM analysis of amyloid growth with time (2, 36, 48, and 72 h); (A-A3) without NP, 
(B-B3) with ZnONPuncap (C) with ZnONPST, (D) ZnONPassmb. ZnONPwas administered at 0 h. 
7.2.6 Effect of time of NP administration on amyloid structure 
We further attempted to understand the effect of various ZnONP administration time on 
amyloid growth. We administered NP at 0, 36 and 48 h (Figure S46) in amyloid samples and 
samples were analyzed after 72 h. From FESEM imaging (Figure S47) we observed that 
inhibitory effect towards amyloid fibrillation of HEWL was still highest when NP was 
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administered at 0 h. When administered at 36 and 48 h, from Figure S46, it was found that all 
three ZnONP produced HEWL amyloid fibers. Therefore, we concluded that administration at 
0 h,i.e., in the lag phase produced highest inhibitory effect, and this fact indeed supports our 
hypothesis that prolonged lag phase and shorter elongation phase perhaps the key behind the 
inhibitory mechanism induced by ZnONPST. 
Therefore, so far we observed that our ZnONP in three different forms could inhibit the HEWL 
amyloid fibrillation to various extents. Nanoparticle plays a multifaceted role, which depends 
on the properties of nanoparticle surface as well as a protein of interest. The variations of these 
factors also vary the effect of nanoparticle on amyloid formation. The three different form of 
ZnONP, which was made up of core size of 10-15 nm and having varying size due to surface 
capping and formation of self-assembly of ZnONP of 10-15 nm core size. Moreover, self-
assembly of NP by starch altered the effect of NP on cellular toxicity and amyloid growth. In 
fact, Linse et al. and Cabaleiro-Lago et al. reported that the effect of nanoparticle on the 
amyloid growth depends on the various factors such as binding strength, NP to protein ratio 
on the surface, intrinsic stability and aggregation propensity of protein, surface hydrophobicity 
of NP [37, 153]. The catalytic and inhibitory effects of NPs were most pronounced with the 
least hydrophobic nanoparticles. Therefore, nanoparticles show dual role, catalyzing and 
inhibition, which depends on the inherent stability of protein, nanoparticle surface properties, 
protein to nanoparticle ratio, and strength of interaction. The variations of these factors also 
change the effect of nanoparticles on amyloid formation.  
7.2.7 Cellular toxicity assay 
 Amyloid has already been reported to be highly toxic to cells, which were mediated via ROS 
generation [117, 215, 216]. To analyze, the death mechanism, here we analyzed the cellular 
toxicity of amyloid samples (70 μM) (formed in the presence of three different ZnONP 
samples) in N2a (mice neural cell line) and HaCaT (human keratinocyte) cells. The cell 
viability assay was performed by standard MTT assay after 24 h post administration and 
expressed as percentage cell viability. We observed that pure amyloid caused 78% and ~80% 
cell death in HaCaT and N2a cells, respectively, while amyloid formed with different ZnONP 
(ZnONPuncap, ZnONPST, and ZnONPassmb) showed a cell death of 21%, 8%, and 29%, 
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respectively in HaCaT cells and 24%, 12% and 22% respectively in N2a cells (Figure 7A & 
C). Similar assay was also performed with 50 μM (optimized concentration) of ZnONPuncap, 
ZnONPST, and ZnONPassmb, which showed toxicity in both the cells (Figure 7.7 A) while 
ZnONPST showed minimum (~ 9% in HaCaT and 16% in N2a cell death) cellular toxicity. 
Therefore, it was clearly proved that all three ZnONP not only changed the quantity and 
structure of amyloid (see Figure 7.4, 7.5 and 7.6) but also reduced their cytotoxicity. The results 
also support our earlier observation that protein aggregates produced with ZnONP results 
lower amount of cross β-sheet (Figure 7.7 A-C) and thick fibrillar bodies, which were perhaps 
the reasons of causing reduced level of toxicity.  
Further, to estimate ROS generation by cells, we administered N-acetyl cysteine (NAC), an 
ROS inhibitor and gallic acid (ROS mediated apoptosis-inducing agent, a positive control) in 
culture [221]. When, we administered NAC (5 mM) at 0 h in cells, and cell viability assay was 
performed, the MTT assay demonstrated a cell death within 10% in both cells for pure amyloid 
(Figure 7.7 B & D) while gallic acid showed only 5-6% cell death (Figure 7.7 B & D) after 24 
h post administration. These results indicate that amyloid and gallic acid predominantly caused 
ROS mediated apoptotic cell death. However, when NAC was administered, all three ZnONP 
samples showed ignorable level of cellular toxicity in both cells indicated that the cell death 
by pure ZnONPs was caused by ROS generation (Figure 7.7 A, B, C, and D). Rest 12-15% 
cell death which still occurred was perhaps due to other kinds of cell death mechanism. 
Therefore, from our cell viability assay, we proved that HEWL amyloid was highly toxic to 
both N2a cells and HaCaT cells and such toxicity was predominantly caused due to ROS 
generation. However, when amyloid was produced in the presence of ZnONP, such toxicity 
was reduced significantly while ZnONPST demonstrated lowest cell death (10%) (Figure.7.7 
A & C). Such drop of toxicity was perhaps associated with the interaction of ZnONP with 
amyloid forming HEWL molecules (probably through hydrophobic interaction), which further 
produced higher amount of thin, shorter fibers and loose aggregates rather than long and thick 
(toxic) fibers. Further, it was perhaps the interaction between HEWL with ZnONP (uncap, 
assembly) which also lessen the ROS dependent toxicity of both NP and amyloid. 
 145 
 
From here, we proposed a mechanism to demonstrate how the interaction of three different 
forms of ZnONP with HEWL produced fibrillar amyloids and aggregates of different 
proportion (Figure 7.8). Although three forms of ZnONP caused the change of amyloid 
structure by altering fiber thickness and length, ZnONPST was observed to reduce the β-sheet 
formation and toxicity in both cells (N2a, and HaCaT) maximally.  
The above results also support our earlier observations of reduced cross β-sheet amount and 
fibrillar bodies of protein amyloids produced with ZnONP (see Fig. 7.4A-C), which were 
perhaps the reasons of causing reduced level of toxicity. Bieschke et al. [217] reported that 
mature α-synuclein and its fibrils are toxic to the PC12 cells while polyphenol (-)-epi-
gallocatechine gallate (EGCG) treatment reduces the cellular toxicity by remodeling of fibrils 
and reducing β-sheet formation .Therefore, here perhaps lack of formation of mature fibrils 
reduced cellular toxicity. Moreover, capping of ZnONP with starch showed a cellular toxicity 
to 9% and 16% for HaCaT and N2a cells, respectively. However, formation of starch mediated 
self-assembly by ZnONP (ZnONPassemb) could not mitigate the cellular toxicity below 26% for 
HaCaT and 24% for N2a. The reason was perhaps having the largest size (avg size is 163 nm) 
of all ZnONPs used in our study which reduces surface to volume ratio and hence, the surface 
activity towards amyloid inhibition as well as toxicity. 
Moreover, we already observed that amyloid sample possessed high surface hydrophobicity. 
The reason is the misfolding of the protein which exposes hydrophobic residues on its surface 
that further trigger aggregation through hydrophobic interaction. Here, in our present study, 
we observed that samples having lower amount of surface hydrophobicity (amy@ZnONPST, 
amy@ZnONPuncap, and amy@ZnONPassmb) showed a reduced ROS generation and cellular 
death. In fact, Mannini et al. [218] recently reported that cellular toxicity of amyloid sample 
varies with surface hydrophobicity of protein oligomers . 
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Figure 7.7 The effect of ZnONP (uncapped, starch capped, self-assembly), native lysozyme (HEWL), 
amyloid (Amy), amyloid formed in the presence of various ZnONP (50 μM) was analyzed on the 
cellular toxicity. Gallic acid was used as a positive control for ROS-based apoptotic death. Cell viability 
analysis was performed in (A) HaCaT cells (B) HaCaT cells in the presence of N-acetyl cysteine (5 
mM), an ROS scavenger. (C) Mice neuroblastoma cell line (N2a) (D) N2a in the presence of N-acetyl 
cysteine.  
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Figure 7.8 Schematic representation of HEWL amyloid formation in the presence of three different 
types of ZnO nanoparticles (NP). (A) Amyloid is formed without NP having long and thick fibers. (B) 
Amyloid produced in the presence of ZnONPuncap demonstrated thin and fragmented fibers of HEWL 
that indicated that direct interaction of HEWL with ZnONP surface reduced the secondary deposition 
over fibers that caused the formation of thin fibers. (C) When HEWL interacts with densely starch 
capped ZnONP, inhibit the amyloid growth and produced less toxic aggregates by increased ζ-potential. 
(D) The presence of heterogeneous surface on the ZnONPassmb caused the production of flat fibers with 
some aggregates. Overall, the variation in surface of ZnONP was found to produce different 
morphology of HEWL aggregates and prevent amyloid fiber to different extent with ZnONPST having 
the highest effect. 
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CHAPTER 8 
CONCLUSION AND FUTURE WORK 
8.1 Conclusion 
In the present thesis, we studied in detail the molecular interaction of two monomeric proteins 
bovine α-lactalbumin (BLA), and hen egg white lysozyme (HEWL) with three different 
nanoparticles (NPs) gold, silver, and zinc oxide under various conditions to understand 
structural and functional change of the proteins and their conjugate formation. All three NPs 
were successfully synthesized using starch as capping as well as reducing agent with NaOH as 
a reaction accelerator. Further, we also synthesized PEG (poly ethyl glycol) capped AuNP 
(AuNPPEG) and AgNP (AgNPPEG), uncapped ZnONP and self-assembly of ZnONP by varying 
reaction parameters. The results showed that starch capped (AuNPST, AgNPST) and PEG 
capped (AuNPPEG and AgNPPEG) NP have size in between 15-25 nm while starch capped, 
uncapped, self-assembly of ZnONP have 25 nm, 10 nm, and 163 nm, respectively. All NPs 
were successfully characterized using FESEM, TEM, XRD, UV-Vis spectroscopy, DLS 
particle size analyzer, and zeta potential analysis for shape, size, and stability. Further, the 
surface activity of synthesized AuNP and AgNP were analyzed by measuring their heavy metal 
sensing and ZnONP by photocatalytic dye degradation potential.  
To, monitor the interaction of NPs with protein (BLA, and HEWL), we used various 
spectroscopic techniques such as fluorescence as well as circular dichroism spectroscopy for 
assessing structural changes of proteins. We concluded that both the proteins undergo 
substantial conformational change (tertiary as well as secondary) upon interactions. Further, it 
was revealed that the stability was also compromised in different stress conditions such as the 
presence of strong denaturant guanidine hydrochloride (0-6 M) and temperature. However, it 
was also observed that BLA in AgNPST-BLA and HEWL in ZnONPST-HEWL conjugates were 
become tolerant to proteinase-K while both the proteins did not demonstrate any resistance in 
other NP-proteins complex.  
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In the second phase, we also studied amyloid formation propensity of HEWL in the presence 
of NPs. The results showed that the presence AuNPST and AgNPST produced small fragments 
of amyloid fiber with aggregates while amyloid prepared with ZnONPST showed more 
amorphous aggregates. From amyloid growth analysis, it was observed that dose of NP and 
administration time played crucial role in amyloid growth inhibition and such inhibition was 
found to be substantial during the NP dose in nucleation phase of amyloid. It was also observed 
by circular dichroism (CD) spectroscopic analysis that such suppression effect of amyloid 
formation was associated with reduced β-sheet contents. Further, our investigation showed that 
surface capping agent also affected the amyloid inhibition potential of NP. The PEGylated 
AuNP and AgNP showed higher potential to inhibit amyloid growth than starch capped NP of 
equivalent size; however, amyloid inhibition potential of uncapped and self-assembly of 
ZnONP was lower than ZnONPST. Our study also concluded that HEWL amyloid was highly 
toxic to both N2a and HaCaT cells, however, when formed in the presence of NP, demonstrated 
a substantial reduction in toxicity. We further concluded that such toxicity, which was 
associated with ROS generation, was perhaps caused due to amyloid fiber formation.  
It was further observed that the effect of NP depends on the capping agent, dose of NP, and 
type of proteins. The inhibition potential of NP highly depends on the core material of NP; 
however, the amyloid growth inhibition potential of NP can be enhanced by varying the 
capping agent and administration time. From here, we concluded that although metal based NP 
altered the structure, function, and stability of proteins; their administration substantially 
inhibited the amyloid growth of HEWL and reduced the cellular toxicity caused by amyloid. 
Therefore, it was concluded that metal-based nanoparticles could be used in finding therapeutic 
approach in various neurodegeneration that are caused by protein amyloid deposition. 
8.2 Future Work 
The following may be proposed as future work. 
1. Similar study should also be done with other key proteins such as blood proteins 
(e.g. albumin, globulin, and fibrinogen etc.) and other cellular proteins. 
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2. In vivo NP-protein interaction should be studied in detail and the results that 
obtained from in vitro may be validated with in vivo study. 
3. Amyloid growth and subsequent NP-mediated effect on amyloid growth should be 
studied in disease carrying animal models for understanding the real impact of 
NPs.  
4. Other metal-based nanoparticles should also be studied. 
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APPENDIX: SUPPLEMENTARY DATA 
 
1. UV-VIS absorbance spectra of AuNP: 
 
Figure S1 the results showed the SPR peak shift and zeta potential of AuNP; (A) & (C) the effect of 
NaOH concentrations (4-8 mM) on SPR and zeta potential; (B) & (D) the effect of reaction temperature 
(60-80 ⁰C) on SPR and zeta potential  
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Figure S2 the results showed the SPR peak shift and zeta potential of AuNP; (A) & (C) the effect of 
various concentration of starch (0.2-1% w/v); (B) & (D) the effect of various concentration of HAuCl4 
(0.2-1% w/v).  
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Figure S3 (A) The effect of higher concentration of NaOH (7, 20, 50, 100 mM) on the size and 
ultimately to the surface plasmon resonance of AuNP. At higher concentration (20-100 mM) SPR 
become broad and showed red shift in comparison to 7 mMNaOH and color change from ruby red to 
deep violet and blue showed the size variation. (B) at lower concentration of starch (0.05%) when 
NaOH concentration was 6 mM produce bright violet color, it showed formation of larger nanoparticles, 
while at 3% starch deep ruby red color. SPR analysis showed red shift for AuNP with 0.05% starch. 
AuNP synthesized using corn starch with (C) NaOH and (D) D-glucose and NaOH.  
2. Semi-quantitative Benedict test for reducing sugar: 
The 1% starch samples were dissolved in water by heating in microwave for 1 min. After 
cooling to room temperature, the sample was divided into three parts and added 2, 4, 7 mM 
NaOH solution and heated for 20 min. After cooling to room temperature, equal volume of 
benedict solution was added and incubates in boiling water for 5 min and observes the color 
variation. The color variation of samples indicates the presence of reducing sugar in solution. 
Such variation was compared with respect to known concentrations (0.5, 1, 2, 3, 4 % w/v) of 
reducing sugar (D-glucose) (Figure S5 showed only 0.5 and 4% images).  
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Figure S4 Benedict test for starch. (a) Benedict solution, (b) 0.5% D-glucose with Benedict solution 
(c) 3% D-glucose with benedict solution. Different concentration of NaOH mixed with 1% starch 
solution and heated for 20 min (d) 2 mM NaOH, (e) 4 mM NaOH, (f) 7 mM NaOH.  The comparison 
of starch solution with known quantity of reducing sugar showed that 7 mM NaOH produced 
approximately 0.1-0.5% reducing species which act as reducing sugar in AuNP synthesis. 
3. Reaction mechanism of AuNP synthesis: 
Ji et al. (2007) and Zhang et al. (2008) reported that reaction of NaOH with auric chloride 
produce intermediate gold hydroxide that causes conversion of yellow color to transparent and 
the order of hydroxide increased from 1.0 to 4.0 with increasing the NaOH concentration. 
Moreover, higher order of Au(OH)x was responsible for the different redox potential and 
reduction rate of gold. 
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4. Retrogrdation of starch:  
 
Figure S5 Retro-gradation of starch by freezing thawing was shown. The bottom of the bottle showed 
retrograded starch (light pink color) with AuNP while dark ruby red color showed AuNP suspension 
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Zinc oxide nanoparticle 
5. Zeta potential analysis 
 
Figure S6 Zeta potential analysis of different samples. (A) Zeta potential of sample with different Zn 
(NO3)2 concentration (5, 10, 20, 50 mM), starch concentration (0.5, 1, 2, 3 % w/v), and calcination 
temperature (60, 70, 80 ⁰C). (B) The effect different Zn (NO3)2 concentration (5, 10, 20, 50 mM). The 
zeta potential of ZnONP prepared using 5 and 10 mM of Zn (NO3)2. (C) The effect different starch 
concentration (0.5, 1, 2, 3 % w/v). (D) The effect of different calcination temperature (60, 70, 80 ⁰C).  
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6. FESEM images of different stages of ZnONP synthesis:  
 
Figure S7 Self-assembly mechanism of ZnONP. The growth of the ZnONP was recorded at different 
time interval of the reaction before calcination (top images) and after calcination process (bottom 
images). 
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Metal based Nanoparticle protein interaction 
7. Effect of NP concentration in protein Fluorescence 
 
Figure S8 Fluorescence spectroscopy analysis of BLA with different molar ratio of AuNPST. (A) 
intrinsic fluorescence of BLA when excited at 295 nm. (B) Tyrosine fluorescence analysis in 
synchronous mode. (C) Tryptophan fluorescence analysis by synchronous fluorescence spectroscopy.  
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Figure S9 Fluorescence spectroscopy analysis of BLA with different molar ratio of AgNPST. (A) 
Intrinsic fluorescence of BLA when excited at 295 nm. (B) Tyrosine fluorescence analysis in 
synchronous mode. (C) Tryptophan fluorescence analysis by synchronous fluorescence spectroscopy. 
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. 
Figure S10 Fluorescence spectroscopy analysis of BLA with different molar ratio of ZnONPST. (A) 
intrinsic fluorescence of BLA when excited at 295 nm. (B) Tyrosine fluorescence analysis in 
synchronous mode. (C) Tryptophan fluorescence analysis by synchronous fluorescence spectroscopy.  
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Figure S11 Fluorescence spectroscopy analysis of HEWL with different molar ratio of AuNPST. (A) 
intrinsic fluorescence of HEWL when excited at 295 nm. (B) Tyrosine fluorescence analysis in 
synchronous mode. (C) Tryptophan fluorescence analysis by synchronous fluorescence spectroscopy. 
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Figure S12 Fluorescence spectroscopy analysis of HEWL with different molar ratio of AgNPST. (A) 
intrinsic fluorescence of HEWL when excited at 295 nm. (B) Tyrosine fluorescence analysis in 
synchronous mode. (C) Tryptophan fluorescence analysis by synchronous fluorescence spectroscopy.  
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Figure S13 Fluorescence spectroscopy analysis of HEWL with different molar ratio of ZnONPST. (A) 
intrinsic fluorescence of HEWL when excited at 295 nm. (B) Tyrosine fluorescence analysis in 
synchronous mode. (C) Tryptophan fluorescence analysis by synchronous fluorescence spectroscopy.  
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Figure S14 ANS binding with NP was analyzed. (A) ANS-AuNP, (B) ANS-AgNP, (C) ANS-ZnONP. 
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8. Effect of Guanidine hydrochloride 
 
 
Figure S15 Fluorescence spectroscopy analysis of BLA with different concentration of guanidine 
hydrochloride (GdnHCl). (A) Intrinsic fluorescence of BLA when GdnHCl concentration increased 
from 0-6 M. (B) intrinsic fluorescence of BLA incubated in 8 M GdnHCl and further diluted in 6-1 M 
GdnHCl. (C) showed variation in fluorescence emission peak with 0-6 M GdnHCl. 
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Figure S16 Fluorescence spectroscopy analysis of BLA conjugate with AuNPST in different 
concentration of guanidine hydrochloride (GdnHCl) and 100 mM DTT. (A) Intrinsic fluorescence of 
BLA when GdnHCl concentration increased from 0-6 M. (B) intrinsic fluorescence of HEWL incubated 
in 8 M GdnHCl and further diluted in 6-1 M GdnHCl. (C) showed variation in fluorescence emission 
peak with 0-6 M GdnHCl during unfolding and refolding. 
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Figure S17 Fluorescence spectroscopy analysis of HEWL with AuNPST in different concentration of 
guanidine hydrochloride (GdnHCl) and 100 mM DTT. (A) Intrinsic fluorescence of HEWL when 
GdnHCl concentration increased from 0-6 M. (B) intrinsic fluorescence of HEWL incubated in 8 M 
GdnHCl and further diluted in 6-1 M GdnHCl. (C) showed large variation in fluorescence emission 
peak with 0-6 M GdnHCl during unfolding and refolding. 
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Figure S18 Fluorescence spectroscopy analysis of BLA with AgNPST in different concentration of 
guanidine hydrochloride (GdnHCl) and 100 mM DTT. (A) Intrinsic fluorescence of BLA when 
GdnHCl concentration increased from 0-6 M. (B) intrinsic fluorescence of BLA incubated in 8 M 
GdnHCl and further diluted in 6-1 M GdnHCl. (C) showed variation in fluorescence emission peak 
with 0-6 M GdnHCl during unfolding and refolding. 
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Figure S19 BLA and LYS unfolding and folding in in Different concentration of GdnHCl (0, 1, 2, 4, 6 
M), at 25 0C. (A) unfolding of BLA, (B) refolding of BLA, (C) unfolding of HEWL, (D) refolding of 
HEWL.  
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Figure S20 BLA and LYS unfolding and folding in in Different concentration of GdnHCl (0, 1, 2, 4, 6 
M), at 25 0C. (A) Unfolding of BLA-AuNPST, (B) refolding of BLA-AuNPST, (C) unfolding of HEWL-
AuNPST, (D) refolding of HEWL-AuNPST. 
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Figure S21 Fluorescence spectroscopy analysis of HEWL with different concentration of guanidine 
hydrochloride (GdnHCl) and 100 mM DTT. (A) Intrinsic fluorescence of HEWL when GdnHCl 
concentration increased from 0-6 M. (B) intrinsic fluorescence of HEWL incubated in 8 M GdnHCl 
and further diluted in 6-1 M GdnHCl. (C) showed variation in fluorescence emission peak with 0-6 M 
GdnHCl during unfolding and refolding. 
 
 
 
 
 172 
 
 
 
Figure S22 Fluorescence spectroscopy analysis of HEWL with AgNPST in different concentration of 
guanidine hydrochloride (GdnHCl) and 100 mM DTT. (A) Intrinsic fluorescence of HEWL when 
GdnHCl concentration increased from 0-6 M. (B) intrinsic fluorescence of HEWL incubated in 8 M 
GdnHCl and further diluted in 6-1 M GdnHCl. (C) showed variation in fluorescence emission peak 
with 0-6 M GdnHCl during unfolding and refolding. 
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Figure S23 BLA and LYS unfolding and folding in in Different concentration of GdnHCl (0, 1, 2, 4, 6 
M), at 25 0C. (A) Unfolding of BLA-AgNPST, (B) refolding of BLA-AgNPST, (C) unfolding of HEWL-
AgNPST, (D) refolding of HEWL-AgNPST. 
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Figure S24 Fluorescence spectroscopy analysis of BLA with ZnONPassmb different concentration of 
guanidine hydrochloride (GdnHCl) and 100 mM DTT. (A) Intrinsic fluorescence of BLAwhen GdnHCl 
concentration increased from 0-6 M. (B) intrinsic fluorescence of BLA incubated in 8 M GdnHCl and 
further diluted in 6-1 M GdnHCl. (C) showed variation in fluorescence emission peak with 0-6 M 
GdnHCl during unfolding and refolding. 
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Figure S25 Fluorescence spectroscopy analysis of HEWL with ZnONPST in different concentration of 
guanidine hydrochloride (GdnHCl) and 100 mM DTT. (A) Intrinsic fluorescence of HEWL when 
GdnHCl concentration increased from 0-6 M. (B) intrinsic fluorescence of HEWL incubated in 8 M 
GdnHCl and further diluted in 6-1 M GdnHCl. (C) showed variation in fluorescence emission peak 
with 0-6 M GdnHCl during unfolding and refolding. 
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Figure S26 BLA and LYS with ZnONP, unfolding and folding in in Different concentration of GdnHCl 
(0, 1, 2, 4, 6 M) and 100 mM DTT, at 25 ⁰C. Moreover, refolding was performed by dilution of protein 
in 8 M GdnHCl solution to 6, 4, 2, 1 M in similar condition and final concentration of protein was 10 
μM in both cases. The result showed that AgNP facilitate BLA and LYS unfolding and refolding both 
the protein regain its initial confirmation easily. 
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Effect of Heating on Protein 
 
Figure S27 Fluorescence spectroscopy analysis of BLA-AuNPST, when sample was incubated at differ 
temperature (25-60 0C). (A) Intrinsic fluorescence of BLA when temperature increased from 25-60 0C 
with increment of 5 0C. (B) Intrinsic fluorescence of BLA when temperature decreased from 60-25 0C 
with decrement of 5 0C. 
 
Figure S28 Fluorescence spectroscopy analysis of BLA-AgNPST, when sample was incubated at differ 
temperature (25-60 0C). (A) Intrinsic fluorescence of BLA when temperature increased from 25-60 0C 
with increment of 5 0C. (B) Intrinsic fluorescence of BLA when temperature decreased from 60-25 0C 
with decrement of 5 0C. 
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Figure S29 Fluorescence spectroscopy analysis of BLA-ZnONPST, when sample was incubated at 
differ temperature (25-60 ⁰C). (A) Intrinsic fluorescence of BLA when temperature increased from 25-
60 ⁰C with increment of 5 ⁰C. (B) Intrinsic fluorescence of BLA when temperature decreased from 60-
25 ⁰C with decrement of 5 ⁰C. 
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CD Spectroscopy 
 
Figure S30 Circular dichroism spectroscopy analysis of BLA, when sample was incubated at differ 
temperature (25-60 ⁰C). (A) Variation in spectra of BLA when temperature increased from 25-60 ⁰C 
with increment of 5 ⁰C indicated the secondary structural changes due increment of temperature. (B) 
Temperature dependent refolding of BLA when temperature decreased from 60-25 ⁰C with decrement 
of 5 ⁰C. 
 
 
Figure S31 Circular dichroism spectroscopy analysis of AuNPST-BLA, when sample was incubated 
at differ temperature (25-60 ⁰C). (A) variation in spectra of BLA when temperature increased from 25-
60 ⁰C with increment of 5 ⁰C indicated the secondary structural changes due increment of temperature. 
(B) Temperature dependent refolding of BLA when temperature decreased from 60-25 ⁰C with 
decrement of 5 ⁰C. 
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Figure S32 Circular dichroism spectroscopy analysis of AgNPST-BLA, when sample was incubated 
at differ temperature (25-60 ⁰C). (A) variation in spectra of BLA when temperature increased from 25-
60 ⁰C with increment of 5 ⁰C indicated the secondary structural changes due increment of temperature. 
(B) Temperature dependent refolding of BLA when temperature decreased from 60-25 ⁰C with 
decrement of 5 ⁰C. 
 
Figure S33 Circular dichroism spectroscopy analysis of ZnONPST-BLA, when sample was incubated 
at differ temperature (25-60 ⁰C). (A) variation in spectra of BLA when temperature increased from 25-
60 ⁰C with increment of 5 ⁰C indicated the secondary structural changes due increment of temperature. 
(B) Temperature dependent refolding of BLA when temperature decreased from 60-25 ⁰C with 
decrement of 5 ⁰C. 
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Fluorescence spectroscopy 
 
Figure S34 Fluorescence spectroscopy analysis of HEWL-AuNPST, when sample was incubated at 
differ temperature (25-60 ⁰C). (A) Intrinsic fluorescence of HEWL when temperature increased from 
25-60 ⁰C with increment of 5 ⁰C. (B) Intrinsic fluorescence of HEWL when temperature decreased 
from 60-25 ⁰C with decrement of 5 ⁰C. 
 
Figure S35 Fluorescence spectroscopy analysis of HEWL-AgNPST, when sample was incubated at 
differ temperature (25-60 ⁰C). (A) Intrinsic fluorescence of HEWL when temperature increased from 
25-60 ⁰C with increment of 5 ⁰C. (B) Intrinsic fluorescence of HEWL when temperature decreased 
from 60-25 ⁰C with decrement of 5 ⁰C. 
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Figure S36 Fluorescence spectroscopy analysis of HEWL-ZnONPST, when sample was incubated at 
differ temperature (25-60 ⁰C). (A) Intrinsic fluorescence of HEWL when temperature increased from 
25-60 ⁰C with increment of 5 ⁰C. (B) Intrinsic fluorescence of HEWL when temperature decreased 
from 60-25 ⁰C with decrement of 5 ⁰C. 
 
CD spectroscopy 
 
Figure S37 Circular dichroism spectroscopy analysis of HEWL, when sample was incubated at differ 
temperature (25-60 ⁰C). (A) Variation in spectra of HEWL when temperature increased from 25-60 ⁰C 
with increment of 5 ⁰C indicated the secondary structural changes due increment of temperature. (B) 
Temperature dependent refolding of HEWL when temperature decreased from 60-25 ⁰C with 
decrement of 5 ⁰C.  
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Figure S38 Circular dichroism spectroscopy analysis of HEWL with AuNPST, when sample was 
incubated at differ temperature (25-60 ⁰C). (A) Variation in spectra of HEWL when temperature 
increased from 25-60 ⁰C with increment of 5 ⁰C indicated the secondary structural changes due 
increment of temperature. (B) Temperature dependent refolding of HEWL when temperature decreased 
from 60-25 ⁰C with decrement of 5 ⁰C.  
 
 
Figure S39 Circular dichroism spectroscopy analysis of HEWL with AgNPST, when sample was 
incubated at differ temperature (25-60 ⁰C). (A) Variation in spectra of HEWL when temperature 
increased from 25-60 ⁰C with increment of 5 ⁰C indicated the secondary structural changes due 
increment of temperature. (B) Temperature dependent refolding of HEWL when temperature decreased 
from 60-25 ⁰C with decrement of 5 ⁰C. 
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Figure S40 Circular dichroism spectroscopy analysis of HEWL with ZnONPST, when sample was 
incubated at differ temperature (25-60 ⁰C). (A) Variation in spectra of HEWL when temperature 
increased from 25-60 ⁰C with increment of 5 ⁰C indicated the secondary structural changes due 
increment of temperature. (B) Temperature dependent refolding of HEWL when temperature decreased 
from 60-25 ⁰C with decrement of 5 ⁰C.  
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Proteinase-K digestion: 
 
Figure S41 Proteinase-K digestion assay of various NP-BLA conjugates, 20 μl of all loading sample 
contains 20 μg of BLA. (A) AuNPST-BLA, (B) ZnONPST –BLA. 
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Amyloid-nanoparticle interaction 
 
Amyloid hydrodynamic size analysis:  
 
Figure S42 The DLS analysis of amyloid samples (Amy, Amy-ZnONPuncap, Amy-ZnONPST, Amy-
ZnONPassemb) prepared in the presence of (A) none, (B) ZnONPuncap, (C) ZnONPST, (D) ZnONPassmb.  
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Far-UV circular dichroism (CD) spectral measurement of various amyloid samples: 
 
Figure S43. Circular dichroism spectroscopic analysis of different amyloid samples (Amy, Amy-
ZnONPuncap, Amy-ZnONPST, Amy-ZnONPassmb) prepared with ZnONP (uncap, starch capped, and 
assembly). The amyloid synthesis protocol was given in ‘Materials and methods’ section. 
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Time dependent ThT fluorescence spectral measurement of various amyloid samples 
 
 
Figure S44 Thioflavin-T analysis of amyloid samples (Amy, Amy-ZnONPuncap, Amy-ZnONPST, Amy-
ZnONPassmb) at every 12 h time interval and up to 120 h. (A) amyloid without NP (Amy), (B) Amy-
ZnONPuncap, (C) Amy-ZnONPST, (D) Amy-ZnONPassmb. 
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Time dependent CD spectral measurement of various amyloid samples: 
 
Figure S45 Circular dichroism spectral analysis of different amyloid samples (Amy, Amy-ZnONPuncap, 
Amy-ZnONPST, Amy-ZnONPassmb) with growth period of amyloid formation (h). (A) amyloid without 
NP (Amy), (B) Amy-ZnONPuncap, (C) Amy-ZnONPST, (D) Amy-ZnONPassmb. 
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Effect of administration time of ZnONP on amyloid formation monitored by zeta 
potential, ThT, and ANS fluorescence measurement: 
 
Figure S46 Measurement of zeta potential, hydrophobicity (measured at 350 nm) and Thioflavin-T 
fluorescence intensity (measured at 440 nm) of various amyloid samples (Amy-ZnONPuncap, Amy-
ZnONPST, Amy-ZnONPassmb). ZnONPuncap, ZnONPST and ZnONPassmb of 10μM were administered 
during nucleation, elongation and maturation phase of amyloid growth. (A) Amy-ZnONPuncap, (B) 
Amy-ZnONPST, (C) Amy-ZnONPassmb. 
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Effect of administration time of ZnONP on amyloid formation monitored by FESEM 
imaging 
 
Figure S47 FESEM analysis of various amyloid samples and morphological changes due to variation 
in administration time (nucleation, elongation, and maturation phase); administration of (A) 
ZnONPuncap, (B) ZnONPST and (C) ZnONPassmb during elongation phase (36 h); Administration of (A1) 
ZnONPuncap (B1) ZnONPST and (C1) ZnONPassmb during maturation phase (48 h). 
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